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Abstract 
 
  Members of the basic helix-loop-helix (bHLH) proneural family of 
proteins, including Mash1, are crucial transcription factors (TFs) in 
neurogenesis. More recently, a role for Mash1 in the specification of 
oligodendrocyte precursor cells (OPCs) has been demonstrated. Here we 
investigate the role of Mash1 in lineage commitment of neural progenitors and 
more specifically the mechanisms underlying Mash1 activity in oligodendroglial 
cell fate specification.  
 
  We use an in vitro cell culture system to perform Mash1 locational 
analysis. Mouse OPCs were cultured as oligospheres that expressed Mash1, a 
proportion of which also coexpressed the early OPC marker platelet-derived 
growth factor receptor  (PDGFR) and oligodendrocyte promoting TFs 
including the bHLH TF Olig2 and the high mobility group (HMG) TF Sox9. We 
use a chromatin immunoprecipitation (ChIP)-on-chip strategy and found that 
Mash1 protein binds to proximal genomic regions of early OPC genes such as 
Olig1 and Sox8, late oligodendrocyte genes including myelin oligodendrocyte 
glycoprotein (Mog) and oligodendrocyte myelin glycoprotein (Omg), and other 
genes of interest including Brevican  (Bcan),  Notch1  and  Sulfatase1 ( Sulf1). 
Mash1 also bound distal genomic regions of Olig2 and Sox9 in oligosphere 
cultures. To formulate a TF combinatorial code for the activation of these 
putative enhancers, TF synergy were analysed with luciferase reporter assays. 
Furthermore, to isolate genomic regions with activity in the oligodendroglial 
lineage in vivo we used mouse transient transgenics. We hypothesise that Mash1  4  
interacts with either neuronal- or oligodendroglial-specific cofactors, and that 
these interactions modulate Mash1 activity. To address this question we 
performed Sox9 and Olig2 ChIP and found that some Mash1 bound elements 
were also occupied by these TFs in oligosphere cultures. 
 
  In conclusion, using an in vitro cellular system and ChIP-on-chip 
technology to interrogate proximal promoter regions bound by Mash1, we can 
begin to elucidate the molecular mechanisms of Mash1 function in 
oligodendroglial cell fate specification. 
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      I n t r o d u c t i o n  
        20 
1.1 A brief historical and evolutionary perspective 
 
  At the beginning of the 20
th century in 1921, Pio del Rio Hortega 
provided the first detailed histological description of oligodendrocytes. Rio 
Hortega created the word ‘oligodendrocyte’, from the Greek -oligo- for few, -
dendro- for tree, and -cyte- for cell, specifically to describe a cell with less 
processes compared to other cells of the central nervous system (CNS). A 
classification system for oligodendrocytes based on their location was devised 
and consisted of three main subgroups, interfascicular (along axonal tracts), 
perineural satellite (around neuronal cell bodies), and perivascular (in close 
proximity to capillaries). Rio Hortega hypothesised that oligodendrocytes played 
a major role in the generation and maintenance of the myelin sheath. Indeed, 
electron microscopy (EM) and immunocytochemistry studies have since 
provided evidence in support of this theory (Bunge et al., 1962; Hirano, 1968; 
Mori and Leblond, 1970; Ling et al, 1973; Sternberger et al., 1978). 
Oligodendrocytes mainly function to generate rapid conduction of action 
potentials in a non-linear manner between interruptions in the insulating myelin 
membrane that ensheaths the axons of neurons. Prior to the description of 
oligodendrocytes in 1858 Rudolf Virchow coined the word myelin derived from 
the Greek myelos, which means marrow. Louis-Antoine Ranvier later described 
the breaks between sections of myelin as “nodes of Ranvier”, in 1878. 
 
  The acquisition of the myelin sheath and thus the myelin-synthesising 
cells of the peripheral nervous system (PNS) and CNS, Schwann cells and 
oligodendrocytes respectively, have undoubtedly played a crucial role in  21 
vertebrate evolution (reviewed Zalc, 2006; Zalc et al., 2008). Notably, despite 
being ensheathed by glial cells invertebrate axons are not insulated with compact 
myelin, and subsequently are only capable of generating action potential that 
propagate at a mere 1m/s. However, this speed is ample for the survival of small 
animals in the size range of 0.1-30cm. Invertebrates with a larger body size, such 
as squids, cuttlefishes and octopods that belong to the Cephalopod class, have 
adapted by increasing their axonal diameter to 1 mm, and consequently increased 
the speed at which their action potentials are propagated in order to survive. In 
contrast, vertebrates have responded to this challenge in the form of the myelin 
sheath. Notably, this structure facilitates the propagation of action potentials to 
reach an incredible velocity of 50-100m/s, without increasing the diameter of 
their axons. However, the ancestral vertebrate axons of lancelets, hagfishes and 
lampreys that belong to the Agnatha (in Greek, no jaw) class are not myelinated 
(Bullock et al., 1984). The most ancient living myelinated vertebrate species are 
the Chondrichthyes or cartilaginous-jawed fish, which include sharks and rays 
(Kitagawa et al., 1993); it is therefore considered that the acquisition of myelin 
and a hinged-jaw occurred simultaneously in evolution (Zalc & Coleman, 2000).  
  
  The history behind the discovery of oligodendrocytes in the CNS and the 
great evolutionary feat of myelin acquisition in vertebrates are fascinating. 
However, our current understandings of the molecular mechanisms that control 
the generation of oligodendrocytes from neural progenitors in the 
neuroepithelium of the vertebrate CNS are still in its infancy.  
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1.2 Oligodendrocytes in disease: Multiple Sclerosis 
 
  Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS 
that was first described in 1868 by Jean-Martin Charcot. MS has three major 
classifications: 1) relapsing and remitting, which is exemplified by episodes of 
neurological dysfunction combined with phases of stability; 2) primary-
progressive, in which progressive neurological disability occurs from the 
beginning; 3) and secondary-progressive, whereby progressive neurological 
disability arises later in the course of the disease. Axonal loss, a prominent 
feature of MS not only results from inflammation caused during periods of this 
disease (Kutzelnigg et al., 2005), but potentially also from neurodegeneration 
due to a lack of trophic support (Bjartmar et al., 2003). Notably, the progressive 
loss of axons in MS patients, are a major contributor to the accumulation of 
irreversible neurological defects associated with this disorder (Trapp and Nave, 
2008). The prevalence of MS varies with racial background and geographical 
location. Indeed, with a prevalence of 1/800, MS is the most common cause of 
neurological disability in young white adult populations in Europe and North 
America. Although there are no cures presently for this demyelinating disease, 
numerous treatments are available to help relieve the symptoms and relapses, as 
well as slow down the progression of MS (reviewed Nicholas and Chataway, 
2007).  
 
  Following the pathological loss of myelin in diseases like MS, new 
myelin sheaths are generated around demyelinated axons of the adult nervous 
system, a phenomenon that is otherwise referred to as remyelination (reviewed  23 
Franklin and Ffrench-Constant, 2008). The process of remyelination can be 
partitioned into two core phases, firstly the colonisation of the lesion by OPCs, 
and secondly the differentiation and maturation of these cells to form functional 
myelinating oligodendrocytes. Mature oligodendrocytes contact proximal 
demyelinated axons and generate myelin sheaths, to reinstate rapid propagation 
of action potential by saltatory conduction (Smith et al., 1979) and rectify 
neurological deficits (Jeffery and Blakemore, 1997; Liebetanz and Merkler, 
2006). Although the vast majority of MS lesions experience remyelination, in 
more cases than not this process does not restore the myelin sheath completely 
(Blakemore, 1974), and ultimately results in failure (Ludwin and Maitland, 
1984). Failure in remyelination may arise from three principal causes: 1) a deficit 
in OPC numbers; 2) a defect in the recruitment of OPCs; 3) a defect in the 
differentiation and maturation of OPCs into myelinating oligodendrocytes 
(Franklin, 2002).  
 
  Presently, there are no corrective therapies in the clinic to actively 
promote remyelination in the adult nervous system of MS afflicted patients. 
Therapeutic strategies under investigation in animal models of demyelination 
include exogenous cell replacement therapies using transplantation, and 
promotion of endogenous repair with autologous stem and OPC populations. 
Pioneering experimental studies instigated almost 30 years ago, clearly 
highlighted the ability of glial cells to myelinate following transplantation into 
the CNS of demyelination disease rodent models (Duncan et al., 1981; 
Lachapelle et al., 1983; Blakemore and Crang, 1985). Since then, numerous 
studies have exploited these methods to introduce a wide range of cell types to  24 
enhance remyelination, these include, primary OPCs (Groves et al., 1993; Zhang 
et al., 1999; Windrem et al., 2004), Schwann cells (Blakemore and Crang, 1985; 
Honmou et al., 1996; Bachelin et al., 2005), olfactory ensheathing cells 
(Imaizumi et al., 1998; Barnett et al., 2000), neural stem cell (NSC) lines 
(Hammang et al., 1997) and embryonic stem (ES) cell derived glial precursors 
(Brustle et al., 1999).  Nevertheless, there are crucial issues, including the source 
of cells and the mode of delivery that need to be addressed if these approaches 
are to be translated into the clinic. Briefly, ES cells offer a number advantages, 
not only can they provide a limitless supply of OPCs, but individual patient 
tailored treatment can be delivered. Nonetheless, the in vitro differentiation of 
human ES cells into oligodendrocytes is arduous, requiring an extended period of 
time and define culture conditions (Nistor et al., 2005).  
 
1.3 Regionalisation and patterning of the ventral telencephalon 
 
  The cerebrum is a complex region of the vertebrate CNS, and is derived 
from the embryonic structure, the telencephalon. The telencephalon commences 
as a relatively simple neuroepithelium at the most anterior part of the neural 
plate. In brief, the neural plate forms in the early embryo following neural 
induction, and ultimately gives rise to the nervous system. Indeed, following 
these early patterning events, the embryonic telencephalon can be grossly 
partitioned into the ventral subpallium, which gives rise to the mammalian basal 
ganglia, and the dorsal pallium, which gives rise to the mammalian cerebral 
cortex (Figure 1).  
  26 
  The ventral telencephalon comprises a pair of discrete progenitor 
domains, the lateral (LGE) and medial (MGE) ganglionic eminences, which form 
the striatum and pallidum, respectively (Puelles et al., 2000). On the other hand 
the neocortex the principal element of the dorsal telencephalon, mainly consists 
of excitatory glutamatergic neurons (which originate from the cortical ventricular 
zone (VZ), an area bordering the ventricles of the developing cortex) and GABA 
(-aminobutyric acid)-ergic inhibitory interneurons (generated in the VZ of the 
ganglionic eminences of the ventral telencephalon and subsequently migrating 
dorsally into the cortex). 
 
  In the developing telencephalon, a dorsal source of Wnt and bone 
morphogenetic protein (BMP), and a ventral supply of Sonic hedgehog (Shh) 
morphogenetic signals specify positional identity along the dorsoventral (DV) 
axis, analogous to the scenario in the embryonic spinal cord (Figure 2) (Ulloa 
and Briscoe, 2007; reviewed Hoch et al., 2009; Lupo et al., 2006; Ciani and 
Salinas, 2005; Liu and Niswander, 2005; Fuccillo et al., 2006). BMP and Wnt 
molecules are released from the dorsal midline and paramedial neuroectoderm, 
whilst ventral regions are responsible for the generation of Shh signal, from the 
anterior mesendoderm, the ventral hypothalamus and from the rostroventral 
telencephalon (preoptic area and MGE). Notably, positional identity along the 
DV axis of the forebrain is highly intricate and is dependent on the interactions 
and crossregulation between other rostral patterning signals including fibroblast 
growth factors (Fgfs) (Mason, 2007). 
  
  28 
  Expression of the homeobox TFs Pax6 and Gsh2 in the telencephalon are 
spatially restricted (reviewed in Hebert and Fishell, 2008; Schuurmans and 
Guillemot, 2002). Indeed, their domains of expression border the pallial-
subpallial boundary in the lateral pallium and dorsal LGE, respectively, and their 
mutual antagonism is required for its positioning (Yun et al., 2001). These TFs 
are responsible for creating regional identities of pallial and subpallial domains. 
Notably,  Pax6 null mice demonstrate a dorsal expansion of gene expression 
normally associated with the ventral territories of the telencephalon, while Gsh2 
null mice exhibit a ventral expansion of dorsal lateral gene expression (Corbin et 
al., 2000; Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 2001). It is 
evident that the fully established telencephalon, characteristically subdivided into 
different regions, with distinct morphologies, connectivities and neurochemical 
profiles, as well as patterns of gene expression initiated by morphogenetic 
signals, portrays the primary acquisition of regional identity by progenitor 
populations (Figure 3) (reviewed in Schuurmans and Guillemot, 2002).  
  The mammalian telencephalon has been the theme of numerous studies. 
Notably outstanding breakthroughs have been achieved using the telencephalon 
as a model system, these include the discovery of neural stem cells and their 
multipotential properties, as well as the identification of discrete populations of 
neural progenitors and their adopted modes of division (Davis and Temple, 1994; 
Doetsch et al., 1999; Morshead et al., 1994; Noctor et al., 2004; Reynolds and 
Weiss, 1992). Moreover, progenitor cultures are easily established from the 
telencephalon, and thus this system lends significant advantages for in vitro 
manipulation and experimentation (Conti et al., 2005; Davis and Temple, 1994; 
Gage et al., 1995; Johe et al., 1996; Reynolds and Weiss, 1992).   30 
1.4 Oligodendrogenesis in the developing telencephalon and spinal cord 
 
1.4.1 The origins of oligodendrocytes 
 
  Oligodendrocyte progenitors were first identified in rat optic nerve cell 
cultures by immunolabeling with antibodies against A2B5 ganglioside, and 
referred to as oligodendrocyte-type-2 astrocyte progenitor cells (O-2A 
progenitors; Raff et al., 1983), to indicate their bipotential to differentiate into 
either oligodendrocytes or astrocytes (type-2 subtype), according to culture 
medium conditions. In light of the fact that an antigenic phenotype of type-2 
astrocytes has not been identified in vivo, including in transplantation studies 
with purified O-2A progenitor cells (Espinosa de los Monteros et al., 1993; 
Groves et al., 1993), raised the possibility that O-2A progenitors are likely a 
culture artefact and thus the precursor cells are now more commonly referred to 
as OPCs. Lineage studies have shown that spinal motorneurons and 
oligodendrocytes are generated sequentially from a common pool of progenitors 
in the motorneuron progenitor domain (pMN) in the developing spinal cord 
(reviewed Richardson et al., 2000 and Rowitch et al., 2002). Moreover, in the 
brain a precursor for both oligodendrocytes and GABAergic neurons has been 
proposed (He et al., 2001). It is evident from these data that oligodendrocytes 
share progenitors with neurons rather than astrocytes in the developing CNS.  
 
  The sequential stages of OPC maturation and differentiation are well 
characterised, and are easily identified by transformations in morphology and 














Figure 4. The oligodendroglial lineage: morphology and gene expression.  
Schematic summary of the oligodendroglial lineage progression in the pMN 
domain in the developing mouse spinal cord (Rowitch, 2004).  
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  During mouse development, OPCs are first identified in the VZ, of the 
ventral spinal cord and ventral forebrain at approximately 12.5 days of 
embryonic development (embryonic day 12.5, E12.5), by their characteristic 
bipolar morphology and expression of specific early markers, including 
PDGFR, a transmembrane protein tyrosine kinase, and the bHLH and Sox 
(SRY related HMG box) TFs, Olig1 and Sox10, respectively. At this stage, 
OPCs exhibit a strong migratory behaviour and infiltrate the surrounding 
parenchyma whilst they continue to proliferate. By E14.5, the expression of the 
single membrane-spanning chondroitin sulphate proteoglycan, NG2, is induced 
and these cells develop a multipolar morphology, at which point late precursor 
markers such as the cell surface O4 marker are upregulated. Mature OPCs 
eventually exit the cell cycle, they downregulate PDGFR and NG2 expression 
and begin to express mature oligodendrocyte markers such as myelin basic 
protein (MBP), a component of the myelin membrane. Finally, mature 
oligodendrocytes associate with neighbouring axons and form the myelin sheath. 
  
  Oligodendrocytes are generated from a define subset of neural 
progenitors in multiple locations in the CNS (Figure 5) (reviewed Richardson et 
al., 2006). In the spinal cord, OPCs are predominantly specified in the VZ of the 
ventral pMN progenitor domain at E12.5 (Warf et al. 1991; Noll and Miller 
1993; Pringle and Richardson 1993; Yu et al. 1994; Timsit et al. 1995). 
Interestingly, earlier in development this same region is responsible for the 
formation of motoneurons (Richardson et al. 1997; Sun et al. 1998; Lu et al. 
2002; Takebayashi et al. 2002; Zhou and Anderson 2002). A secondary wave of 
OPCs are generated at more dorsal regions (dI3-5) of the spinal cord at E14.5,  33 
which accounts for about 20% of OPCs (Cai et al. 2005, Vallstedt et al. 2005, 
Fogarty et al. 2005). In the forebrain, like in the spinal cord, OPCs are mainly 
produced from a ventral territory extending from the MGE to the anterior 
entopeduncular area (AEP) at E12.5, these colonise the forebrain by mechanisms 
of migration and proliferation (Spassky et al. 1998, 2001; Olivier et al. 2001; 
Tekki-Kessaris et al. 2001). A later source of embryonic OPCs is generated in 
the LGE and/or caudal ganglionic eminence (CGE) (Kessaris et al. 2006), and 
this is followed by a final wave of oligodendrogenesis at postnatal stages in the 
most dorsal domain of the telencephalon, the cortex (Kessaris et al. 2006). 
Indeed, the progression of OPC specification from ventral to dorsal regions 
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  Although region specific OPC populations have been described in the 
developing telencephalon, on the basis of regionally restricted Nkx2.1, Gsh2, and 
Emx1 TF expression, it is plausible that the generation of OPCs is in fact not 
itself regionally restricted but proceeds in a 'Mexican wave' from ventral to 
dorsal domains (Kessaris et al. 2006). Interestingly, the first OPCs to be specified 
in the ventral telencephalon are almost completely absent in postnatal animals, 
instead they are replaced by OPC populations generated later in development and 
include cells derived from the LGE/CGE throughout the second wave of 
oligodendrogenesis in the telencephalon (Kessaris et al. 2006). Note that the 
significance of this cell replacement phenomenon remains unresolved, as does 
the question of functional heterogeneity of OPC populations specified from 
molecular distinct regions of the telencephalon. Numerous hypothesis have been 
proposed in an attempt to explain the substitution of early born OPCs population 
and include the possibility that they are competitively eliminated by later born 
OPCs, or simply that an incessant turnover of oligodendrocytes during adulthood 
may result in the progressive loss of early born OPCs and replacement of cells 
from stem cells residing in the adult subventricular zone (SVZ). The SVZ is 
predominately derived from the embryonic LGE/CGE and cortex (Young et al., 
2007), and is one source of new oligodendrocytes in the adult (Levison and 
Goldman 1993, 1997; Luskin and McDermott 1994), the vast majority of which 
are generated form pre-existing PDGFRA+/NG2  glial cells (Rivers et al., 2008).  
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1.4.2 Intrinsic and extrinsic regulators of oligodendrocyte cell fate 
specification 
 
A fundamental question in vertebrate developmental neurobiology is to 
understand how multipotent neural progenitors, particularly abundant at early 
stages of neural development, and characterised by their capacity to proliferate, 
self renew and to generate cells in several neural lineages, are able to generate 
neurons, oligodendrocytes and astrocytes in a temporal sequence and at specific 
locations. It is believed that initially NSCs divide symmetrically to enlarge the 
progenitor pool size. A switch in the mode of division to asymmetric delineates 
the initiation of neurogenesis, to generate two unequal cell types, a stem cell 
identical to the parent cell and a committed neuronal progenitor cell. On the 
contrary the onset of gliogenesis is demarcated by restoration in the mode of 
division to symmetric. The mechanisms underlying these remarkable changes in 
progenitor behaviour and fate during CNS development are not fully understood, 
but are thought to involve a combination and interplay between intrinsic 
attributes of neural progenitors (including TFs and epigenetic alterations), as well 
as modifications of their extrinsic signalling environment (such as extracellular 
factors and their corresponding downstream intracellular signalling pathways) 
(Temple, 2001).  
 
1.4.2.1 Extrinsic regulators of oligodendrocyte cell fate specification 
 
  In the developing telencephalon progenitors must decide whether to adopt 
a neuronal or glial cell fate, a selection that is influenced by numerous signalling  37 
pathways. Notably, the complexity in the relay of extrinsic signals to a given 
progenitor are considerable, not only are there extensive interactions between 
pathways where levels of activity within each pathway are significant, but the 
same signal may promote different cell fates depending on intrinsic cellular 
properties. Furthermore, the regulation of gene expression and activity of TFs by 
extrinsic signals, substantially contribute to the ultimate selection between 
neuronal or glial cell fates (reviewed in Kessaris et al., 2008; Guillemot, 2007).  
 
  The molecular mechanism of the hedgehog signalling pathways have 
been well characterised in vertebrate and invertebrate species. Briefly, during 
vertebrate neural development canonical hedgehog signalling is initiated by Shh, 
one of three homologues of the Drosophila hedgehog protein (Echelard et al., 
1993; Chiang et al., 1996; Wijgerde et al., 2002). Shh binds to the twelve-pass 
membrane receptor patched (Ptc1) (Stone et al., 1996; Goodrich et al., 1997; 
Marigo et al., 1996) to relieve the constitutive repression of the seven-pass G-
protein-coupled receptor smoothened (Smo) (Ingham and McMahon, 2006; Chen 
and Struhl, 1996). Ultimately, Shh signal transduction results in the formation of 
either repressor or activator types of zinc finger transcription factors that belong 
to the Gli family (Gli1, Gli2 and Gli3) (Bai et al., 2004; Aza-Blanc et al., 1997). 
  In the developing telencephalon, neuroepithelial cells proximal to the 
ventral midline secrete the classical morphogen, Shh, which diffuses to create a 
concentration gradient. In this system, Shh is responsible for the specification of 
ventrally derived OPCs (Alberta et al., 2001; Nery et al., 2001; Tekki-Kessaris et 
al., 2001). The induction of oligodendrogenesis by Shh is mediated through the 
oligodendrocyte promoting bHLH TFs, Olig1 and Olig2 (Lu et al., 2000; Yung et  38 
al., 2002). Moreover, Shh has been shown to be both necessary and sufficient for 
the expression of Olig1 and Olig2 (Lu et al., 2000; Nery et al., 2001; Zhou et al., 
2000).  
 
  FGF signalling is transduced through a family of four transmembrane 
receptor tyrosine kinases (FGFR1–4) in all vertebrates (reviewed Mason, 2007). 
During telencephalic development the basic FGF2 functions to promote the 
expansion of neural progenitors in the VZ (Ghosh and Greenberg, 1995; Raballo 
et al., 2000). However, high level of FGF2 signalling activity support 
oligodendrogenesis in progenitor cultures, that is independent of Shh function. 
Indeed, cultures derived from the dorsal telencephalon of Shh mutant mice, or 
cultures subject to inhibition of Shh activity by cyclopamine (11-deoxojervine), 
retain the capacity to generate OPCs (Chandran et al., 2003; Kessaris et al., 2004; 
Nery et al., 2001). Moreover, in the embryonic dorsal spinal cord a small 
population of OPCs are specified in response to FGF signalling, independently of 
Shh signalling (Cai et al., 2005; Fogarty et al., 2005). More recently a role of 
FGF receptor signalling in the generation oligodendrocyte progenitors in the 
zebrafish hindbrain was established (Esain et al., 2010). FGF-receptor signalling 
in zebrafish ventral hindbrain progenitors not only controls olig2 expression, in 
cooperation with Shh, but also promotes the expression of both sox9a and sox9b 
during the late gliogenesis phase, and thus promotes oligodendrogenesis in the 
Olig2 positive domain.  
 
  PDGF signalling is required for the in vitro differentiation of embryonic 
multipotent forebrain NSCs into an oligodendroglial lineage that is mediated  39 
through an Erk1/2-dependent signalling pathway and subsequent Olig2 
activation (Hu et al., 2008). Interestingly a subset of stem cells in the SVZ of 
adult rodents express PDGFR, and PDGF signalling in this region has been 
shown to promote the generation of oligodendrocytes (Jackson et al., 2006). 
Further functions of PDGF signalling activity in OPC proliferation, survival and 
migration in animal models and cell culture systems have been described (Barres 
and Raff, 1994; Fruttiger et al., 1999; Finzsch et al., 2008; Noble et al., 1988; 
Richardson et al., 1988; Barres et al., 1992; Armstrong et al., 1990; Klinghoffer 
et al., 2002; Calver et al., 1998).  
 
  The core Notch signalling pathway is evolutionarily conserved, and is 
activated following extracellular interactions between the ligand Delta or Serrate 
(Jagged) on one cell, with the Notch receptor (a single-pass, transmembrane, 
heterodimeric protein) on the adjacent cell. Ligand binding activates a succession 
of proteolytic events, which involve a presenilin–-secretase complex (Selkoe 
and Kopan, 2003), and culminate in the cleavage and release of the Notch 
intracellular domain (NICD) into the cytoplasm. The NICD translocates into the 
nucleus (Struhl and Adachi, 1998; Schroeter et al., 1998) aided by nuclear 
localization signals (Stifani et al., 1992), where it functions to activate and recruit 
elements of a complex containing the Notch signalling effectors suppressor of 
hairless (CBF1/RBPj) (Fortini and Artavanis-Tsakonas, 1994) and mastermind 
(Smoller et al., 1990), which subsequently direct the assembly of transcriptional 
complexes to drive target gene expression. The major effector of the pathway 
downstream of the Notch receptor is the DNA-binding protein suppressor of 
hairless.  40 
  
  Indeed, activation of the Notch receptor through its ligands Delta and 
Serrate is crucial for the control of cell fate choice during CNS development. The 
generation of neuronal cells precedes that of glial cells and active Notch 
signalling is vital for the maintenance of proliferative non-committed neural 
progenitor populations into the gliogenic phase. Evidently, a deficiency in Notch 
signalling in zebrafish embryos results in a surplus of neurons in the spinal cord 
at the cost of oligodendroglial cells (Appel et al. 2001; Park and Appel, 2003). 
On the contrary, an excess in oligodendroglial cells at the expense of motor 
neurons arises following the expression of a constitutively active form of the 
Notch receptor (Park and Appel, 2003). In combination these data led to the 
proposal that Notch signalling is essential for early specification events in the 
oligodendroglial lineage. However, Notch signalling has also been demonstrated 
to play an active role during oligodendroglial differentiation. Notably, in vitro 
studies in the developing rat optic nerve showed that oligodendrocyte maturation 
is inhibited as a result of constitutive activation of Notch signalling (Wang et al. 
1998). Furthermore, in vivo studies have since shown that a loss of Notch 
signalling results in the premature differentiation of OPCs into oligodendrocytes 
(Genoud et al., 2002; Givorgi et al., 2002), while expression of an active form of 
the Notch receptor in transgenic zebrafish embryos impeded OPC differentiation 
(Park and Appel, 2003). Collectively, these data indicate that Notch signalling 
might regulate both the specification of OPCs and their subsequent 
developmental maturation to oligodendrocytes. 
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1.4.2.2 Intrinsic regulators of oligodendrocyte cell fate specification 
 
  To date numerous key molecular determinants that function to promote 
oligodendrogenesis have been identified. Although the molecular transcriptional 
mechanisms controlling oligodendrogenesis have been mostly studied in the 
context of the developing spinal cord, it is hypothesised that these TFs also 
regulate oligodendrogenesis in the telencephalon. 
 
1.4.2.2.1 Olig genes 
 
 The  ato-related genes characterized by the presence of family-specific 
residues in their bHLH domain in vertebrates include the Olig gene family (Lee, 
1997) and contains two major determinants of the oligodendroglial cell fate, 
namely Olig1 and Olig2 genes. In the developing spinal cord these TFs strongly 
support neuronal and oligodendroglial cell fate specification, whilst actively 
inhibiting the generation of astrocytes (Lu et al., 2002; Zhou and Anderson, 
2002). Olig2 is expressed in the ventral pMN domain of the spinal cord, where it 
is required for the generation of oligodendrocytes and motorneurons (Lu et al., 
2002; Zhou and Anderson, 2002; Takebayashi et al., 2002). Note that Olig2 has a 
number of distinct functions within this progenitor domain. At first Olig2 
functions to promote the identity of the pMN domain by actively repressing 
alternative fates (Mizuguchi et al. 2001; Novitch et al. 2001). Olig2 represses 
Irx3 a TF involved in the acquisition of V2 interneuron identity in the developing 
ventral spinal cord. Notably in Olig2 null mice the p2 domain and thus the V2 
interneuron population are subject to a ventral expansion. In addition, Olig2 also  42 
functions to maintain the precursor pool in the pMN domain by repressing the 
expression of MN specific differentiation factors in the neuroepithelium. Not 
surprisingly, Olig2 expression in motorneuron progenitors is transient and is 
subject to rapid down regulation prior to neuronal differentiation. Interestingly, 
whilst the vast majority of neural bHLH TFs function as activators, Olig2 is 
known to perform as a transcriptional repressor (Cabrera and Alonso, 1991; 
Johnson et al., 1992; Mizuguchi e al., 2001; Novitch et al., 2001). Indeed Olig2 
strongly inhibits neuronal differentiation in this ventral domain through active 
competition with Ngn2, firstly for dimerisation with E-proteins and secondly for 
binding to degenerate E-box elements in the promoter of the post-mitotic 
motorneuron Hb9 gene (Lee et al., 2005).  
  Although the function of these genes in more rostral domains of the 
neuraxis, such as the telencephalon, are less well characterised it is proposed that 
its function are analagous. Olig1 expression is specifically restricted to OPCs as 
soon as they arise in the embryonic ventral telencephalon. In contrast Olig2 
expression is significantly broader and is present in ventral neuroepithelial 
progenitors of the VZ prior to OPC specification that generate both 
oligodendrocytes and neurons (Furusho et al., 2006; He et al., 2001; Takebayashi 
et al., 2000; Tekki-Kessaris et al., 2001; Yung et al., 2002). Olig1 and Olig2 
expression are maintained throughout oligodendrocyte lineage progression up 
until the point of terminal differentiation (Lu et al., 2000; Zhou et al., 2000). 
 
  Olig1 gain of function data in cortical derived progenitors either from the 
developing embryo or in culture, results in the generation of ectopic 
oligodendrocytes, as does Olig2 overexpression in cultured embryonic cortical  43 
progenitors and in the adult SVZ (Lu et al., 2000, 2001; Marshall et al., 2005; 
Balasubramaniyan et al., 2004; Copray et al., 2006). Olig2 null embryos present 
a complete loss of oligodendrocytes in the spinal cord, however a few OPC 
remnants are evident in specific regions of the developing brain, which are lost 
following elimination of Olig1 function (Lu et al., 2002; Zhou and Anderson, 
2002). Despite the fact that both GABAergic and cholinergic interneuronal 
subtypes are generated from the ventral telencephalon, Olig2 null embryos only 
display a fractional loss of cholinergic neurons (Furusho et al., 2006). In 
combination, these data suggest that perhaps Olig2 plays a less significant role in 
neurogenesis in more rostral regions of the developing nervous system, as 
compared to its function in the specification of oligodendroglial cell fates. In 
contrast, Olig1 function is required for oligodendrocyte maturation and is 
essential for physiological myelination (Xin et al., 2005) and remyelination 
activities in demyelinating lesions (Arnett et al., 2004; Lu et al., 2002).  
 
  In the embryonic brain as in the spinal cord Olig2 is involved in the 
specification of both oligodendroglial and neuronal lineages, suggesting that 
other factors act in combination with Olig2 to select between the two lineages. 
Indeed Mash1 and Olig2 interact at a genetic level and act through a common 
pathway to specify early-born OPCs in the ventral telencephalon during 
development (Parras et al., 2007). A functional synergy between these TFs has 
also been identified in neurosphere cultures form rat spinal cord using retroviral 
overexpression of Mash1 and Olig2 (Sugimori et al., 2007).   
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1.4.2.2.2 Sox genes 
 
  Members of the Sox group of TFs are characterised by a conserved HMG 
DNA-binding domain, approximately 80 amino acids in length that was initially 
discovered in the mammalian Sry protein (Bowles et al., 2000; Wegner, 1999; 
Schepers et al., 2002). Based on the phylogenetic analysis of the HMG domains, 
Sox genes can be divided into distinct subgroups, termed SoxA to SoxH, which 
include the Sox group E comprising Sox8, Sox9 and Sox10 genes. Notably, Sox 
proteins within the same group usually demonstrate an amino acid identity of at 
least 70%, whilst those from different groups share minimal sequence identity 
outside their HMG domain (Wegner, 1999). Sox proteins directly bind DNA 
sequences (A/T)(A/T)CAA(A/T)G and are dependent on cofactors for target 
gene specificity (reviewed Kamachi et al., 2000; Wilson and Koopman, 2002). 
Notably Sox10, a key regulator in cell fate specification, lineage progression and 
terminal differentiation of neural crest derived Schwann cells (Britsch et al., 
2001; Schreiner et al., 2007), is dependent on co-regulator interactions for its 
function during Schwann cell development. Specifically, Sox10 interacts with 
the class III POU protein Oct6 prior to myelination to induce TF Krox20 
expression (Ghislain and Charnay, 2006). Subsequently, Krox20 functionally 
synergises with Sox10 to activate expression of specific myelin genes, including 
connexin-32 and myelin protein zero, during the final phase of terminal 
differentiation and myelin formation (Bondurand et al., 2001; LeBlanc et al., 
2007; Peirano et al., 2000a). Moreover Sox10 and Olig1 functionally synergise 
to activate mbp gene expression in zebrafish (Li et al., 2007). Sox proteins bind 
the minor groove of DNA, causing significant modifications in its conformation.  45 
It has been suggested that these specific changes may bring proteins on distal 
gene promoters and enhancers in closer proximity to facilitate interactions.  
 
  Members of the same Sox group tend to share expression and function 
(reviewed Guth and Wegner, 2008; Kiefer, 2007; Wegner and Stolt, 2005). 
Notably these TFs modulate a range of processes during development, including 
sex determination, chondrogenesis, neural crest formation, and participate in 
multiple aspects of CNS development, including gliogenesis. Indeed 
oligodendrocyte specification and differentiation are dependent on the function 
of  SoxE group genes, particularly Sox9 and Sox10. During oligodendrocyte 
development SoxE gene expression is partially overlapping. Sox9 is expressed in 
a uniform manner along the entire length of the VZ of the embryonic spinal cord, 
both dorsally and ventrally. Moreover its expression is maintained in OPCs as 
they emerge from the VZ and migrate into the surrounding parenchyma, and in 
oligodendrocytes as they differentiate and myelinate, after which its expression is 
down regulated (Stolt et al., 2003). Sox8 is expressed in progenitors restricted to 
the ventral domain of the VZ in an oligodendrocyte competent region. In contrast 
Sox10 expression is exclusively limited to specified OPCs (Stolt et al., 2005). 
Note Sox8 and Sox10 expression are maintained in mature oligodendrocytes, 
even after Sox9 expression is down regulated. In the telencephalon, Sox9 is 
expressed in the ventricular zones in dorsal and ventral territories and its 
expression is also maintained in OPCs as they invade the surrounding 
parenchyma following their generation (this study, Figure 11). The role(s) of 
Sox9 in oligodendrogenesis in these rostral domains are yet to be characterised. 
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  Conditional null mutants of Sox9, in which Sox9 function is specifically 
ablated in neural progenitors, results in a dramatic reduction in the generation 
oligodendrocytes and astrocytes, with a concomitant increase in the production 
of motor neurons and to a lesser extent V2 interneurons (Stolt et al., 2003). These 
data clearly display Sox9 as a major player in the neuron-glia switch (Stolt et al., 
2003). Expression of Sox9 in a neuroblastoma cell line, leads to the activation of 
specific astrocyte and oligodendrocyte markers, at the expense of neuron markers 
whose expression are repressed (Stolt et al., 2003). In contrast, whilst OPCs are 
specified as normal in Sox10 null embryos, the process of differentiation is 
perturbed, resulting in a significant decrease of mature oligodendrocytes (Britsch 
2001; Stolt 2002). Although Sox8 is expressed in both progenitors and 
oligodendrocytes, Sox8 mutant mice do not exhibit any apparent defects in glial 
generation (Stolt et al 2004). Partial functional redundancies between SoxE group 
genes are evident from studies in compound mutants, which demonstrate an 
increase in the severity of defects associated with the single mutants (Stolt et al., 
2003; Stolt et al., 2004; Stolt et al., 2005). 
 The  SoxD genes Sox5 and Sox6 are expressed just prior to the onset of 
oligodendroglial cell fate specification and are maintained in OPCs, and down-
regulated in terminally differentiating cells (Stolt et al., 2006). SoxD genes 
negatively regulate SoxE group genes. Indeed Sox5  or  Sox6 null mice 
demonstrate precocious specification of VZ cells to OPCs, a phenotype that is 
more pronounced in the compound double mutants. Moreover, Sox5 and Sox6 
double mutant mice exhibit precocious terminal differentiation of 
oligodendrocyte progenitors. Clearly, SoxD proteins function in the regulation of 
oligodendrocyte progression during development by inhibiting SoxE function.  47 
1.4.2.2.3 Nkx2 genes 
 
  In the embryonic spinal cord oligodendrogenesis occurs in neighbouring 
domains of the VZ, which express Olig2 and the homeobox Nkx2.2 genes. 
Although OPC populations from these domains are originally distinct, either 
expressing Olig2 or Nkx2.2, ultimately simultaneous expression of these genes 
in the same cell makes it unfeasible to distinguish between these two principal 
populations (Fu et al., 2002). Notably gain of function studies with Olig2 and 
Nkx2.2 in the chick spinal cord, demonstrated the capacity of these factors to 
synergise at a functional level to generate ectopic oligodendrocyte 
differentiation. The generation of OPCs in Nkx2.2 null mice appears to be 
normal, however these mutants display defects in the maturation of OPCs (Qi et 
al., 2001), to suggest that the functional interaction between Olig2 and Nkx2.2 
are likely to play a prominent role in OPC differentiation, rather than in 
oligodendrocyte specification.  
  Nkx2.1, a close relative of the Nkx2.2 gene, is expressed in proliferative 
progenitors in the developing ventral telencephalon. Although OPCs are absent 
in the telencephalon of Nkx2.1 null mice (Nery et al., 2001), this phenotype most 
likely arises as an indirect consequence of the regulation of Shh expression by 
Nkx2.1. Certainly, the competency of the Nkx2.1 mutant telencephalon to 
produce oligodendrocytes is maintained in progenitor cultures following 
overexpression of Shh, thus excluding a major role of Nkx2.1 in 
oligodendrogliogenesis (Nery et al., 2001). 
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1.4.2.2.4 Proneural bHLH genes  
 
  Proneural genes were first discovered in Drosophila on the basis of their 
involvement in early phases of neural development (Ghysen and Dambly-
Chaudiere, 1988; Garcia-Bellido, 1979). The achaete-scute gene complex and 
atonal genes were initially identified by the extent of their sequence similarity 
(Figure 6A) (Gonzalez et al., 1989; Villares and Cabrera, 1987; Jarman et al., 
1993; Goulding et al., 2000a, 2000b; Huang et al., 2000). Further sequence 
resemblance with other genes, including the oncogene myc, the sex-
determination gene daughterless, and the muscle-determination gene MyoD 
(Villares and Cabrera, 1987; Murre et al., 1989a) eventually resulted in the 
identification of the bHLH domain, a structural motif that confers specific DNA-





















Figure 6. Structure and properties of neural bHLH proteins.  A, A 
dendrogram of the sequence of the bHLH domain of invertebrate (blue) and 
vertebrate (red) neural bHLH proteins. Note that proteins are categorised into 
discrete families on the basis of sequence similarities within the bHLH domain. 
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 Classification  of  achaete-scute and atonal genes as proneural in function, 
was founded on the fact that they were expressed in the ectoderm by groups of 
cells referred to as ‘proneural clusters’, as well as their ability to generate neural 
progenitors (Campuzano and Modolell, 1992; Jan and Jan, 1994; Jimenez and 
Modolell, 1993). A combination of loss and gain of function analyses have 
isolated numerous bHLH genes with distinct proneural activity in Drosophila. 
Achaete-scute and atonal have been well-characterised and together account for 
the origin of most of the Drosophila PNS. These studies revealed that achaete-
scute genes function in the development of the fly external sense organs (such as 
the mechanosensory and chemosensory organs), whilst atonal genes were 
demonstrated to function in the development of internal chordotonal organs 
(Jarman et al., 1993). 
 
  Proneural bHLH proteins function as transcriptional activators (Cabrera 
and Alonso, 1991; Johnson et al., 1992), and bind to degenerate DNA sequences, 
known as E-boxes (CANNTG) (Figure 7). Formation of heterodimeric 
complexes are critical for DNA binding, and this is achieved with the alternative 
splice variants of the E2A gene, namely E12 and E47 E-proteins, (Murre et al 
1989b). Molecules that inhibit proneural gene activity include the vertebrate 
HLH Id (inhibitor of differentiation) genes, which lack a basic motif for DNA 
binding and act as repressors of bHLH activity by inhibiting their dimerisation 
(Massari and Murre, 2000; Campuzano, 2001; Yokota, 2001). Briefly, Ids 
actively compete for E-proteins, forming heterodimers that are blocked in their 
ability to bind DNA. Other inhibitors of proneural gene activity include the 
vertebrate Hes/Her/Esr proteins (the hairy and enhancer of split factors in  51 
Drosophila) (Davis and Turner, 2001; Kageyama and Nakanishi, 1997). These 
proteins not only function as typical DNA-binding repressors of proneural gene 
transcription (Chen et al., 1997; Ohsako et al., 1994; Van Doren et al., 1994), but 
are also thought to inhibit the activity of proneural proteins by interfering with 
proneural–E-protein complex formation (Davis and Turner, 2001; Kageyama and 
Nakanishi, 1997). Note that the HLH proteins (ID2 and ID4), as well as negative 
regulatory bHLH Hes genes (Hes1 and Hes5), inhibit the formation of 
oligodendrocytes in vitro (Kondo and Raff, 2000a, 2000b; Wang et al., 2001). 
Moreover, in addition to binding to the ubiquitously expressed E2A proteins, ID2 
and ID4 also directly interact with OLIG1 and OLIG2 in vitro to inhibit 






















Figure 7. Mechanisms of bHLH TF activity. A, bHLH TFs form heterodimers 
with E-proteins and bind E-box sequences (CANNTG) to activate the 
transcription of target genes. B, Hes proteins directly repress the transcription of 
proneural genes by binding to N-box sequences (CACNAG) in proneural gene 
promoters.  C, Hes proteins repress the activity of proneural proteins through 
binding to proneural heterodimers and recruiting repressor complexes to target 
gene promoters. D, Id proteins passively repress proneural protein activity by 
binding to and sequestering E-proteins, thus inhibiting the formation of proneural 
heterodimers (Ross et al., 2003). 
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  Critical to the function of proneural genes is the activation of the Notch 
signalling pathway (Artavanis-Tsakonas, 1999), by a process  commonly referred 
to as lateral inhibition (Figure 8). In this model proneural genes are initially 
expressed in groups of equivalent neurectodermal cells (Jarman et al., 1993; 
Campuzano and Modolell, 1992; Blader et al., 1997; Ma et al., 1996; Henrique et 
al., 1997). Stochastic upregulation of a proneural gene in a target cell directly 
induces an increase in the levels of the Delta ligand (Figure 8A & B). 
Consequently, the Notch signalling cascade is activated in adjacent cells, and 
results in the expression of repressor molecules that belong to the bHLH 
Enhancer of Split group of genes, which in turn down regulate proneural gene 
expression in that cell. Notably, through initial establishment of lateral inhibition 
and subsequent activation of an auto-regulatory loop, proneural gene expression 
are restricted to single cells which are thus destined for neural differentiation 
(Artavanis-Tsakonas, 1999; Chitnis and Kintner, 1996; Lewis, 1998).  
  More recently real-time imaging analysis demonstrated that Notch 
effectors, proneural genes and Notch ligands are expressed in an oscillatory 
manner by neural progenitors in the developing mouse brain (Shimojo et al., 
2008), raising the question of whether a subtle stochastic difference is gradually 
amplified and fixed as defined in the classic view of lateral inhibition (review in 
Kageyama et al., 2008) (Figure 8C). This type of oscillatory expression, that is 
unsynchronised between neighbouring cells, poses a  number of distinct 
advantages including the maintenance of a group of cells in an undifferentiated 
state by mutual activation of Notch signalling, in addition to the generation of 
neural progenitor diversity. 
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Figure 8. Two models for lateral inhibition in vertebrates. A & B, Classic 
view of lateral inhibition. Initially all neural progenitors are equivalent and 
express proneural and Notch ligand genes, such as Dll1, at similar levels (time 
1). A subtle stochastic difference between cells in proneural and Dll1 expression 
(time 2) is amplified by lateral inhibition, causing subsets of cells to express 
proneural genes and Dll1 at high levels and to differentiate into postmitotic 
neurons (cell 1, time 3). These selected cells activate Notch signalling in 
neighbouring cells, which subsequently become negative for proneural and Dll1 
expression and are maintained as neural progenitors (cell 2) (Bertrand et al., 
2002; Kageyama et al., 2008). C, Revised view of lateral inhibition. Proneural 
and Dll1 expression oscillates, as a result of Hes1 oscillation. Note that this 
pattern of oscillation is dynamic, and therefore it does not facilitate cell fate 
prediction (Kageyama et al., 2008).  
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Indeed, members of the proneural bHLH family of proteins are crucial 
TFs that play pivotal evolutionary conserved roles in neurogenesis both in 
vertebrates and invertebrates (reviewed Bertrand et al., 2002; Ross et al., 2003). 
Vertebrate genes related to achaete-scute and atonal on the basis of the sequence 
similarity in the bHLH domain have been identified. Achaete-scute homologue 1 
(ash1) has been isolated in a range of species, including the mouse (Mash1), 
chick (Cash1), zebrafish (Zash1), Xenopus (Xash1) and human (hASH1), as 
have the atonal-related genes Neurogenins (Ngns). Proneural TFs are expressed 
in progenitors of the mammalian telencephalon and include Mash1 in the basal 
ganglia, and Ngn1/Ngn2 as well as Mash1 (albeit at reduced levels compared to 
Ngns) in the cortex (Britz et al., 2006). In the developing mammalian CNS, 
proneural factors Mash1 and Ngn2, regulate the transformation of NSCs into 
mature neurons, including the acquisition of generic and subtype-specific 
properties of neurons, Notch signalling activation, cell cycle exit and neuronal 
migration (Bertrand et al., 2002; Hand et al., 2005; Helms and Johnson, 2003; 
Schuurmans et al., 2004; Heng et al., 2008), in addition to regulating the 
commitment of  multipotent progenitors to a neuronal or an astroglial fate (Nieto 
et al., 2001; Sun et al., 2001; Tomita et al., 2000). Involvement in these distinct 
processes, suggest that proneural proteins have the capacity to activate a large 
number of target genes in a context dependent manner and in a precisely 
orchestrated temporal sequence.  
  Gain of function analysis has demonstrated the potential of proneural 
genes to induce neural progenitor differentiation to form functional mature 
neurons (Farah et al., 2000; Mizuguchi et al., 2001; Nakada et al., 2004). These 
data clearly support the notion that these proneural genes are sufficient to initiate  57 
a complete neuronal program of differentiation. On the other hand, loss of 
function analysis with Mash1 null mutant mice (Guillemot et al., 1993), present a 
severe disruption in the process of neurogenesis. As expected, these defects are 
most prominent in regions where Mash1 is normally expressed, namely the 
ventral telencephalon and the olfactory sensory epithelium (Casarosa et al., 1999; 
Cau et al., 2002; Guillemot et al., 1993; Horton et al., 1999). Undeniably, these 
defects are inherently linked to a loss of progenitor populations within these 
domains, in addition to a failure to express the Notch ligands Delta and 
Serrate/Jagged, and to thus activate Notch signalling. Moreover, loss of 
proneural bHLH gene activity, leads to the premature emergence of restricted 
astrocyte precursors and subsequently premature astroglial differentiation (Nieto 
et al., 2001; Tomita et al., 2000). Notably, in vitro clonal analysis clearly suggest 
that this phenomenon reflects a dual role of proneural proteins in the 
commitment of multipotent progenitors to the neuronal lineage and the specific 
inhibition of alternate astroglial cell fates (Nieto et al., 2001; Parras et al., 2004). 
Interestingly, Mash1 is the only proneural gene to be expressed in the ventral 
telencephalon, and although there is a loss of SVZ progenitors and of postmitotic 
neurons in this region (particularly in the globus pallidus), a large fraction of 
neurons are normally produced particularly in the striatum, to suggest that other 
genes with specific proneural activity are yet to be discovered in this domain. 
(Casarosa et al., 1999; Horton et al., 1999). Specification of the striatum depends 
on the function of the Gsh1 and Gsh2 homeobox genes, which are expressed in 
the VZ of the LGE (Corbin et al., 2000; Toresson et al., 2000; Toresson and 
Campbell, 2001; Yun et al., 2001, 2003). Moreover the fact that Gsh2 specifies 
striatal projection neuron and olfactory bulb interneuron identity at distinct time  58 
points during telencephalic neurogenesis (Waclaw et al., 2009), suggest that 
Gsh2 may compensate for the loss of Mash1 function in this region.  
  
  Although Mash1 is more commonly associated with its function in 
neurogenesis, this typical proneural bHLH factor also plays an active role in the 
regulation of oligodendrogenesis. Indeed, Mash1 is widely co-expressed with 
Olig2, a major determinant of oligodendroglial fate, throughout embryogenesis 
in the ventral telencephalon where OPCs are specified, as well as in the white 
matter of the postnatal brain, and in OPC cultures (Gokhan et al., 2005; Kondo 
and Raff, 2000a; Parras et al., 2004 Parras et al., 2007; Wang et al., 2001). 
Mash1 null mutant mice present a reduction in the numbers of OPCs in the 
olfactory bulb (Parras et al., 2004). In addition clonal analysis of Mash1 null 
progenitors in culture demonstrated that mutant progenitors that would otherwise 
generate neurons and oligodendrocytes instead form astrocytes, while glial 
progenitors that generate astrocytes and oligodendrocytes were not affected 
(Parras et al., 2004). Indeed, these data clearly elucidate a role of Mash1 in the 
specification of a subpopulation of oligodendrocytes. Note however, whether 
different subsets of OPCs with distinct lineal origins also differ in their 
requirement for Mash1 in vivo remains to be addressed.  
  In the embryonic ventral telencephalon, a sub population of OPCs 
expresses Mash1 protein as soon as they emerge in the VZ of the ventral 
forebrain at E12.5 and E14.5 (Parras et al., 2007). Moreover, a significant 
proportion of OPCs at E12.5 originate from Mash1 positive progenitors in this 
domain, as defined by the loss of PDGFR positive cells in the AEP of Mash1 
null mutant mice (Parras et al., 2007). These data highlight a critical role for  59 
Mash1 function in the generation of the first wave of OPCs in the ventral 
forebrain between E11.5 and E13.5, whilst its function is dispensable for the 
production of subsequent waves of OPCs in the embryonic forebrain. Mash1 
gain of function in the embryonic dorsal telencephalon results in the induction of 
PDGFR gene expression (Parras et al., 2007). However other OPC markers fail 
to be expressed in these ectopically induced cells. These data suggest that Mash1 
functions in combination with other TFs in the specification of OPCs.  Indeed 
data from Mash1 and Olig2 double mutant mice demonstrated that these TFs 
genetically synergises in the specification of early born OPCs in the embryonic 
ventral telencephalon (Parras et al., 2007).  
  In vivo and in vitro gain and loss of function studies in more caudal 
domains of the developing CNS support the idea that Mash1 acts as an 
instructive factor for the  induction of oligodendroglial cell fate specification 
(Sugimori et al., 2007). OPCs are severely reduced in number, but not 
completely absent, in the embryonic spinal cord of Mash1 null mice. Similar to 
the situation in more rostral regions, OPC numbers are gradually recovered later 
in development, to suggest that other factors are likely implicated in the 
generation of OPCs. More recently a role for Mash1 in the differentiation of 
OPCs into myelin-expressing oligodendrocytes at late embryonic stages in the 
spinal cord was demonstrated (Sugimori et al., 2008). Interestingly, retrovirus-
mediated overexpression of Mash1, redirected the fate of proliferating adult 
hippocampal stem/progenitor progeny in their in vivo niche, from a neuronal to 
an exclusive oligodendroglial fate (Jessberger et al., 2008). Altogether, these data 
suggest that Mash1 activity is modulated at the cellular level in a regional and 
temporal manner.  60 
  Although there is not much information on the molecular mechanisms by 
which proneural proteins regulate transcription or the co-factors that are involved 
in the activation of target genes, it is evident that these interactions modulate 
their  transcriptional activity (reviewed Powell and Jarman, 2008). The myogenic 
bHLH protein, MyoD interacts with a plethora of molecules including DNA 
binding TFs, Mef2 and Pbx, and chromatin remodelling cofactors such as the 
histone acetylases CBP/P300 and PCAF and some components of the SWI/SNF 
complex (Tapscott, 2005). The proneural bHLH Ngn proteins, recruit CBP/P300 
to activate target promoters (Ge et al., 2006; Koyano-Nakagawa et al., 1999; Sun 
et al., 2001). More recently Mash1 and the POU proteins Brn1 and Brn2 were 
shown to interact on the promoter of the Notch ligand Delta1 gene and 
synergistically activate its transcription, a key step in neurogenesis (Castro et al., 
2006).  
 
1.5 A model for the transcriptional control of neural cell fates in the 
telencephalon   
 
  In combination, these data provide support for the construction of a 
simple conceptual model for the transcriptional control of cell fate specification 
in the developing telencephalon. Similar to its expression in the spinal cord, 
Sox9 is expressed in the VZ of the telencephalon, and thus may be implicated in 
the specification of oligodendrocyte cell fates within this domain, as has been 
demonstrated in more caudal regions of the CNS. Furthermore, a role for Mash1 
and Olig2 bHLH transcription factors in the generation of oligodendrocytes in 
the ventral telencephalon are well established, thus it is plausible to propose that  61 
Sox9 may also contribute to this function. Essentially, this model proposes that 
modifications in the expression levels of three core TFs, namely Olig2, Sox9 and 
Mash1 can provide a rationale for the commitment of neural progenitors in the 
ventral telencephalon to form neurons, oligodendrocytes and subsequently 
astrocytes in that temporal sequence. Note that an assumption of this model is 
that ventral neural progenitor cells of the telencephalon generate neurons 
followed by oligodendrocytes, which has been demonstrated (He et al., 2001). 
Briefly, the model proposes that Sox9, a repressor of the neuronal fate in the 
ventral spinal cord, is originally expressed at low levels in telencephalic 
progenitor cells of the VZ coexpressing Olig2 and Mash1, and thus lead to 
neuronal fate selection. The mechanisms underlying the initial reduced level of 
expression of the gliogenic gene Sox9 are not understood, however Mash1 may 
repress this gene in neuronal precursors, comparable to the  mode of repression 
of the Sox10 gene by Mash1 in neural crest-derived neuronal precursors (Kim et 
al., 2003). Subsequently a progressive increase in the levels of Sox9 expression 
would trigger a change in the cell fate selection of progenitor cells to generate 
oligodendrocytes. Down regulation of repressors of the astroglial cell fate, Olig2 
and Mash1, in Sox9 expressing progenitors would then mark the end of the 
oligodendroglial phase and the selection of the astroglial fate. Note that whilst 
this model details a TF combinatorial code for the generation of Mash1-
dependent OPCs, it is clearly evident that Mash1-independent OPC population 
generated in vivo must incorporate other factors for oligodendroglial cell fate 
specification.  
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1.6 Promoter occupancy using ChIP-on-chip genomic technology 
 
  A key question in trying to understand the molecular mechanisms 
underlying the activity of a particular TF, is how genomic information is 
translated into gene regulation. Indeed, over the past decades this issue has been 
fervently pursued and has led to a conventional opinion of transcriptional 
regulation whereby cis-regulatory elements, including promoters and enhancers, 
modulate the levels of gene transcription (Lee and Young, 2000; Sandelin et al., 
2007). Transcriptional activity is regulated by DNA-binding factors through 
proximal promoters and distal enhancers. Notably, these site-specific protein-
DNA interactions not only help to recruit new factors that are essential for 
transcriptional activity but moreover function to stabilise pre-existing 
conformations at the core promoter.  
  Recent progress in chromatin immunoprecipitation experiments followed 
by microarray (ChIP-on-chip) or by sequencing (ChIP-seq) techniques (Figure 
9), have enabled the creation of specific protein–DNA interaction maps at a 
genomic scale from a given cell type (Wederell et al., 2008; Xu et al., 2007; 
Robertson et al., 2007). Briefly, ChIP involves the treatment of cells with 
formaldehyde to form crosslinks between DNA-binding proteins and DNA, 
followed by chromatin fragmentation using sonication or enzymatic digestion 
methods. Immunoprecipitation of crosslinked chromatin with a specific antibody 
that recognises the factor of interest, enriches for chromatin bound regions and 
thus the discovery of all the binding sites in the genome for the factor of interest. 
Precipitated fragments are purified, and using polymerase chain reaction (PCR) 
techniques, particular genes of interest can be analysed. However, the coverage  63 
of analysis can be extended to a genome-wide scale by ChIP-on-chip or ChIP-
seq. Briefly, for ChIP-on-chip the immunoprecipitated sample and control input 
DNA, are labelled with different fluorescent dyes and subsequently hybridized to 
microarrays. In this approach, binding sites are identified by the actual intensity 
of the signal of the immunoprecipitated sample relative to the signal of the input 
DNA sample for every probe tiled on the microarray, using ChIP-on-chip peak-
calling programs (Johnson et al., 2008; Bieda et al., 2006). In  ChIP-seq, the 
immunoprecipitated sample is analysed using high-throughput next-generation 
sequencers, and binding sites are identified using ChIP-seq peak-calling 
programs (Robertson et al., 2007; Zhang et al., 2008; Fejes et al., 2008; Jothi et 
al., 2008; Hoffman et al., 2009). Notably, genome wide profiling of site-specific 
TFs is an extremely powerful technique, and has made significant contributions 
to the understanding of the patterns and specificity of TF binding, and stability of 

















Figure 9. Chromatin immunoprecipitation (ChIP) methods: ChIP-on-chip 
and ChIP-seq. (Farnham, 2009) 
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1.7 Neurospheres as a model for studying cell fate specification 
 
  Stem cells are defined as undifferentiated cells, which maintain their 
capacity for self-renewal and multipotentiality. Note that because of the lack of 
definitive markers stem cells are commonly defined by these functional 
characteristics. Indeed using a serum-free culture system Reynolds and Weiss  
demonstrated that a single cell from the adult CNS had the capacity to proliferate 
and form a non-adherent cluster of undifferentiated cells, otherwise termed as a 
neurosphere (Reynolds and Weiss., 1992) that was able to generate secondary 
spheres after dissociation and could differentiate into neurons, astrocytes and 
oligodendrocytes. Indeed, they demonstrated that the cell they had isolated 
exhibited critical stem cell attributes, namely extensive self-renewal, the capacity 
to give rise to a large number of progeny and multipotency (Potten and Loeffler, 
1990; Hall and Watt, 1989). These findings lay the foundations for further 
studies in this field, which have since established a culture system that uses 
epidermal growth factor (EGF) and FGF2 as mitogens that enable the reliable 
production of undifferentiated CNS precursors that can be expanded as 
neurospheres or differentiated into mature cells of the CNS (Reynolds and 
Weiss., 1992, 1996; Gritti et al., 1995, 1999, 1996; Weiss et al., 1996a, 1996b). 
 
  The neurosphere culture system has been used for numerous applications, 
including in assays to define the presence of stem cells particularly in the CNS 
(Reynolds and Weiss, 1992; Gritti et al., 1999; Weiss et al., 1996a; Hitoshi et al., 
2002; Lu and Wong 2005; Yang and Levison, 2006; Morshead et al., 1994; 
Maslov et al., 2004; Marshall et al., 2005). Notably, NS cells have been isolated  66 
from various areas of the embryonic brain as well as from proliferative regions in 
the adult nervous system (Weiss et al., 1996a; Gritti et al., 2002). Furthermore, 
this culture system has been exploited to study factors and events that regulate 
stem cell maintenance or differentiation to try to identify a specific molecular 
signature of ‘stem cell identity’ (Ivanova et al., 2002; Ramalho-Santos et al., 
2002) and to investigate neural development, in particular neurogenesis and 
gliogenesis (Marshall et al., 2005; Enwere et al., 2004; Kohyama et al., 2005; 
Pitman et al., 2004; Deleyrolle et al., 2006). 
  Whilst some studies propose that neurosphere cultures maintain regional 
identities and intrinsic differences that correspond to the CNS regions they were 
originally isolated from (Hitoshi et al., 2002; Parmar et al., 2002; Ostenfeld et al., 
2002), other studies suggest that the differentiation potential and spatial identity 
of these cultures are deregulated (Santa-Olalla et al., 2003; Hack et al., 2004; 
Gabay et al., 2003; Machon et al., 2005).  It is therefore not surprising that an 
ongoing debate ensues regarding the physiological relevance of neurosphere 
cultures for studies in stem and progenitor cell diversity, phenotype and fate. 
Moreover neurospheres are not only formed from stem cells but also from 
progenitor cells with a limited capacity for self-renewal (Reynolds and Rietze, 
2005). It is calculated that, less than 10% of neurospheres are derived from bona 
fide  NSCs. While the serum-free neurosphere culture system provides an 
invaluable tool for assaying progenitor cell populations under defined conditions, 
it is important to note that these cultures are heterogeneous and variable. 
Nevertheless, this culture system is relevant to model neural development to 
study oligodendrogenesis from NSC-derived progeny and to identify specific 
factors involved in these processes.   67 
1.8 Aims of the present work 
 
This project has aimed towards understanding the gene regulatory 
networks downstream of Mash1 in lineage commitment of neural progenitors 
and specifically the mechanisms underlying Mash1 activity in oligodendroglial 
commitment, for which nothing is known. We hypothesise that Mash1 interacts 
with either neuronal- or oligodendroglial-specific cofactors and that these 
interactions are responsible for modulating Mash1 activity and subsequent 
regulation of target promoters in different cells, resulting in the specification of 
neuronal or oligodendroglial commitment, respectively.  
 
There have been three main components to this work: 
 
1) An in vitro cellular system to investigate the molecular mechanisms of Mash1 
in oligodendroglial cell fate specification was used to identify genomic regions 
bound by Mash1 with ChIP-on-chip technology. 
 
2) Mouse transient transgenics were used to interrogate the in vivo activity of 
genomic segments bound by Mash1 in order to isolate regions with activity in the 
oligodendroglial lineage.  
 
3) ChIP analysis of other oligodendroglial promoting TFs, namely Olig2 and 
Sox9, were performed to identify TF co-occupancy in genomic regions bound by 
Mash1.  
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2.1 Animals  
 
  Mice were housed, bred and treated according to the guidelines approved 
by the UK Home Office under the Animals (Scientific Procedures) Act 1986. 
Transgenic mouse lines, Rosa26YFP (Srinivas et al., 2001), Sox10Cre (Matsuoka 
et al., 2005) and Mash1 (Guillemot et al., 1993), were genotyped as described 
below. Wild-type Parkes mice were used. Timed-mated mice were set up and 
midday of the day of vaginal plug discovery was considered as embryonic day 




  All mice were genotyped by PCR using 1μl of non-quantified extracted 
DNA. Genomic DNA was extracted from tail or ear biopsies by overnight 
incubation in 100mM Tris HCl, pH8.5, 200mM NaCl, 5mM EDTA, 0.2% SDS, 
100mg/ml proteinase K at 55°C.  Samples were centrifuged at 10,000rpm for 10 
minutes, the supernatant was precipitated using 1 volume of isopropanol, 
centrifuged and washed with 70% ethanol. Genomic DNA was resuspended in 
50μl of water. PCR were performed using LIM buffer (67mM Tris HCL, pH8.8, 
6.7mM MgCl2, 170mg/ml BSA, 16.6mM (NHS4)2SO4), 10% DMSO, 1.5mM 
dNTPs, 22.5ng of each primer reverse and forward, and 1.25 units of Taq DNA 
polymerase (AB gene). 
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Rosa26YFP  mice were genotyped using forward primer 5’- 
gctctgagttgttatcagtaagg-3’, reverse wild-type locus 5’-gcgaagagtttgtcctcaacc-3’, 
reverse transgenic locus 5’-ggagcgggagaaatggatagt-3’. The PCR program used 
was 95°C, 2.5 minutes, 35 cycles of 94°C, 30 seconds, 55°C, 30 seconds, 72°C, 
45 seconds and a final extension at 72°C, 10 minutes. 
 
Sox10Cre  mice were genotyped using forward primer 5’- atccgaaaagaaaacgttga-
3’ and reverse primer 5’-atccaggttacggatatagt-3’. The PCR program used was 
94°C, 3 minutes, 35 cycles of 94°C, 1 minute, 53°C, 1 minute 10 seconds, 72°C, 
1 minute and a final extension at 72°C, 5 minutes.  
 
Mash1  mice were genotyped using forward primer 5’-ccaggactcaatacgcaggg-3’ 
and reverse primer 5’- gcagcgcatcgccttctatc-3’ for the Mash1 allele, and 
forward primer 5’-ccaggactcaatacgcaggg-3’ and reverse primer 5’-
ctccgggagcatgtccccaa-3’ for the Mash1 wild-type allele. The PCR program used 
was 94°C, 5 minutes, 35 cycles of 94°C, 1 minute, 60°C, 1 minute, 72°C, 1 
minute and a final extension at 72°C, 10 minutes.  
 
Transient Transgenic mice were genotyped for the presence of the lacZ gene 
using forward primer 5’-gcacatccccctttcgccagctggcgtaat-3’, and reverse primer 
5’-cgcgtctggccttcctgtagccagctttca-3’. The PCR program used was 95°C, 5 
minutes followed by 33 cycles of 94°C, 1 minute, 58°C, 1 minute, 72°C, 1 
minute.  Product is approximately 400bp. 
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2.2 Molecular Biology: Cloning 
 
  All plasmids used for cloning were analysed and prepared using standard 
Qiagen maxiprep and miniprep kits according to manufacturers instructions.   
Restriction digests were carried out according to Current protocols in Molecular 
Biology using buffers and restriction enzymes from Roche or New England 
Biolabs.  Restriction digests were purified using a Qiagen gel extraction kit 
according to the manufacturers instructions or by phenol/chloroform extraction.  
Plasmids were grown in competent DH5a Escherichia Coli bacteria in Luria-
Bertani (LB) medium containing 100mg/ml of the antibiotic ampicillin (Sigma).  
All LB/agar plates used for the isolation of single colonies contained 100mg/ml 
of ampicillin. 
 
2.2.1 Isolation of RNA and cDNA synthesis 
 
  To generate an Engrailed repressor of Mash1, and expression constructs  
for Sox9 and Olig2 the open reading frame of mouse Mash1 bHLH, Sox9 and 
Olig2 respectively, were isolated by reverse transcriptase-PCR (RT-PCR).  Total 
RNA was extracted from the heads of two E13 embryos dissected in phosphate 
buffered saline (PBS).   Tissue was transferred to 1ml of TRIzol (Invitrogen) and 
homogenised on ice.  The suspension was incubated at room temperature for 5 
minutes before adding 300μl of chloroform and inverting the mixture several 
times, followed by incubated at room temperature for 3 minutes. Phases were 
then separated by centrifugation at 4°C, 12,000g for 15 minutes.  The aqueous 
upper phase was removed and precipitated using 500μl isopropanol for 10   72 
minutes at room temperature.  The sample was then centrifuged at 4°C, 12,000g 
for 10 minutes and the pellet washed in 1ml of 75% ethanol and subsequently 
centrifuging at 4°C, 12,000g for 5 minutes.  The pellet was then air-dried and 
dissolved in 100μl RNase free water.  All solutions used throughout this protocol 
were made using RNase free water.  The concentration of the RNA was checked 
with a spectrophotometer and the integrity of the sample was confirmed by 
running 3μg of sample in a 1% Tris-acetate- ethylenediaminetetraacetic acid 
(TA-EDTA or TAE) gel. Single stranded cDNA was synthesised using the High 
Capacity RNA-to-cDNA Kit according to the manufacturers instructions 
(Applied Biosystems). Briefly, 2μg of total RNA were used per 20μl reaction, 
which was incubated at 37°C for 60 minutes and stopped by heating to 95°C for 
5 minutes.  
 
2.2.2 Cloning full-length mouse Mash1 bHLH domain, Sox9 and Olig2 
expression constructs 
  
  Mash1 bHLH open reading frame was amplified with high fidelity PCR 
using gene specific primers (forward primer 5’-attaccatggtggcgcgccgcaacgagcgc-
3’ which had an NcoI restriction enzyme site incorporated, and reverse primer 
5’-gtatgaattcgtggtgctcgtccagcagctg-3’, with an EcoRI site for cloning) and mouse 
cDNA as template. PCR was performed as follows 95°C, 5 minutes, 30 cycles of 
94°C, 1 minute, 55°C, 1 minute, 72°C, 1 minutes and a final extension at 72°C, 
10 minutes. The resulting 135bp product was purified by gel extraction and 
digested using NcoI/EcoRI restriction enzymes.  This fragment was then ligated 
with pSlax EngR vector also digested with NcoI/EcoRI restriction enzymes and   73 
minipreps were sequenced to identify full-length mouse Mash1 bHLH. 
Subsequently Mash1 bHLH-EngR (the mouse Mash1 bHLH domain in frame 
with the EngR domain; Smith and Jaynes, 1996) was subcloned upstream of an 
IRES and an NLS-tagged GFP in the pCAGGS expression vector, otherwise 
referred to as pCAGGS IRES GFP.  
 
  Olig2 and Sox9 expression constructs were cloned from mouse cDNA 
with high fidelity PCR into the EcoRV/NheI sites of the pCAGGS IRES GFP 
vector. In brief, the Olig2 open reading frame was amplified using gene specific 
primers (forward primer 5’-gtacgatatcgccaccatggactcggacgccagcct-3’ containing 
a EcoRV cloning site and a Kozak sequence preceding the start codon, reverse 
primer 5’-gtccgctagctcacttggcgtcggaggtga-3’, containing an NheI restriction site 
for cloning). PCR was performed as follows 95°C, 5 minutes, 35 cycles of 94°C, 
1 minute, 55°C, 1 minute, 72°C, 2 minutes and a final extension at 72°C, 10 
minutes. The resulting 972bp product was purified by gel extraction and digested 
using EcoRV/NheI restriction enzymes. The Sox9 open reading frame was 
amplified with gene specific primers (forward primer 5’-
gtacgatatcgccaccatgaatctcctggacccct-3’ containing a EcoRV cloning site and a 
Kozak sequence preceding the start codon, reverse primer 5’-
gtccgctagctcagggtctggtgagctgt-3’, containing an NheI restriction site for 
cloning). PCR was performed as follows 95°C, 5 minutes, 35 cycles of 94°C, 1 
minute, 50°C, 1 minute, 72°C, 4 minutes and a final extension at 72°C, 10 
minutes. The resulting 2927bp product was purified by gel extraction and 
digested using EcoRV/NheI restriction enzymes.  Olig2 and Sox9 fragments 
were then ligated with pCAGGS IRES GFP vector also digested with   74 
EcoRV/NheI restriction enzymes and minipreps were sequenced to identify full 
length mouse Olig2 and Sox9 respectively. Olig2 and Sox9 protein expression 
was verified by immunofluorescence with antibodies to Olig2 and Sox9, 
respectively. The mix for all high fidelity PCRs contained LIM buffer, 10% 
DMSO, 04mM dNTPs, 750ng each primer, 2.5 units of Pfu DNA polymerase 
and 100ng of cDNA.  
 
2.2.3 Cloning Sox9,  Olig2,  Notch1 and Brevican putative enhancers for 
reporter gene assays 
 
  For luciferase reporter assays, Olig2 and Sox9 putative distal enhancer 
elements were cloned from mouse genomic DNA with high fidelity PCR into the 
NheI/SalI sites of the luciferase reporter vector p-glob-Luc. In detail, the Olig2 
genomic element was amplified with gene specific primers (forward primer 5’-
gtacgtcgacagacccataaacacatagata-3’ containing an SalI cloning site, reverse 
primer 5’-gtccgctagcagaggtttgcttctggaagct-3’ containing an NheI cloning site). 
PCR was performed as follows 95°C, 5 minutes, 40 cycles of 94°C, 1 minute, 
58°C, 1 minute, 72°C, 2 minutes and a final extension at 72°C, 10 minutes. The 
resulting 848bp product was purified by gel extraction and digested using 
SalI/NheI restriction enzymes. The Sox9 genomic element was amplified using 
gene specific primers (forward primer 5’-gtacgtcgactaaaccaccgggaacattca-3’ 
containing an SalI cloning site, reverse primer 5’-gtccgctagcgcacccctattctgttggg-
3’ containing an NheI cloning site). PCR was performed as follows 95°C, 5 
minutes, 40 cycles of 94°C, 1 minute, 55°C, 1 minute, 72°C, 1 minute and a final 
extension at 72°C, 10 minutes. The resulting 187bp product was purified by gel   75 
extraction and digested using SalI/NheI restriction enzymes.  Olig2 and Sox9 
fragments were then ligated with p-glob-Luc vector also digested with 
SalI/NheI restriction enzymes and minipreps were sequenced to identify full 
length mouse Olig2 and Sox9 genomic elements, respectively.  
  
  For the generation of transgenic reporter mice, Olig2, Sox9, Notch1 and 
Brevican putative enhancer sequences were cloned from mouse genomic DNA 
with high fidelity PCR into the NotI/SpeI sites as 3' enhancer element into a lacZ 
reporter vector harbouring the basal human -globin promoter (BGZA). In detail, 
the Olig2 genomic element was amplified using gene specific primers (forward 
primer 5’- gtacgcggccgcagacccataaacacatagata-3’ containing an NotI cloning 
site, reverse primer 5’- gtccactagtagaggtttgcttctggaagct-3’ containing SpeI 
cloning site). PCR was performed as follows 95°C, 5 minutes, 40 cycles of 94°C, 
1 minute, 58°C, 1 minute, 72°C, 2 minutes and a final extension at 72°C, 10 
minutes. The resulting 848bp product was purified by gel extraction and digested 
using NotI/SpeI restriction enzymes. The Sox9 genomic element was amplified 
using gene specific primers (forward primer 5’-
gtacgcggccgctaaaccaccgggaacattca-3’ containing an NotI cloning site, reverse 
primer 5’-gtccactagtgcacccctattctgttggg-3’ containing SpeI cloning site). PCR 
was performed as follows 95°C, 5 minutes, 40 cycles of 94°C, 1 minute, 55°C, 1 
minute, 72°C, 1 minute and a final extension at 72°C, 10 minutes. The resulting 
187bp product was purified by gel extraction and digested using NotI/SpeI 
restriction enzymes. The Notch1 genomic element was amplified using gene 
specific primers (forward primer 5’-gtacgcggccgccaggagtggtggatccctc-3’ 
containing a NotI cloning site, reverse primer 5’-  76 
gtccactagtctaggaaggaaattgacccgtgt-3’ containing a SpeI cloning site). PCR was 
performed as follows 95°C, 5 minutes, 35 cycles of 94°C, 1 minute, 55°C, 1 
minute, 72°C, 2.5 minutes and a final extension at 72°C, 10 minutes. The 
resulting 1632bp product was purified by gel extraction and digested using 
NotI/SpeI restriction enzymes. The Brevican genomic element was amplified 
using gene specific primers (forward primer 5’-
gtacgcggccgcgacttctcattggttaaaggg-3’ containing a NotI cloning site, reverse 
primer 5’-gtccactagtcttggtttctttcctagctc-3’ containing a SpeI cloning site). PCR 
was performed as follows 95°C, 5 minutes, 35 cycles of 94°C, 1 minute, 50°C, 1 
minute, 72°C, 2 minutes and a final extension at 72°C, 10 minutes. The resulting 
1166bp product was purified by gel extraction and digested using NotI/SpeI 
restriction enzymes. Olig2,  Sox9,  Notch1 and Brevican putative enhancer 
sequences were then ligated with BGZA vector also digested with NotI/SpeI 
restriction enzymes and minipreps were sequenced to identify corresponding full 
length mouse genomic elements. The mix for all high fidelity PCRs contained 
LIM buffer, 10% DMSO, 04mM dNTPs, 750ng each primer, 2.5 units of Pfu 
DNA polymerase and 100ng of genomic DNA.  
   
2.3 Generation of transgenic mice and LacZ staining 
  
  All fragments for pronuclear injection were linearised with NotI 
restriction enzyme and gel purified on a 1% TAE gel followed by extraction 
using GFX Gel Band Purification Kit (GE Healthcare) and resuspended in 
injection buffer (10mM Tris-HCl pH 8.0, 0.1mM EDTA). Transgenic mice were 
generated by standard procedures using fertilized eggs from (CBA x   77 
C57BL/10)F1 embryos and founder animals. Staged transgenic embryos were 
dissected from the uterus in cold PBS and fixed in 4% paraformaldehyde (PFA) 
at 4°C for 30 minutes, and washed with PBS. LacZ positive embryos, determined 
by PCR genotype, were cryoprotected in 20% (w/v, in PBS) sucrose overnight at 
4°C, frozen in embedding medium, Optimal Cutting Temperature (OCT) (BDH), 
and stored at -80°C. Sections (10μm) were prepared using a Microm cryostat 
(Zeiss). Embryo sections were stained at 37°C overnight in X-Gal staining 
solution (5mM K3Fe(CN)6, 5mM K4Fe(CN)6, 5mM EGTA, 0.01% deoxycolate, 
2mM MgCl2, 0.4mg/ml X-gal, 0.02% NP-40 in PBS). The staining reaction was 
stopped by washing in PBS/0.02% NP-40, sections were post-fixed with 4% PFA 
for 20 minutes at room temperature, washed with PBS three times for 10 
minutes, and mounted with Aquamount (BDH). Images were captured using a 
ProgRes C14 camera (Jenoptik) linked to an Axioplan II microscope (Zeiss). 
Images were processed using and Adobe Photoshop CS v8.0 (Adobe Systems) 
software package. 
 
2.4 Flow cytometric analysis and cell sorting 
 
  Sox10Cre/Rosa26YFP embryos (E12.5) were dissected in cold 
Dulbecco’s Modified Eagle’s Medium (DMEM, Invitrogen) and the ventral 
telencephalon dissociated using a P200 Gilson to obtain a single cell suspension 
and passed through a 40μm cell strainer (VWR). Cells were subsequently sorted 
for GFP expression and 7-Aminoactinomycin D (7-AAD), to exclude dead cells, 
using a MoFlo cytometer (Dako UK, Ely, United Kingdom). Flow cytometry 
data were analysed on FlowJo 8.8.6 software package.    78 
2.5 In vitro cell culture 
 
2.5.1 NS5 cells 
 
  NS5 cells were cultured as described previously (Conti et al., 2005), with 
the following modification; cells were propagated on laminin-coated flasks 
(10g/ml, Sigma) rather than on gelatin.  
 
2.5.2 Neurosphere formation and neurosphere-derived NSCs as monolayer 
cultures 
 
  Parkes embryos (E13.5) were dissected in DMEM:F12 (Gibco) 
supplemented with 100 IU/ml Penicillin and 100μg/ml Streptomycin (Gibco) on 
ice. Ventral telencephalic tissues were isolated and transferred into 0.5ml 
neurosphere proliferation medium (NPM). Briefly, for 100ml of NPM; DMEM-
F12, -L-Glutamine (Gibco), 93.5ml; 40% Glucose (Sigma), 1.5ml; final 
concentration 100U/ml Penicillin, 1ml; final concentration 100μg/ml 
streptomycin sulphate, 1ml; L- Glutamine (200mM stock), 1ml; N2 supplement 
10X (Invitrogen), 1ml; B27 5X (Invitrogen), 2ml; Human recombinant bFGF 
(R&D Systems) 1μg/μl stock, 2μl; Human recombinant EGF (R&D Systems) 
1μg/μl stock, 2μl. The tissues were mechanically dissociated using a P200 
Gilson to obtain a single cell suspension and passed through a 40μm cell strainer 
(VWR). The numbers of cells were counted using a haemocytometer, and cells 
were then plated at a density of 5 x 10
4 cells/ml in NPM in tissue culture dishes.  
Cells were cultured at 37°C, 5% CO2 and 24 hours later cells were again   79 
dissociated and passed through a cell strainer.  Seventy-two hours after initial 
seeding the medium was replaced with fresh NPM. Primary neurospheres formed 
in this assay were maintained in culture for a total of 10 days, with a medium 
change every day.  
  For NSC monolayer cultures primary neurospheres were mechanically 
dissociated after 10 days of neurosphere formation using a P200 Gilson in the 
presence of Accutase (Sigma) and passed through a 40μm cell strainer (VWR) to 
obtain a single cell suspension. Cultures were propagated with NPM as described 
above on poly-ornithine (10g/ml, Sigma) and laminin (5g/ml, Sigma) coated 
culture flasks. Cultures were thereafter maintained as adherent cultures for a total 
of 10 passages after which fresh cultures were started.  
 
2.5.2.1 Neurosphere differentiation 
 
  Primary neurospheres at day 10 of neurosphere formation were 
transferred into neurosphere differentiation medium (same as NPM, but without 
EGF and FGF mitogens) on poly-ornithine (10g/ml, Sigma) and laminin 
(5g/ml,Sigma) coated glass coverslips. Neurospheres were allowed to 
differentiate for 5 days at 37°C, 5% CO2, and half of the medium changed every 
day with fresh neurosphere differentiation medium. 
 
2.5.3 Oligospheres Cultures 
 
Oligospheres were cultured as described previously (Chen et al., 2007).  
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2.6 Immunohistochemistry and Immunocytochemistry 
 
  Mouse embryos were dissected in ice-cold PBS and heads were fixed in 
4% PFA for 30 minutes at 4°C, washed with PBS, transferred into 15% sucrose 
in phosphate buffer (PB) pH 7.2 overnight at 4°C, embedded in 7.5% gelatin, 
15% sucrose in PB at 42°C, frozen in –40°C isopentane and stored at –80°C. 
Sections (10μm) were prepared using a Microm cryostat (Zeiss). For 
immunohistochemistry, frozen sections were air dried, washed in PBS at 42°C to 
remove the gelatin and processed for immunofluorescence. At least three 
embryos were analysed per condition, unless specified otherwise. Sections were 
treated with a blocking solution (PBS plus 10% normal goat or donkey serum 
and 0.1% TritonX-100, PBS-T) for 30 minutes at room temperature and 
incubated with primary antibodies overnight at 4°C. Oligospheres were allowed 
to pellet by gravity in a microcentrifuge tube, rinsed briefly with PBS, fixed with 
4% PFA at 4°C for 10 minutes, washed three times with PBS and further 
processed as described for embryonic tissue above. At least five oligospheres 
were analysed per condition, unless specified otherwise. For 
immunocytochemistry, cells were fixed for 10 minutes with 4% PFA at room 
temperature, washed with PBS, blocked for 15 minutes at room temperature and 
incubated with primary antibodies overnight at 4°C.  
 
  Primary antibodies; rabbit anti--galactosidase (1:20,000; Cappel), rabbit 
anti-GFAP (1:1,000; DAKO), mouse anti-Tuj1 (1:1,000; Sigma), mouse anti-
HuC/D (1:200; Molecular Probes), rabbit anti-GFP (1:1,000; Molecular Probes), 
sheep anti-GFP (1:1,000; Molecular Probes), rabbit anti-MBP (1:1,000; Abcam),   81 
goat anti-Sox9 (1:500; R&D Systems), rat anti-PDGFR (1:800; BD 
Pharmigen), mouse anti-O4 (a kind gift from B. Zalc), mouse anti-Mash1 (1:100; 
Hybridoma supernatant, generated in-house), rabbit anti-Sox2 (1:800; Chemicon) 
and rabbit anti-Olig2 (1:1,000; Chemicon). Corresponding conjugated 
fluorescent secondary antibodies, Alexa 488 (green 1:1,000; Millipore) or Cy3 or 
Cy5 (red; 1:500; and blue; 1:500 respectively; Jackson ImmunoResearch), were 
incubated for 2 hours or 1 hour at room temperature for tissue sections or 
monolayer cell cultures, respectively. Sections were washed in PBS, incubated at 
room temperature with 4’,6-Diamidino-2-phenylindole (0.1g/ml, DAPI, Sigma) 
for 15 minutes, and washed again with PBS before mounting with fluorescent 
mounting medium Aquamount (BDH). Note that some oligosphere sections the 
nuclei were counterstained with TOTO-3 (1:1,000) for 2 hours at room 
temperature (simultaneously with the secondary antibodies). Images were 
acquired with an epifluorescent microscope (Axioplan II, Zeiss) equipped with a 
CCD (charge-coupled device) digital camera (ProgRes C14, Jenoptik) and 
Openlab software (Improvision), or a laser scanning confocal microscope 
(Radiance 2100, BioRad). Cell counts were performed on representative fields.  
Images were processed using and Adobe Photoshop CS v8.0 (Adobe Systems) 
software package. 
 
2.7 Cell Transfections 
 
  Neurosphere-derived NSCs were transfected using the mouse NSCs 
Nucleofector™ kit and optimised protocols provided by the manufacturer 
(Lonza). Briefly, 5  10
6 cells were resuspended in 100l of the mouse NSC   82 
Nucleofector™ solution (pre-warmed to room temperature). Cells were mixed 
with 5g of DNA, transferred into an Amaxa certified cuvette and transfected 
with the program A-33. Immediately after transfection, 500μl of the 37°C pre-
warmed culture medium was added, and cells were plated onto PORN/laminin 
coated coverslips at a final concentration of 200,000 cells/ml (100,000 cells/well) 
in differentiation medium. All cDNAs were expressed from pCAGGS IRES 
GFP. Medium was changed three hours after plating, when the majority of cells 
had adhered, to remove cellular debris. Data are represented as means of 
triplicates, and experiments were repeated three times.  
 
2.9 Luciferase assays 
 
  NS5 cells were seeded 1 day earlier  onto 48-well plates (Nunc) at a 
density of 1.2x10
5cells/well and maintained under propagation culture conditions 
(as described in Conti et al., 2005). Transient transfections were performed using 
lipofectamine transfection reagent according to the manufacturers instructions 
(Invitrogen).  All cDNAs were expressed from pCAGGS IRES GFP (Sox9EngR 
expression construct, transactivation domain of chick Sox9 containing amino 
acid 265–495 replaced by Engrailed transcriptional repressor domain; Cheung et 
al., 2005; and the Mash1 expression construct; Geoffroy et al., 2009).  The 
luciferase reporter constructs used the -globin minimal promoter.  The amount 
of expression and reporter plasmid used for each transfection was 375ng/well.  
Cells were harvested 24 hours after transfection and extracts were assayed 
according to manufacturers instructions using the Promega luciferase system.   
Values (relative luciferase units, RLU) were corrected for protein expression   83 
through co-transfection with CMV--gal plasmid and measurement of -
Galactosidase (250ng plasmid/well). Data is shown as the mean of quadruplicate 
values obtained from representative experiments. The error bars represent the 
standard deviation of the mean, which was calculated from quadruplicates. 
 
2.10 Quantitative RT-PCR 
 
  For quantitative real-time RT-PCR analysis, RNA was extracted from 
oligosphere and neurosphere cultures with TRIzol (Invitrogen) as described 
above, followed by Qiagen RNeasy kit according to the manufacturers 
instructions. The integrity of the RNA was assessed by spectrophotometry. A 
total of 25ng of RNA was used for reverse transcription with the High Capacity 
RNA-to-cDNA Kit (Applied Biosystems) to synthesis cDNA as described above. 
Final volumes of cDNA were diluted 1:3 and 2μl were used as template for 
amplification. The following program was used 50°C, 2 minutes, 95°C, 10 
minutes, 40 cycles of 95°C, 15 seconds, 60°C, 1 minute, 72°C, 1 minute. To 
quantitate mRNA levels, cDNA samples were analyzed in triplicate by Real-
Time PCR using TaqMan Gene Expression Assays for the appropriate genes, on 
an Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems). 
Transcript levels of targets were normalized to levels of housekeeping gene, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, as an internal 
control. Assay ID; Sox10, Mm01300162_m1; PDGFR, Mm01211694_m1; 
Olig2, Mm01210556_m1; Sox9, Mm00448840_m1; Mash1, Mm03058063_m1; 
GAPDH, Mm03302249_g1. Data is shown as the mean of triplicate values   84 
obtained from representative experiments. The error bars represent the standard 
deviation of the mean, which was calculated from triplicates. 
 
2.11 Chromatin Immunoprecipitation Assays 
 
  ChIP assays were performed with oligosphere culture material, with a 
monoclonal mouse anti-Mash1 antibody (Hybridoma supernatant, generated in-
house), polyclonal rabbit anti-Sox9 (AB5535, Chemicon), polyclonal rabbit anti-
Olig2 (AB9610, Chemicon) or a purified mouse IgG1,  isotype antibody 
(BioLegend) as a negative control. Chromatin from oligosphere cultures were 
prepared at either 5 or 14 days of oligosphere formation. Briefly, oligospheres 
were washed in Hank's buffered salt solution (HBSS, Gibco), fixed with 1% 
formaldehyde (Sigma) for 10 minutes at 4°C, quenched with 125mM of glycine 
(Sigma) for a further 8 minutes at room temperature, and washed with PBS 
supplemented with a Protease Inhibitor cocktail (PI, Roche). Oligospheres were 
then lysed with sodium dodecyl sulfate (SDS) lysis buffer (1% SDS, 10mM 
EDTA, 50mM Tris pH8.0) for 30 minutes at 4°C. Chromatin fragmentation was 
carried out using sonication with a Bioruptor (UCD-200, Diagenode) for 30 
minutes, with an interval cycle time of 30 seconds on, 30 seconds off. The 
concentration of the chromatin was checked by spectrophotometry and the 
integrity and size of fragments confirmed by running 1-3μg of sample in a 2% 
TAE gel. 
 
  Chromatin immunoprecipitation (IP) assays with anti-Mash1 antibody 
were performed with 30μg of chromatin per IP. Initially, chromatin was pre-  85 
cleared with 50μl of Dynabeads Sheep anti-Mouse IgG (110-31, Invitrogen) in IP 
buffer (1X IP buffer [10X IP Buffer, 0.2M HEPES pH8.0, 2M NaCl; 0.02M 
EDTA]; 0.1% Na-DOC; 1% Triton X-100, 1mg/ml BSA; 25X PI) for 1.5 hours 
at 4°C. Pre-cleared chromatin was then incubated with 3μl of Mash1 antibody 
overnight at 4°C rocking (for control IP 3μl of purified mouse IgG1,  isotype 
antibody were used). The following day 50μl of pre-blocked beads were added 
per IP for 2 hours at 4°C. Beads were then captured with a magnet and 50μl of 
chromatin from the negative control sample set aside (to be used at 5% input 
chromatin), beads were washed 5 times with RIPA buffer containing 0.5M LiCl, 
and once with TE buffer (10mM Tris-HCl pH8.0, 1mM EDTA). Note all washes 
were done for 4 minutes at room temperature in rotation. Beads were then 
resuspended in elution buffer (10mM Tris pH8.0, 1% SDS) for 10 minutes at 
65°C. The supernatant was then incubated with proteinase K for 2 hours at 42°C, 
and crosslinks were reversed overnight at 65°C. Chromatin was then extracted by 
phenol/chloroform, and precipitated with NaAc and ispopropanol, and the pellet 
washed with 75% ethanol, after which it was air dried and re-suspended in 120μl 
of water.  
  Chromatin IP assays with anti-Olig2 (AB9610, Chemicon) and anti-Sox9 
(AB5809, Chemicon) antibodies were performed essentially as above, with the 
following modifications: (i) chromatin was diluted in reduced SDS buffer 
(50mM HEPES-KOH pH7.5, 150mM NaCl, 2mM EDTA, 1% TritonX-100, 
0.1% NaDOC and 0.1% SDS) rather than IP buffer; (ii) 5μl of anti-Olig2 and 
anti-Sox9 antibodies were added per IP, and were incubated overnight with 
chromatin and 50μl of pre-blocked beads; (iii) after Olig2 or Sox9 IPs, beads 
were washed three times with reduced SDS buffer, once with reduced SDS   86 
buffer supplemented with 0.35M NaCl, twice with NP40 wash buffer (10mM 
Tris-HCl pH8.0, 0.25M LiCl, 1mM EDTA, 0.5% NP40 and 0.5% NaDOC) and 
once with TE buffer; (iv) to retrieve immunoprecipitates, magnetic beads 
Dynabeads ProteinG (100-04D, Invitrogen) for Olig2 and Sox9 have been used.  
  Immunoprecipitated DNA sequences were quantified by real-time PCR 
(primers are listed below; primers were designed with Primer3 Tool 
[http://frodo.wi.mit.edu/primer3/] and amplicon sequences where checked by 
BLAST against the mouse genome to ensure specificity) by using the iCycler iQ 
Real-Time PCR Detection System (BioRad) and a SYBR-Green-based kit for 
quantitative PCR (iQ Supermix, BioRad). Quantities of immunoprecipitated 
DNA were calculated by comparison to a standard curve generated by serial 
dilutions of input DNA. The data were plotted as means of at least two 
independent ChIP assays and error bars represent standard deviations. IP 
efficiency was calculated as the ratio of precipitated sequence over total amount 
of sequence in the input chromatin. 
 
  The primers used for amplification: ActinB forward, 5’-
gccatgttcaatggggtact-3’, reverse, 5’-ggtgctaagaaggctgttcc-3’; DeltaM forward, 
5’-gcgtggctgtcattaagg-3’, reverse, 5’-ggtgctgtctgcattacc-3’; Delta3 forward, 5’-
atttcctgtccgtttgcctctc-3’, reverse, 5’-gtaaatgtcgccatctgc-3’; Lfng forward, 5’-
ttaaccaggccagctgtatg-3’, reverse, 5’-cattgtccgccagctttg-3’; Fbxw7 forward, 5’-
cagctatgttcctgctgtgc-3’, reverse, 5’-caacttctgcctgcttcctc-3’; Delta1 ORF forward, 
5’-gtctcaggaccttcacagtag-3’, reverse, 5’-gagcaaccttctccgtagtag-3’; Fbxw7 ORF 
forward, 5’-ctcgtcacattggagagtgg-3’, reverse, 5’-caggagcttggtttcctcag-3’; Sox9 
forward, 5’-gagtaaaccaccgggaacat-3’, reverse, 5’-aacgctaactgtggaatcgaa-3’;   87 
Olig2 forward, 5’-acaatgtcaggccattagtatgtt -3’, reverse, 5’-acagaatggtgctgttcagg-
3’; Dll4 forward, 5’-ggccaggatgaggatatg-3’, reverse, 5’-ggtcctcagctgtatggtaatg-
3’; Tubb3 forward, 5’-aggggacgaagcaaagagta-3’, reverse, 5’-
aggaacctccacccaagag-3’; Map2 forward, 5’-cgaatgactgccttccctat-3’, reverse, 5’-
cccctccttacacaccaaac-3’; Brevican forward, 5’-ttcccactttcctcctcttg-3’, reverse, 5’-
gtaaggtcacagcccccac-3’; Cspg4 forward, 5’-ggtacacagatggggctcac-3’, reverse, 
5’-cagctactcctgcccttcc-3’; Ascl1 forward, 5’-tcccttttgtaggggttgaa-3’, reverse, 5’-
ctgttcccgttcctgttcc-3’; Olig1 forward, 5’-ccacccggaactctcttct-3’, reverse, 5’-
acttcatcagccccttcttg-3’; Mog forward, 5’-aaccctttcgcttcaggct-3’, reverse, 5’-
tccctttccaggtcttgatg-3’; Sox8 forward, 5’-ctgtccccgtacccatctta-3’, reverse, 5’-
ggctcaccattcctagttgg-3’; Sulf1 forward, 5’-gggagcagatggatgtaattc-3’, reverse, 5’-
tgcagcgactttaatgatcc-3’; Sulf1 forward, 5’-tctgcaaaccaccattagga-3’, reverse, 5’-
gatgaggaagatgtgggctt-3’; Nfasc forward, 5’-gccaagtagcagaagtgacg-3’, reverse 5’-
tttcctgccaatgtgtttct-3’; Notch1 forward, 5’-ttaatcgcctcccaacaata-3’, reverse 5’-
cttttctcccccttgcag-3’; Tyro3 forward, 5’-tgctgtgtggttaaagaggg-3’, reverse 5’-
tgggtgtccctgatctcata-3’; Pld1 forward, 5’-tgcagaagttaaggaaataagcc-3’, reverse 5’-
ttgttgctatgtctaccccg-3’; Hmgcs2 forward, 5’-cccttcagtctcgtccaagt-3’, reverse 5’-
taagtggaaaggaagccctg-3’; Hnrpdl1 forward, 5’-ccacgcgaactcaaaactta-3’, reverse 
5’-gggggaatcggtgtaaaag-3’; Gna12 forward, 5’-gttgggaaatagcgatgagg-3’, reverse 
5’-tgaaaatgatgacccaccc-3’; Ptpro forward, 5’-ggcctgacttctctctgctt-3’, reverse 5’-
actctgccattaccctcca-3’; BB128963 forward, 5’-ggggtttccagtgtttgttc-3’, reverse 5’-
catgaaatcgttgcactcaaa-3’; Gab1 forward, 5’-gaccctagattcccgatgag-3’, reverse 5’-
caagatgctgattgtgagatga-3’; Nf1 forward, 5’-caggcaggaagacattttca-3’, reverse 5’-
atgctaactgacccatgcag-3’; Sox9 forward, 5’-tcaccacaccagcttcgt-3’, reverse 5’-
tgcttagaaatggtcttttgga-3’; Cmtm5 forward, 5’-ttgtctttggcatctgtggt-3’, reverse 5’-  88 
aaggggaagggtggatgt-3’; Fstl1 forward, 5’-cacactgggaacatttgagttt-3’, reverse 5’-
tgagctgaacactttaacccc-3’; Olig1 forward, 5’-cttccagaaccctcagcc-3’, reverse 5’-
gctgccaaaccttcagtcta-3’; Sox8 forward, 5’-ggtttgggtctacatggacag-3’, reverse 5’-
aggtctgagtgtgccaagc-3’; Sema6a forward, 5’-tgctgagaacgtggttaaagat-3’, reverse 
5’-ccgggttcctttttggtat-3’.  
 
  For the preparation of chromatin material for hybridisation to the 
oligodendrocyte specific array, whole genome amplification was performed with 
GenomePlex complete Whole Genome Amplification (WGA) Kit (Sigma), with 
modifications previously described (O’Geen et al., 2006). Technical replicates of 
Mash1 coprecipitated chromatin and control IgG coprecipitated chromatin were 
fluorescently labelled with cyanine 5-dUTP dye and input chromatin with 
cyanine 3-dUTP according to Agilent instructions. The oligodendrocyte specific 
array was designed using eArray Agilent software (Diogo Castro, NIMR), and 
printed using SurePrint technology (Agilent). Labelled immunoprecipitated 
chromatin were hybridised onto the custom designed oligodendrocyte specific 
array, scanned on an Agilent DNA Microarray Scanner and the initial data 
extraction performed using Agilent Feature Extractor Software, version 9.5.1 
(Doug King, Windeyer Institute, UCL). Further binding data analyses were 




All statistical comparisons were carried out using the ‘Student's’ t-Test. 
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3.1 Mash1 and OPCs 
 
  Mash1 is a bHLH TF essential for neural differentiation and specification 
in the nervous system. Indeed, genetic fate-mapping studies using inducible Cre-
lox technology have shown that Mash1 is present in a range of cell populations 
throughout different domains of the CNS, which include proliferating progenitor 
cells that are already committed to differentiate (Battiste et al., 2007; Kim et al., 
2008). Consistent with a broad role in neural specification during CNS 
development, specific progenitors expressing Mash1 initially generate neurons, 
and then switch to promote an oligodendroglial cell fate.  
 
  Previous results have shown that the function of the proneural gene 
Mash1 is necessary for the specification of an oligodendroglial fate in the 
developing brain and spinal cord, as well as in the postnatal brain (Parras et al., 
2004, 2007; Sugimori et al., 2007). Briefly, a subpopulation of OPCs generated 
from localised ventral domains of the embryonic telencephalon requires Mash1 
for their specification (Parras et al., 2007). Notably, Mash1 expression is 
detected in a subset of OPCs as they emerge in the VZ during the first wave of 
oligodendrogenesis in the telencephalon at E12.5-E14.5, and this particular 
population is lost in Mash1 null mutant mice (Parras et al., 2007).  
 
  The fact that Mash1 is involved in regulating the acquisition of distinct 
cell fates, namely neurons and oligodendrocytes in the CNS, suggests that it 
functions cooperatively with distinct factors to specify neurogenesis and 
oligodendrogenesis, respectively. Indeed, Olig2 has been shown to synergise  91 
with Mash1 in the generation of OPCs in loss and gain of function analyses, in 
the developing mouse ventral telencephalon during the first wave of 
oligodendrogenesis and in rat neurosphere primary cultures, respectively (Parras 
et al., 2007; Sugimori et al., 2007). Other oligodendrocyte promoting factors in 
the CNS include Sox9 (Stolt et al., 2003). However, whether Sox9 is capable of 
functionally synergising with Mash1 to specify an oligodendroglial cell fate, 
remains to be established. To further investigate the relationship between Mash1 
and Sox9 in OPC specification, we first examined their expression during the 
first wave of oligodendrogenesis using PDGFR, one of the first known markers 
to be expressed in OPCs in the CNS (Woodruff et al., 2001). At E12.5 a subset 
of cells in the VZ of the ventral telencephalon coexpressed Mash1 and Sox9 
(Figure 10A and A1, white arrows), and a smaller number also coexpressed 
PDGFR (Figure 10A and A1, white arrowhead). Mash1 expression was 
maintained in cells away from the VZ, although at low levels, and some of these 
cells coexpressed Sox9 and PDGFR (Figure 10A and A2, white arrowheads), 
whilst others coexpressed Sox9 alone (Figure 10A, white arrow). At E13.5 a 
subset of cells in the VZ and away from the VZ of the ventral telencephalon 
coexpressed Mash1 and Sox9 (Figure 10B, B1 and B2, white arrows), and some 
of these also expressed PDGFR (Figure 10B, B1 and B2, white arrowheads). In 
conclusion, these preliminary spatial and temporal analysis of Mash1 and Sox9 
expression with the early OPC marker PDGFR, highlight the potential for these 
TFs to cooperate in the specification of early born OPCs in the developing 
ventral telencephalon. 
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  Certainly, we do not understand the precise molecular mechanisms 
through which Mash1 functions in oligodendroglial cell fate specification. We 
propose the following, firstly that Mash1 activity is modulated in a regional 
temporal manner, secondly that Mash1 forms part of a combinatorial network of 
TFs necessary for OPC specification, and finally that Mash1 behaves in a cell 
autonomous manner to generate oligodendroglial cells in the CNS.  
 
3.2 In vivo cellular system to assay Mash1 function in oligodendrogenesis 
 
  To begin to address the mechanisms underlying the role of Mash1 in the 
specification of oligodendroglial cells in the ventral telencephalon, we first 
searched for a suitable cellular model system amenable to molecular and 
genomic analysis using a ChIP-on-chip approach. The Sox10Cre/Rosa26YFP 
transgenic mouse line irreversibly marks the progeny of Sox10+ cells with the 
yellow fluorescent protein (YFP), including oligodendrocytes in the developing 
ventral telencephalon (Figure 11A) (Matsuoka et al., 2005; Srinivas et al., 2001). 
At E12.5 a sub-population of GFP+ OPCs expressed Mash1 in the VZ and in 
cells migrating away from the VZ (Figure 11A1, white arrows), some of which 
also expressed PDGFR (Figure 11A1, white arrowheads). Fluorescence 
activated cell-sorting (FACS) analysis of Sox10 Cre/Rosa26YFP ventral 
telencephalon at E12.5 revealed a very small fraction of GFP+ cells (2000 cells/ 
ventral telencephalon), amounting to approximately 1.49% of the entire tissue 
(Figure 11B). Note that these numbers are insufficient for a genomic strategy, 
such as ChIP-on-chip, where a minimum of 1 million FACS sorted cells per 
ChIP replica are required (Carlos Parras and Diogo Castro, personal  94 
communication). We concluded that in the developing embryo oligodendrocyte 
progenitor populations are relatively small, thus their isolation for the purpose of 
genomic analysis unfeasible. We therefore opted for an in vitro cellular approach 
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3.3 In vitro cellular system to assay Mash1 function in oligodendrogenesis 
 
3.3.1 CG-4 cell line is a cell fate restricted model  
 
  CG-4  cells are a stable cell line derived from rat primary cultures of 
bipotential O-2A progenitor cells (Louis et al., 1992). They are maintained in a 
proliferative state in serum-free culture medium supplemented with mitogens 
FGF-2 and PDGF, and have the capacity to differentiate into either 
oligodendrocytes or type 2-astrocytes (Louis et al., 1992). Although this cell line 
has been extensively used to study oligodendrocyte differentiation and 
maturation, in addition to the process of myelination successfully (Wang et al., 
2009; Hoshina et al, 2007; Wei et al., 2007; Zhao et al., 2006; Miskimins et al., 
2002; Schnädelbach et al., 2001; Espinosa de los Monteros et al., 1997; Solly et 
al., 1997; Ranjan and Hudson, 1996; Bhat and Zhang, 1996; Franklin et al., 
1995; Tontsch et al., 1994), it represents an already cell fate restricted model that 
is not appropriate to study the step of specification of multipotent progenitors to 
the oligodendroglial lineage. Indeed, this cellular model does not recapitulate the 
in vivo differentiation potential of Mash1+ progenitors in the ventral 
telencephalon, which generate neurons and oligodendrocytes in a sequential 
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3.3.2 NS5 cell line represents a late stage neural progenitor with a highly 
restricted differentiation potential 
 
  The adherent NS5 cell line, derived from ES cells in the presence of EGF 
and FGF-2 mitogens, constitutes a pure and homogenous tripotential neural stem 
cell line that has the capacity to differentiate efficiently into neurons, astrocytes, 
and oligodendrocytes (Conti et al., 2005; Glaser et al., 2007). Furthermore, these 
cells can be expanded indefinitely, and thus present a reliable source of neural 
progenitors for dissecting the mechanisms of neural differentiation. Established 
protocols for the generation of oligodendrocytes, that consist of an initial phase 
of proliferation with FGF2, PDGF and forskolin, followed by a differentiation 
period in the presence of thyroid hormone (T3) and ascorbic acid, have 
demonstrated that this differentiated cell type can be efficiently generated from 
NS5 cells (Glaser et al., 2007). Although, approximately 20% of cells in these 
differentiated cultures contain O4+ oligodendrocytes (Glaser et al., 2007), we 
have been unable to generate oligodendrocytes from the NS5, and thus have not 
been capable of replicating these data successfully. In the presence of foetal calf 
serum (FCS), NS5 cells preferentially differentiated into astrocytes and produce 
only few neurons (data not shown). We thus propose that these cells represent a 
later stage neural progenitor, and therefore have a limited neurogenic and 
oligodendrogenic potential.  
  
  To determine whether NS5 cells are nevertheless an appropriate model to 
study oligodendroglial lineage specification by TFs we used a gain of function 
strategy and introduced single or combinations of TFs. To date a number of key  98 
molecular determinants of OPC specification have been identified, these include 
the bHLH transcription factors Olig1 and Olig2 (Lu et al., 2002; Takebayashi et 
al., 2002; Zhou et al., 2002) and the HMG transcription factor Sox9 (Stolt et al., 
2003). Moreover a synergy between Mash1 and Olig2 in the specification of the 
oligodendroglial cell fate has been well documented both in vivo and in vitro 
(Parras et al., 2007; Sugimori et al., 2007). We first analyse the endogenous basal 
level of expression of these oligodendrocyte promoting TFs in propagating NS5 
cells (Figure 12A). Mash1 was expressed in a non-uniform pattern with ranging 
levels of protein expression in the NS5 cells (Figure 12B and E,) and both Olig2 
and Sox9 were expressed in all cells albeit at variable levels (Figure 12C and F, 
respectively). Note that a large proportion of Olig2 and Sox9 expressing cells 
also coexpressed Mash1 (white arrowheads in Figure 12D and G, respectively). 
Endogenous overlapping expression patterns of these TFs in the NS5 cells raised 
the possibility that this line may retain intrinsic cellular properties important for 
oligodendroglial cell fate specification. Notably, although the neuronal 
differentiation of NS5 cells is poor and eventually ends in significant cell death 
following EGF withdrawal, Mash1 overexpression under conditions of 
propagation results in the efficient generation of Tuj1+ neurons after 48 hours 
(Ben Martynoga, personal communication). These data clearly highlight the 
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  To test the idea that NS5 cells retain the competence to generate 
oligodendrocytes, Mash1, Olig2 and Sox9 TFs were expressed individually and 
in combination under propagation conditions. Briefly, we use Nucleofector 
technology that lends high efficiency and robust transfection with high cell 
viability in cells that are difficult to transfect, such as the NS5, to transport DNA 
directly into the nucleus. A bicistronic vector (pCAGGS-IRES-nls-GFP) that 
encoded either Mash1, Olig2 or Sox9 and nuclear targeted version of the jellyfish 
green fluorescent protein (GFP, as a marker to identify transfected cells; 
pCAGGS-Mash1-IRES-nls-GFP; pCAGGS-Olig2-IRES-nls-GFP; and 
pCAGGS-Sox9-IRES-nls-GFP, respectively), under the control of the CMV 
immediate enhancer/-actin (CAG) promoter, was used to attain high transgene 
levels of expression (Niwa et al., 1991). Seventy-two hours after nucleofection, 
cultures were analysed by immunocytochemistry to identify differentiated cell 
types, Tuj1+ neurons, O4+ oligodendroglia and GFAP+ astrocytes, respectively. 
We found that no single factor or indeed combination of factors were sufficient 
to drive oligodendroglial cell fate specification in NS5 cells. Moreover whilst 
overexpression of Mash1 alone generated Tuj1+ neurons (data not shown), 
neither Olig2 nor Sox9 TFs induced the expression of the differentiated cell 
markers analysed. In conclusion, these data demonstrate that the exogenous 
addition of Olig2 and Sox9 TFs alone are insufficient to drive differentiation in 
NS5 cells.  
  Notably, these results were unexpected since a specific role for these 
factors in oligodendroglial cell fate specification in culture have been well-
documented. Briefly, ectopic expression of Sox9 in the mouse Neuro2a 
neuroblastoma cells, leads to the induction of several oligodendrocyte markers,  101 
including Sox10, proteolipid protein (PLP) and 2,3-cyclic nucleotide 3-
phosphodiesterase (CNP) (Stolt et al., 2003). A function of Olig2 in 
oligodendroglial cell fate when overexpressed in both human and rodent 
progenitors has been well established (Hwang et al., 2009; Maire et al., 2009; 
Sugimori et al., 2007; Copray et al., 2006; Marshall et al, 2005). Neurosphere 
cultures established from E13.5 rat spinal cords, infected with a recombinant 
retrovirus to overexpress Olig2 induce the generation of O4+ oligodendrocytes 
(Sugimori et al., 2007).  In addition, neurosphere-derived NSCs isolated from the 
embryonic mouse brain (E14), transfected with Olig2 expression vector using the 
Nucleofector system, induces the development of fully mature oligodendrocytes 
after 4 days in culture, and functional oligodendrocytes in the demyelinated 
corpus callosum of cuprizone treated animals (Copray et al., 2006). However, on 
the contrary exposure of NS5 cells to a recombinant Olig2 protein variant 
containing the transduction domain from the human immunodeficiency virus-1, 
transcriptional activator protein (TAT), under oligodendrocyte promoting culture 
conditions (Glaser et al., 2007) are insufficient to instruct oligodendroglial fate 
specification (Kristin Stock, personal communication). 
  Olig2 activity is modulated according to the cellular context. In the 
developing spinal Olig2 functions sequentially in motorneuron and 
oligodendrocyte fate specification. This dual action is facilitated by spatio-
temporal alterations in the expression domains of other TFs with which Olig2 
functionally interacts (Zhou et al 2001). Just prior to OPC formation, the 
domains of Olig2 and Nkx2.2 expression switch from being mutually exclusive 
to overlapping, and Neurogenins 1 and 2 are extinguished within this region. 
Indeed, coexpression of Olig2 and Nkx2.2, promotes ectopic and premature  102 
oligodendrocyte differentiation in the embryonic chick spinal cord (Zhou et al 
2001; Sun et a., 2001) and are necessary and sufficient for oligodendrocyte 
differentiation and myelin gene expression (Fu et al., 2002).  
  Together, these data raise the possibility that perhaps Olig2 protein levels 
are already saturating, or that cofactors required for its function are limiting, and 
thus increasing the levels of Olig2 are simply insufficient to promote 
oligodendrogenesis in NS5 cells. These hypothetical scenarios could also 
account for the inability of Sox9 to induce an oligodendroglial cell fate in NS5 
cells. In conclusion, we propose that NS5 cells represent a late stage progenitor 
with a highly restricted differentiation potential, which can only be overruled 
with an instructive differentiation factor, such as Mash1. Consequently, this in 
vitro cellular system was regarded as unsuitable for investigating the role of 
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3.3.3 Primary neurosphere-derived NSC cultures  
 
  The fact that primary multipotent neural progenitor cells generate 
oligodendroglial lineage-restricted precursors following overexpression of 
specific TFs (Sugimori et al., 2007: Copray et al., 2006; Balasubramaniyan et al., 
2004; Lu et al., 2000), suggests that primary cultures may have an enhanced 
intrinsic ability to generate oligodendroglial cells in response to TFs. Primary 
neurosphere-derived NSC cultures were therefore established from E13.5 ventral 
telencephalon. In brief, non-adherent spherical clusters of cells otherwise 
referred to as neurospheres formed after 10 days in vitro in the presence of EGF 
and FGF-2 (Figure 13A). Neurospheres were tripotential, and 5 days after growth 
factor withdrawal gave rise to neurons, astrocytes and oligodendrocytes (Figure 
13B & C). Dissociated neurospheres were pooled and expanded as monolayer 
cultures (Figure 14A), which expressed the neuroepithelial marker Sox2 (Figure 
14B). We first examine basal endogenous levels of Mash1, Olig2 and Sox9 TFs. 
Primary cultures expressed Mash1 in a non-uniform pattern with ranging levels 
of protein expression (Figure 14C, F). Olig2 and Sox9 were expressed in all cells 
albeit at variable levels (Figure 14D and G, respectively), and a large proportion 
coexpressed Mash1 (Figure 14E and H, respectively, white arrowheads). 
Notably, neurosphere-derived NSC cultures exhibited some degree of 
heterogeneity, and contained small numbers of GFAP+ astrocytes (Figure 14I), 
Tuj1+ neurons (Figure 14J) and O4+ oligodendroglial cells (Figure 14K).  
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  To promote the generation of oligodendroglial cells we used a gain of 
function approach, and introduced single or combinations of TFs, Mash1, Olig2, 
and Sox9, as described previously. We analysed the effect of these TFs 3 days 
after nucleofection under propagation conditions (in the presence of mitogens, 
EGF and bFGF-2). Mash1 overexpression resulted in the exclusive generation of 
Tuj1+ neurons (Figure 15E white arrowheads & Figure 16B, in 43% of GFP+ 
cells). Sox9 overexpression induced the formation of O4+ oligodendroglial cells 
(Figure 15I white arrowheads & Figure 16C, in 29% of GFP+ cells) and less 
efficiently GFAP+ astrocytes (Figure 15G white arrowhead & Figure 16A, in 4% 
of GFP+ cells), in accordance with its role as a general promoter of gliogenesis 
(Stolt et al., 2003). Interestingly, Olig2 overexpression was not a strong inducer 
of oligodendrogenesis (Figure 15L white arrowhead & Figure 16C, in 3% of 
GFP+ cells). We propose that crucial co-factor(s) and or stimuli required for 
Olig2 function in OPC specification are absent in these cultures, perhaps similar 
to the NS5 cell line.  
  The combined overexpression of Mash1 and Sox9 generated Tuj1+ 
neurons (Figure 15N white arrowheads & Figure 16B, in 38% of GFP+ cells) 
and significantly more O4+ oligodendroglial cells than Sox9 alone (Figure 15O 
white arrowheads & Figure 16C, in 58% of GFP+ cells). These data suggest that 
Mash1 and Sox9 cooperate to specify O4+ oligodendroglail cells . Interestingly, 
these O4+ oligodendroglial cells demonstrated a highly branched and elaborate 
morphology in comparison to those generated by expression of Sox9 alone that 
may reflect the previously reported role of Mash1 in oligodendrocyte 
differentiation (Sugimori et al., 2008). The 5% reduction in the production of 
Tuj1+ neurons resulting from Mash1 and Sox9 coexpression as compared to  107 
expression of Mash1 alone, may result from the potential repressive activities of 
Sox9 on neuronal specification (Stolt et al., 2003). Nevertheless, coexpression of 
Mash1 and Sox9 fails to direct uncommitted progenitors towards one specific 
cell fate choice, thus making the contribution of Mash1 activity in 
oligodendroglial or neuronal cell fate acquisition non dissociable. Surprisingly, 
the combined overexpression of Mash1 and Olig2 did not synergise to generate 
O4+ oligodendroglial cells, as has been previously reported in rat spinal cord 
primary cultures (Sugimori et al., 2007), and neurons were exclusively generated 
with this combination of TFs (Figure 15Q white arrowheads & Figure 16B, in 
37% of GFP+ cells). Contrary to the Nucleofector specifications, we were only 
capable of attaining very low transfection efficiencies (1.5-2%), with a 
concomitant high percentage of cell death (approximately 50%), in adherent 
primary neurosphere-derived NSCs. All together, we concluded that this in vitro 
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Figure 15.  Cell-fate specification activities of Mash1 Sox9 and Olig2 in 
monolayer neurosphere-derived NSCs. Overexpression of single or 
combination of transcription factors, analysed 3 days after nucleofection in the 
presence of growth factors EGF and FGF-2. Immunostained with an anti-GFP 
antibody, and anti-GFAP, anti-Tuj1 and anti-O4 antibodies, to detect astrocytes, 
neurons and oligodendroglial cells, respectively. A-C, Control cultures 
transfected with CAGGS empty vector give rise to small numbers of GFAP+ 
astrocytes (A, white arrowhead) and Tuj1+ neurons (B, white arrowhead), but no 
oligodendroglial cells (C).  D-F, Mash1 gain of function results in the generation 
of Tuj1+ neurons (E, white arrowheads) but no astrocytes (D), or 
oligodendroglial cells (F). G-I, Overexpression of Sox9 gives rise to a small 
number of GFAP+ astrocytes (G, white arrowhead) and a larger number of O4+ 
oligodendroglial cells (I, white arrowheads). J-L, Olig2 gain of function does not 
have a strong effect on cell fate specification, and generates a small number of 
O4+ oligodendroglial cells (L, white arrowhead). M-O, Combined 
overexpression of Mash1 and Sox9 results in the generation of Tuj1+ neurons 
(N, white arrowheads) and O4+ oligodendroglial cells (O, white arrowheads) but 
no astrocytes (M). P-R, Mash1 and Olig2 gain of function gives rise to Tuj1 + 
neurons (Q, white arrowheads), but no oligodendroglial cells (R). Note that 
nuclei are counterstained with DAPI.  
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Figure 16. Quantification of cell-fate specification activities of Mash1 Sox9 
and Olig2 in monolayer neurosphere-derived NSCs. A-C,  Percentages of 
GFAP+ cells (A), Tuj1+ cells (B) and O4+ cells (C) among GFP+ cells. 
Transcription factors used for nucleofection are shown on the x-axis (mean ± 
standard deviations from three technical replicates). Statistical analysis using 
Students t-test; * P<0.05, ** P<0.01, *** P<0.001. 
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3.3.4 Mouse oligosphere cultures coexpress Mash1, oligodendrocyte 
promoting TFs and an early OPC marker 
 
  Evidently the generation of oligodendroglial cells following exogenous 
additions of a combinatorial set of TFs was problematic. We therefore focused 
on an alternate in vitro cellular system to study the function of Mash1 in 
oligodendrogenesis. Methods for the isolation and purification of rat OPCs from 
the CNS have been described, and include immunopanning (Gard et al., 1993, 
1995; Barres and Raff, 1993), FACS by exploiting cell surface-specific antigens 
(Gard et al., 1995; Behar et al., 1988), differential gradient centrifugation (Vitry 
et al., 2001; Duncan et al., 1992; Goldman et al., 1986) or a shaking method 
based on differential adherent properties of glia (McCarthy and de Vellis, 1980; 
Szuchet and Yim, 1984), which permits the separation of rat OPCs from the 
astroglial cells in the mixed glial culture by shearing forces. In contrast to rat 
OPCs, mouse OPCs have proven more difficult to isolate. Mouse OPCs do not 
share all of the cell surface antigens with their rat counterparts such as A2B5 
(Fanarraga et al., 1995), impeding approaches such as immunopanning and cell 
sorting using FACS as described for rat OPC isolation. In addition, mouse OPCs 
tend to differentiate in mixed glial cultures in vitro and are also relatively 
difficult to separate from astrocytes by shaking methods.  
 
  Several studies described methods to generate self-renewing OPCs from 
neural progenitor/stem cells in different species such as dog and rodents 
(Avellana-Adalid et al., 1996; Zhang et al., 1998a, 1998b; Vitry et al, 1999). 
More recently, a simple procedure to prepare a large, highly enriched population  113 
of OPCs from embryonic multipotent cortical progenitor cells of the mouse was 
described (Chen et al., 2007). These methods allow generation of large numbers 
of mouse OPCs through formation of ‘‘oligospheres’’ from neurospheres. OPCs 
isolated by these procedures can be induced to differentiate into mature 
oligodendrocytes (Chen et al., 2007). Specifically, neurospheres were first 
generated from dissociated E14.5 cortex for a period of 4 days in the presence of 
EGF and FGF-2 mitogens (Figure 17A and B), followed by gradual replacement 
of the media with neuroblastoma B104 conditioned media (CM) to induce 
oligosphere formation for a further 14 days (Figure 17A and C). Oligospheres 
analysed at day 14, expressed Mash1 protein in 52% of all the cells in the 
oligospheres (Fig. 18A and B).  Mash1+ cells also coexpressed Olig2 and 
PDGFR (Figure 18C and E, in 40% of total Mash1+ cells), as well as Sox9 and 
PDGFR (Figure 18D and E, in 34% of total Mash1+ cells). However these 
cultures are heterogeneous and demonstrate variable proportions of Tuj1+ 
neurons (Figure 19A) and GFAP+ astrocytes (Figure 19B), in addition to smaller 
numbers of HuC/D+ immature neurons (Figure 19C) and MBP+ mature 
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  We conclude that the oligospheres were a good system in which to study 
the function of Mash1 in oligodendroglial cell fate specification. Firstly, 
oligospheres contained a significant proportion of Mash1+ cells that coexpressed 
potential cofactors required for oligodendrogenesis, namely Olig2 and Sox9, in 
addition to the early OPC marker, PDGFR. Moreover by modulating the size of 
the starter cultures, sufficient material for subsequent ChIP-on-chip analyses can 
be obtained. Although oligosphere cultures contained some neurons, we propose 
to dissociate the neurogenic and oligodendrogenic function of Mash1 using a 
subtractive approach. Mash1 ChIP-on-chip and ChIP-seq data from the ventral 
mouse telencephalon at a time of peak neurogenesis in development (at E12.5) 
have been generated (Diogo Castro, unpublished data). Indeed, this data set 
could provide a platform on which to potentially subtract Mash1 neurogenic 
targets from the oligosphere data set, and thus enrich for specific 
oligodendroglial targets in these cultures. We therefore use the oligosphere 
culture method as a model to investigate the molecular mechanisms underlying 
Mash1 function in oligodendroglial cell fate specification.   118 
3.4 Mash1 locational analysis in oligosphere cultures with Chip-on-chip 
technology 
 
  To identify promoters of genes expressed in OPCs, which are bound by 
Mash1 in order to uncover the mechanisms that confer oligodendrocyte lineage 
specific expression of Mash1 targets, we performed locational analysis using 
ChIP technology. A specific antibody to Mash1 that has been extensively 
characterised for ChIP (Diogo Castro, personal communication) was used to 
coprecipitate chromatin from mouse oligosphere culture material (at in vitro day 
14 of oligosphere formation). Although no direct targets of Mash1 in the 
oligodendroglial lineage have been reported, we hypothesised that Mash1 shares 
some common targets in the specification of neuronal and oligodendroglial cell 
fates. Critical to the function of proneural genes is the activation of the Notch 
signalling pathway (Artavanis-Tsakonas et al., 1999). Indeed, activation of the 
Notch ligand Delta genes, including Deltalike-1 (Dll1), by proneural factors is 
evolutionarily conserved in neurogenesis (Artavanis-Tsakonas et al., 1999; 
Casarosa et al., 1999; Fode et al., 2000). Delta1 is coexpressed with Mash1 at 
E13.5 in the ventral telencephalon (Castro et al., 2006), including in PDGFR+ 
OPCs (Carlos Parras, unpublished data). Thus, we propose that common targets 
of Mash1 in neuronal and oligodendroglial cell fate acquisition, may include 
genes involved in the Notch signalling pathway, such as Dll1.  
  Previously, an evolutionarily conserved cis-regulatory region in the 
promoter of the mouse Dll1 gene was identified (Beckers et al., 2000), which 
contains a proximal neural enhancer, referred to as DeltaM (Castro et al., 2006). 
The activity of the DeltaM enhancer in vivo is restricted to the dorsal spinal cord  119 
and ventral telencephalon, regions of endogenous Delta1 expression that also 
express Mash1 (Castro et al., 2006). DeltaM activation is dependent on Mash1 
function, indeed Mash1 protein directly associates with DeltaM in the developing 
telencephalon, as defined by ChIP analyses (Castro et al., 2006). In addition to a 
pair of evolutionary conserved E-boxes in the DeltaM sequence, responsible for 
the activation of this enhancer by Mash1, a proximal evolutionarily conserved 
consensus binding site for the POU family of homeodomain proteins, otherwise 
referred to as an octamer (Nishimoto et al., 2003), permit Mash1 and members of 
the POU II and POU III classes to bind cooperatively at the DeltaM sequence 
and subsequently synergise to activate the Dll1 promoter (Castro et al., 2006). 
An  in silico screen to identify conserved genomic regions with a similar 
Mash1/Brn motif (a 15 base pair consensus sequence 
(ATT[A/T]NCAT[A/T/G]CAG[C/G]TG) within 100kb from the most proximal 
gene or within introns, across divergent species using the transcription factor 
binding site (TFBS) cluster program (Donaldson et al., 2005) identified a number 
of positive hits (Castro et al., 2006). These included genes involved in Notch 
signalling (Dll1,  Dll3,  Jagged2, and the glycosyl transferase, Lunatic fringe 
(Lfng)), cell differentiation (insulinoma-associated 1, IA-1 (Insm1), a zinc-finger 
factor essential for pancreatic and intestinal endocrine cell differentiation; 
Mellitzer et al., 2006; Gierl et al., 2006), and in cell cycle (Fbxw7, a subunit of 
an SCF-type ubiquitin ligase complex that targets positive regulators of the cell 
cycle for degradation to promote cell cycle exit; reviewed Onoyama et al., 2008). 
Coprecipitation of these sequences with Mash1 were validated using chromatin 
material prepared from  E12.5 ventral telencephalon and subsequent quantitative 
PCR, or ChIP-PCR, using primer specific sequences to the mouse genome.  120 
These studies found that, whilst an antibody to Mash1 coprecipitated the 
Mash1/Brn motif-containing sequences associated with Delta1, Delta3, Insm1, 
and  Fbxw7, the sequences associated with Lfng were not deemed to be 
significantly coprecipitated (Castro et al., 2006). 
  
  We therefore asked whether the Mash1 proneural protein directly 
interacts with the Dll1,  Dll3,  Dll4,  Lfng,  Fbxw7, and Jagged2 enhancers in 
oligosphere cultures by performing ChIP experiments. An antibody to Mash1 
coprecipitated the DeltaM,  Fbxw7,  Dll3, and Lfng sequences in chromatin 
prepared from oligosphere cultures, but not the Dll4 or Jagged2 sequences nor 
the  Delta1 or Fbxw7 coding sequence (Dll1 ORF and Fbxw7 ORF) used as 
negative controls, or Actin B  another negative control (Figure 20). Conversely, a 
control IgG antibody did not coprecipitated the DeltaM, Fbxw7, Dll3, or Lfng 
sequences nor the Dll1 ORF, Fbxw7 ORF or Actin B (Figure 20). Therefore, in 
oligosphere cultures Mash1 specifically binds to the DeltaM, Fbxw7, Dll3, and 
Lfng genomic regions. Note that DeltaM and Fbxw7 sequences were the most 
robust Mash1 coprecipitated segments, and therefore used to test the relative 
levels of enrichment and thus quality of the ChIP in subsequent experiments. It is 
important to state at this point that we can not be certain that these Mash1 
coprecipitated genomic segments are those bound and present in an 
oligodendroglial rather than a neuronal population, since oligosphere cultures are 
inherently heterogeneous in nature.  
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3.4.1 Validation of oligosphere cultures for Chip-on-chip  
 
  To generate chromatin material for ChIP-on-chip, we cultured and 
characterised mouse oligospheres as described previously. Oligospheres 
expressed Mash1 in approximately 60% of all cells (Figure 21A & B), and 
within the Mash1+ population 27% coexpressed Olig2 and PDGFR (Figure 
21C & E), and 22% coexpressed Sox9 and PDGFR (Figure 21D & E). An 
antibody to Mash1 coprecipitated the DeltaM and Fbxw7 sequences robustly in 
technical chromatin replicates prepared from oligosphere cultures, compared to 
negative control regions that were not coprecipitated in this assay, Dll1 ORF and 
Fbxw7 ORF respectively, as defined by ChIP-PCR (Figure 22). A control IgG 
antibody did not coprecipitate the DeltaM, Fbxw7, Dll1 ORF, nor the Fbxw7 
ORF sequences (Figure 22). We concluded that the robust enrichment of DeltaM 
and  Fbxw7 sequences relative to negative control regions in Mash1 
coprecipitated chromatin preparations, in addition to the lack of DeltaM and 
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3.4.2 An oligodendrocyte specific array to identify Mash1 bound segments 
  
  To identify Mash1 binding events using a ChIP-on-chip strategy, a 
custom designed oligodendrocyte specific array was generated (eArray, Agilent 
Technologies, in collaboration with Diogo Castro). In brief, the array 
specifications were designed so that coverage of 16kb was attained per gene, 
centred on the transcription start site (TSS) (-8kb upstream to +8kb downstream 
of the TSS), with an average distance between probes of 120bp and repetitive 
regions masked. We reasoned that an initial small-scale focused experiment, 
centred on genes previously associated with oligodendrogenesis, would permit 
validation of the oligosphere material and ChIP-on-chip technique before 
embarking on a larger mouse promoter array screen.  
  Initially, to generate the oligodendrocyte specific array, a list of genes to 
be tiled on the array was compiled. These genes were predominantly extracted 
from three published expression array data sets (Dugas et al., 2006; Ligon et al., 
2007; Hu et al., 2004) (Figure 23). The largest contribution of genes to the list 
were derived from the
  first detailed genomic analysis of OL differentiation, 
which documents the progressive gene expression profile of synchronously 
differentiating oligodendrocytes from pure primary rat OPCs (isolated from 
postnatal cortices) upon mitogen withdrawal and T3 exposure (521 genes, Dugas 
et al., 2006). These data detail the specific cell-autonomous gene expression 
modifications involved in the complex transition from a committed OPC to a 
mature oligodendrocyte (Dugas et al., 2006). A smaller set of genes were 
obtained from an expression array study in a rat culture model of OPCs and 
NSCs to identify molecular events that occur during the transition from NSCs to  126 
OPCs (42 genes, Hu et al., 2004). Specifically, NSCs isolated from the 
embryonic rat forebrain were induced to form OPCs using B104CM, and the 
differential expression between these two distinct populations assayed (Hu et al., 
2004).  Notably, these studies identify significant expression changes in OPCs 
when compared with NSCs, and include genes involved in OPC differentiation 
(Hu et al., 2004). In addition, we incorporated a subset of genes from a genome-
wide microarray expression screen comparing wild-type and Olig2 null mutant 
neurospheres (110 genes, Ligon et al., 2007). Notably, Olig2 null neurospheres 
lack the characteristic gene expression signature of the oligodendroglial lineage, 
namely expression of PDGFR, PLP, and MBP markers (Ligon et al., 2007). In 
addition, a literature search was performed to include genes associated with 
oligodendrogenesis that were absent in the aforementioned expression data sets 
(84 genes). Positive controls tiled on the array included elements previously 
shown to coprecipitate with a specific antibody to Mash1, such as Dll1, Fbxw7 
and Insm1 (Castro et al., 2006). Furthermore, a distal putative enhancer of  Olig2 
(approximately 82kb upstream of the Olig2 TSS), identified from an in silico 
screen to map Mash1 (CAGSTG) and Brn (ATTWNYAW) conserved binding 
sites using TFBS cluster, which coprecipitates with Mash1 using chromatin 
prepared from E12.5 ventral telencephalon tissue (a developmental time when 
OPCs are generated in this region) in ChIP-on-chip and ChIP-PCR experiments, 
was tiled on the array (Diogo Castro, unpublished data). Note that Olig2 plays a 
crucial role in oligodendroglial cell fate specification in the developing CNS, and 
thus we include this element in our screen. Housekeeping genes that function as 
internal or reference controls were also tiled on the array. 
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  Technical replicates of Mash1 coprecipitated chromatin and control IgG 
coprecipitated chromatin were fluorescently labelled with cyanine 3-dUTP dye 
and input chromatin with cyanine 5-dUTP dye, and subsequently hybridised onto 
the custom designed oligodendrocyte specific array (hybridisations were 
performed by Doug King, Windeyer Institute, UCL). Arrays were scanned on an 
Agilent DNA Microarray Scanner and the initial data extraction was performed 
using Agilent Feature Extractor Software, version 9.5.1 (performed by Doug 
King, Windeyer Institute, UCL).  
 
3.5 Chip-on-chip analysis 
 
  To identify Mash1 specific binding events, the intensity of the signal of 
the Mash1 coprecipitated chromatin relative to the signal of the input chromatin, 
for every probe tiled on the array, were analysed using the peak-calling ChIP 
Analytics software (Agilent Technologies). We applied inter-array median and 
intra-array Lowess (intensity-dependent) normalisations. Briefly, the intra-array 
Lowess normalisation adjusts for intensity-dependent variation resulting from 
dye properties, which are caused by inconsistencies in the relative fluorescence 
intensity between Cy5 and Cy3 dyes. Note that the ChIP Analytics software 
generates a number of output reports detailing probe and sequence information, 
which are subsequently used to locate specific genomic sequences, and relative 
location of proximal genes on the UCSC Genome Browser 
(http://genome.ucsc.edu/, Kent et al., 2002). The quality control (QC) reports 
generated from the ChIP Analytics software displays a plot of the 
immunoprecipitated extract (IP) versus the whole cell extract (WCE) or input  129 
chromatin, and thus permits the identification of enriched versus unenriched 
targets. Analyses of Mash1 coprecipitated chromatin identified 315 significant 
bound probes (P<0.001), corresponding to a total of 76 bound segments and 
9.7% of all the regions tilled on the array (Figure 24B & Table 1, data is an 
average of 3 replicates). On the other hand, analyses of IgG control 
coprecipitated chromatin detected 49 significant bound probes (P<0.001) 
corresponding to 21 bound segments and 2.7% of all the regions tilled on the 
array (Figure 24A). Note that the proportion of genes with associated binding 
events in Mash1 coprecipitated chromatin, were representative of their relative 
contribution from the different expression array lists originally tiled on the 
oligodendrocyte specific array (Figure 25). We concluded that in mouse 
oligosphere cultures Mash1 was bound to regions proximal to genes that are 
expressed during the transition of an uncommitted NSC progenitor cell to an cell 
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Table 1. List of segments bound by Mash1 in oligospheres. List of significant 
Mash1 bound segments with corresponding proximal gene. Segments on the list 
are in order of descending significance. UCSC Genome Browser 
(http://genome.ucsc.edu/), mouse assembly mm8, NCBI Build 36.  
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3.5.1 Mash1 binds to early OPC and late oligodendrocyte genes and other 
genes with functions throughout oligodendrogenesis 
 
  To obtain a general overview of the quality of Mash1 binding data, and 
validate that Mash1 protein directly interacts with these genomic elements in the 
oligosphere cultures, we performed ChIP-PCR experiments and calculated the 
number of false rate positives. Initially, the robustness of the Mash1 ChIP was 
tested with specific primers for the DeltaM and Fbxw7 sequences, as described 
previously. We found that DeltaM and Fbxw7 sequences were highly enriched in 
oligosphere chromatin preparations using a Mash1 antibody compared to 
negative control regions Dll1 ORF or Fbxw7 ORF, respectively, or to the IgG 
control ChIP (Figure 26A), and therefore used this material for subsequent ChIP-
PCRs.  
  A total of 26 putative elements were randomly selected for ChIP-PCR 
analysis. We found that 54% of these elements were significantly coprecipitated 
with Mash1 when compared to the negative region, Dll1 ORF or to the IgG 
control ChIP (Figure 26B). In addition, we analysed a distal putative enhancer 
element of Sox9 (approximately 500kb upstream of the Sox9 TSS) identified 
from an in silico screen to map Mash1 (CAGSTG) and Brn (ATTWNYAW) 
conserved binding sites using TFBS cluster, which coprecipitates with Mash1 
using chromatin prepared from E12.5 ventral telencephalon tissue in ChIP-on-
chip and ChIP-PCR experiments (Diogo Castro, unpublished data). Notably, the 
Sox9 distal element was significantly coprecipitated with Mash1 in the 
oligospheres compared to the Dll1 ORF negative region or to the IgG control 
ChIP (defined as, Sox9 (vt enhancer), Figure 26B).   136 
Figure 26. Validation of Mash1 bound segments in oligosphere cultures. A & 
B, ChIP-PCR analysis of Mash1 bound segments. A, Validation of oligosphere 
material, DelatM and Fbxw7 regions are enriched significantly in Mash1 ChIP 
compared to control IgG control ChIP (black asterisk) and to negative regions 
Dll1 ORF and Fbxw7 ORF (blue asterisk), respectively. B, qPCR of randomly 
selected segments, significantly enriched regions in Mash1 ChIP compared to 
control IgG control ChIP (black asterisk) and to negative regions Dll1 ORF (blue 
asterisk). Calculated false rate positives: 46%. * P<0.05, ** P<0.01, *** 
P<0.001. 
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  Binding profiles, as a ratio of the IP signal over the whole cell extract 
signal, of segments bound by Mash1 are plotted in relation to their genomic 
location along the x-axis. Specific genomic regions bound by Mash1, as defined 
by the ChIP Analytics programme, are marked with a blue asterisk (Figure 27-
33). Note that background ratios of the control IgG ChIP in some regions are 
high, this may be a result of non-stringent washes during hybridisation. 
Interestingly the expression pattern of genes with proximal regions bound by 
Mash1 in oligosphere cultures, as analysed using Genepaint data base 
(http://www.genepaint.org/; Visel et al., 2004) in the developing mouse CNS at 
E14.5, are not solely restricted to the oligodendrocyte lineage (Figures 27-33) to 
suggest that their expression are regulated by a number of distinct elements. 
Indeed the expression of Sox10, whose function is crucial for the development of 
neural crest–derived and oligodendroglial populations throughout 
embryogenesis, is dynamically regulated. Transgenesis strategies in mouse and 
zebrafish have identified multiple conserved elements with overlapping 
functions, which regulate Sox10 spatial and temporal expression during 
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  Mash1 was bound to previously described regulatory elements, DeltaM 
and  Fbxw7 sequences (Castro et al., 2006), that we use as positive control 
regions in oligosphere cultures (Figure 26A, Figure 27A and 27C, respectively). 
Furthermore, these analyses reveal that Mash1 binds to genomic segments 
proximal to early OPC genes such as Sox8 and Olig1 (Figure 26B, Figure 28A 
and Figure 29A/C). Notably, the Olig2 distal element was significantly 
coprecipitated with Mash1 in the oligospheres compared to the Dll1 ORF 
negative region or to the IgG control ChIP (defined as, Olig2 (vt enhancer), 
Figure 26B and Figure 28C). In addition, Mash1 binds to genes associated with 
mature oligodendrocytes, including Mog and Omg (Figure 26B and Figure 
30A/C). Interestingly, Mog and Omg are not transcribed early in development, 
but are bound by Mash1 in non-differentiated oligospheres. It is plausible to 
suggest that Mash1 may function to prime these regions for rapid induction of 
gene expression in response to the correct cues, or to recruit necessary cofactors 
to these sites to regulate their transcription. 
  Other segments bound by Mash1 that lie proximal to genes of interest 
include;  Brevican  (Bcan) (Figure 26B and Figure 31A), a neural-specific 
chondroitin sulfate proteoglycan (CSPG) (Yamada et al., 1994, Jaworski et al., 
1994), which belongs to the lectican family of CSPGs (reviewed Yamaguchi, 
2000) actively participate in the development and maturation of the nervous 
system (reviewed Zimmermann and Dours-Zimmermann, 2008). Bcan is 
expressed highly in the VZ along the length of the neuraxis during the gliogenic 
phase in late embryonic and early postnatal development (Jaworski et al., 1995; 
Milev et al., 1998). Notably, Bcan plays a role in the development of CNS fibre 
tracts in the postnatal hippocampal fimbria where it is expressed in  146 
oligodendrocytes and white matter astrocytes (Ogawa et al., 2001), it also 
promotes glial cell motility and thus increases glioma cell invasive properties 
(Zhang et al., 1998; Jaworski et al., 1996; reviewed in Nutt et al., 2001); Notch1 
(Figure 26B and Figure 31C), a component of the Notch signalling pathway, 
which is expressed in OPCs of the developing CNS (Givogri et al., 2002). In 
OPCs, the Notch1 receptor functions as an inhibitor of oligodendrocyte 
differentiation. Notably, Notch1 receptor activation by Delta1 or Jagged1 ligands 
inhibits oligodendrocyte differentiation in vitro (Wang et al., 1998). Notch1 also 
functions to prevent OPCs from premature differentiation in vivo, such that 
inhibition of Notch1 signalling results in precocious differentiation of OPCs into 
oligodendrocytes, in addition to premature myelination in the developing CNS 
(Genoud et al., 2002; Givogri et al., 2002). These data suggest that Notch1 is 
required in the temporal regulation of differentiation of OPCs to 
oligodendrocytes;  Guanine nucleotide binding protein (G protein) alpha 12 
(Gna12) (Figure 26B and Figure 32A), is a member of a super-family of signal 
transduction proteins that mediate a range of extracellular signals from G-protein 
coupled receptors to intracellular effectors, regulating cell growth, 
differentiation, and apoptosis (reviewed in Radhika and Dhanasekaran, 2001; 
Kurose, 2003). Gna12, has been associated with glioma cell motility, from 
differential expression studies in glioma and primary glioblastoma cells 
(Tatenhorst et al., 2004); Heterogeneous nuclear ribonucleoprotein D-like1 
(Hnrpdl1) (Figure 26B and Figure 32C), belongs to the subfamily of 
ubiquitously expressed RNA binding proteins, namely the heterogeneous nuclear 
ribonucleoproteins (hnRNPs), that complex with heterogeneous nuclear RNA 
(hnRNA). Hnrpdl1 is highly expressed in the CNS, and is more prominent in  147 
neuronal than glial cells (Akagi et al., 2000). These proteins are associated with 
pre-mRNAs in the nucleus and functions in mRNA biogenesis and mRNA 
metabolism (reviewed in Dreyfuss et al., 1993, Krecic and Swanson, 1999, 
Weighardt et al., 1996); Neurofascin (Nfasc) (Figure 26B and Figure 32E) an 
ankyrin-binding, cell adhesion molecule of
  the L1 subgroup of the 
immunoglobulin G superfamily that has
 been implicated in a variety of processes 
including neurite outgrowth, fasciculation, interneuronal
 adhesion, and formation 
of functional nodes of Ranvier (Rathjen & Schachner,  1984; Grumet et al., 
1991; Volkmer et al., 1992; Davis et al., 1993; Zhang et al., 1998; Sherman et al., 
2005; Zonta et al., 2008). Moreover, a 155-kD isoform (NF155) of the Nfasc 
gene is strongly but transiently up-regulated in oligodendrocytes at the onset of 
myelinogenesis (Collinson et al., 1998), and is a crucial glial component of the 
paranodal axoglial junction (Tait et al., 2000; Charles et al., 2002; Pillai et al., 
2009); and Sulfatase 1 ( Sulf1) (Figure 26B and Figure 33A/C), a secreted 
enzyme that modulates the sulfation state of heparan sulfate proteoglycans 
(HSPGs) (reviewed in Lamanna et al., 2007), is expressed in the oligodendrocyte 
lineage of the developing chick spinal cord and forebrain (Braquart-Varnier et 
al.,  2004; Garcia-Lopez et al., 2009). Moreover, Sulf1 modulates Shh signalling 
in the embryonic ventral spinal cord of the chick, promoting the generation of 
oligodendroglial cells at the expense of neuronal cells, and is therefore thought to 
contribute to the neuronal/glial switch in ventral progenitors (Danesin et al., 
2006).  
 
  Interestingly, when genes with segments bound by Mash1 from ChIP-on-
chip are cross referenced to gene expression data from Mash1 null embryos and  148 
an oligodendroglial specific gene list, we found that 46% of the genes are indeed 
regulated by Mash1 and expressed in the oligodendroglial cell lineage. The 
Mash1 null expression data set were generated from the MGE/AEP region of 
E13.5 embryos, where the first wave of OPCs is produced in the ventral 
telencephalon and ventral thalamus (Carlos Parras, unpublished data). 
Affymetrix MOE430.2 whole genome microarrays were normalised by 
GeneChip Robust Multiarray Averaging (GCRMA; Wu et al., 2004) and 
Significance Analysis of Microarray (SAM; Tusher et al., 2001), these were 
further analysed using BRB-Array tool (www.linus.nci.nih.gov) and gene set 
analysis (GSA) software (Efron and Tibshirani, 2007). Oligodendroglial specific 
gene lists were compiled from: (i) a detailed transcriptome analysis of OPCs and 
differentiated/ myelinating oligodendrocytes from the postnatal mouse forebrain 
(Cahoy et al., 2008); (ii) a comparative analysis of gene expression profiles of rat 
OPCs and differentiated oligodendrocytes  (Nielsen et al., 2006); (iii) in addition 
to expression arrays using PDGFR-GFP and Olig2-GFP mouse lines (Nathaniel 
Heintz, unpublished data).  
  In conclusion, this experiment provides the first set of candidate target 
genes of Mash1 in the oligodendroglial lineage. To determine if these genes are 
indeed specifically regulated by Mash1 in the oligodendroglial lineage rather 
than in neuronal precursors or multipotent progenitors will require further 
analysis. 
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3.6 Validation of putative enhancer elements bound by Mash1 
 
  To investigate the regulatory potential of genomic elements bound by 
Mash1 in oligosphere cultures, we assayed these segments in vitro using 
transcription assays in the NS5 cell line, and asked whether Mash1 protein, alone 
or in combination with other oligodendroglial promoting TFs, including Olig2 
and Sox9, could interact with these elements and activate luciferase reporter gene 
expression. The NS5 cells were chosen for this assay primarily because of the 
ease of obtaining sufficient numbers of homogenous cultures that were 
reproducible from one experiment to the next. Note that the NS5 cells do not 
need to generate OPCs efficiently to be an appropriate model to test the 
transcriptional regulation of OPC genes, and endogenously express 
oligodendrocyte promoting TFs, Sox9 and Olig2 as well as Mash1 (Figure 12B-
G).  
  The proneural protein Mash1, heterodimerises with ubiquitously 
expressed bHLH proteins, including E2A splice variants E12 and E47, and binds 
to an E-box (a six base pair motif (CANNTG)) in promoters of target genes to 
regulate gene expression (Massari & Murre, 2000). bHLH proteins bind to 
specific subsets of E-boxes with different preferences (Bertrand et al., 2002; 
Powell et al., 2004), indeed Mash1 has a tendency to bind to a (CAG[C/G]TG)-
type E-box (Castro et al., 2006). Nevertheless, it is important to note that the 
specificity to bind subsets of E-boxes alone is not sufficient to explain the 
recognition of target promoters by proneural proteins. A TF with a stringent six 
base pair recognition sequence would identify 740,000 sites in a genome of a 
size of 3  10
9 base pairs, which is many more times the number of total genes  150 
contained in the mammalian genome (Kondoh et al., 2004). Evidently, other 
mechanisms must contribute to the specificity of target gene recognition by 
proneural proteins, and may include interactions between different DNA-binding 
proteins.  
  Mash1 and Brn (which bind to octamer sequences (Nishimoto et al., 
2003) proteins functionally synergise to regulate a number of target genes that 
control multiple aspects of the neurogenic program, and include the activation of 
the mouse Dll1 gene through cooperative binding to a proximal evolutionarily 
conserved motif (Castro et al., 2006). More recently, it was demonstrated that 
Mash1 cooperates with the Olig2 bHLH TF, in the specification of an early 
population of telencephalic oligodendrocytes in the embryo (Parras et al., 2007). 
However, the molecular mechanism underlying the functional synergy between 
Mash1 and Olig2 in the oligodendrogenic programme, has not yet been 
elucidated. Similar to Mash1, Olig2 binds degenerate E-boxes, however whether 
Olig2 recognises a specific type of E-box, is yet to be described. A yeast-two 
hybrid screen using mouse Sox9 (101-338 amino acids) as bait against a mouse 
embryo brain library identified Mash1 as a very high confidence interacting 
partner, suggesting that Mash1 and Sox9 may interact at a protein level (James 
Briscoe, personal communication). Together with the fact that Mash1 and Sox9 
are coexpressed in OPCs as soon as they emerge from the VZ of the developing 
ventral telencephalon (Figure 10), we propose that Mash1 and Sox9 have the 
potential to cooperate in the specification of early born OPCs. Indeed, this 
combinatorial code of TFs may also contribute to the molecular mechanisms 
underlying Mash1 function in the oligodendroglial programme. Sox9 binds DNA 
through an SRY-like consensus sequences (WWACAAT, where W, (A/T)),  151 
(Sekido & Lovell-Badge, 2008). Note that other SoxE group proteins, such as 
Sox10 are capable of binding DNA as monomers and dimers that bind to two 
SRY-like binding sites oriented in a head-to-head fashion (Peirano et al., 2000b). 
  
  To confirm that genes with associated genomic elements bound by 
Mash1 were indeed regulated by this proneural factor, we examined their 
expression in the ventral telencephalon of Mash1 mutant embryos. The proneural 
protein Mash1 functions as a transcriptional activator, and therefore genes under 
the control of Mash1 are down regulated in Mash1 null animals (Castro et al., 
2006; Gohlke et al., 2008). We also tested the ability of the genomic elements to 
regulate gene expression in vivo with a lacZ reporter gene using mouse transient 
transgenesis, in order to define their spatial and temporal activity, and therefore 
identify those elements with regulatory capabilities in the oligodendroglial 
lineage in the CNS. 
 
3.6.1 Validation of distal Olig2 enhancer activity 
 
  To identify additional TF binding sites within the non-coding putative 
Olig2 distal enhancer element, we used the orthologous sequence in different 
species to perform phylogenetic footprinting by comparative analysis. Notably, 
the putative Olig2 distal element was found to be evolutionary conserved across 
a diverse number of distantly related species including human, rat, dog, chicken, 
cow and in some regions zebrafish (Figure 34A-C). Detailed analysis of the 
sequence revealed evolutionary conserved putative consensus binding sites for a 
bHLH Mash1 type E-box (Figure 34C, red box), and an octamer motif, for the  152 
POU family of homeodomain proteins (Figure 34C blue box), as expected since 
this element was isolated from an in silico screen on the basis of the presence of 
proximal Mash1 (CAGSTG, where S, (C/G)) and Brn (ATTWNYAW, where W, 
(A/T) and Y, (C/T)) conserved binding sites. In addition we identified a putative 
SRY-like consensus sequences, in close proximity (Figure 34C green box). 
  To investigate the regulatory potential of the putative Olig2 distal 
enhancer in vitro, we used a luciferase based transcription assay to test the ability 
of this genomic element to direct reporter gene expression in the NS5 cell line. 
Note that Olig2 is endogenously expressed in the NS5 cell line (Figure 12C). In 
brief, the luciferase assay is a sensitive method for determining the level of 
luciferase expression in cells transfected with a luciferase reporter vector. The 
reaction catalyzed by luciferase results in the production of light, which can be 
quantitated using a luminometer. Importantly, in mammalian cells luciferase has 
a short half-life of approximately 3 hours and does not accumulate in cells, 
therefore changes in promoter activity are rapidly reflected in luciferase activity.  
  Briefly, the mouse Olig2 distal enhancer was cloned upstream of a 
minimal promoter (-globin) directing basal luciferase expression, and luciferase 
activity was assayed 24 hours post-transfection. We used the previously 
described bicistronic vector (pCAGGS-IRES-nls-GFP), which encoded Mash1, 
Sox9, Olig2, Mash1EngR or Sox9EngR, to attain high levels of expression of 
these factors. Using this assay we examined whether Mash1, Sox9 or Olig2 alone 
could interact with this genomic segment and activate luciferase reporter gene 
expression. Furthermore, we asked whether a potential synergy between Mash1 
and other oligodendroglial promoting TFs namely, Olig2 or Sox9, exist on this 
genomic region. The Olig2 segment showed a high basal level of enhancer  153 
activity without addition of any exogenous TFs (Figure 34D).  Addition of 
Mash1 or Sox9 alone resulted in a small but significant increased enhancer 
activity compared to control. Moreover Mash1 enhancer activity was reduced in 
the presence of Sox9EngR, suggesting that perhaps Mash1 and Sox9 synergise at 
this genomic locus. Addition of Olig2 did not have a pronounced effect in this 
assay. Note that although binding of a factor to an enhancer region can be 
necessary, it may not be sufficient, for high levels of promoter activity.  We 
propose that the high basal activity, the relatively small increases in enhancer 
activity following the exogenous addition of TFs, and the significant repression 
of basal activity with Mash1EngR or Sox9EngR constructs, can be accounted for 
by the fact that Mash1, Olig2 and Sox9 are already endogenously expressed by 
the NS5 cells. Indeed Olig2 and Sox9 expression levels may have reached a 
saturation point, above which the NS5 cells are not responsive. In conclusion, 
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Figure 34. Activation of the Olig2 enhancer requires Mash1 and Sox9 in NS5 
cells. A, Olig2 enhancer (red asterisk) lies approximately 82kb upstream of the 
Olig2 locus, from the UCSC Genome Browser (http://genome.ucsc.edu/ 
[coordinates are from the February 2006, mm8 NCBI Build 36 UCSC Genome 
Browser Mouse assembly]). B, Enlargement of the Olig2 enhancer, an 848bp 
interval. C, Alignment of the Olig2 enhancer sequences from the mouse, human, 
rat, cow, dog, chicken, and zebrafish genomes. Red box delineates the sequences 
of a conserved E-boxes, blue box delineates the sequence of a conserved 
octamer, and a green box delineates the sequence of a conserved SRY-like 
putative consensus sequence. D, Transcriptional assay in NS5 cells cotransfected 
with a Mash1, Sox9, Olig2, Mash1 Engrailed Repressor, or Sox9 Engrailed 
Repressor plasmid and a reporter construct expressing luciferase under the 
control of the Olig2 enhancer. * P<0.05, ** P<0.01, *** P<0.001.   
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  To verify whether Mash1 could play a role in the regulation of Olig2 in 
vivo, Olig2 expression was analysed in Mash1 null animals, during a period 
where Mash1 function is required for oligodendrogenesis in the ventral 
telencephalon. Notably, Olig2 expression was markedly reduced in the VZ of the 
MGE, a region where PDGFR+ OPCs are specified and Mash1 is normally 
expressed, in Mash1 null mutant embryos compared to wild-type aged-matched 
control at E12.5 (Figure 35). These data suggest that Olig2 gene expression in 
the developing ventral telencephalon is likely regulated by Mash1.  
 
The expression of Olig2 in the mammalian CNS, including in the 
oligodendroglial lineage has been well documented (Lu et al., 2000). To 
determine whether the putative Olig2 enhancer could recapitulate part of this 
expression we tested its ability to regulate gene expression in vivo with a lacZ 
reporter gene using mouse transient transgenesis. Briefly, the Olig2 genomic 
segment was cloned upstream of a minimal promoter (-globin) and lacZ coding 
sequence, and injected into mouse pronuclei. Reporter gene expression was 
analysed by X-Gal staining of tissue sections at specific embryonic time points, 
E12.5 and E14.5, respectively. The distal Olig2 element did not show 
independent enhancer activity, and failed to direct reporter gene expression in all 
20+ embryos that were analysed (data not shown). We therefore concluded, that 
the described Olig2 genomic segment contained no regulatory sequences able to 
recapitulate the temporal or spatial pattern of Olig2 expression in mouse transient 
transgenic analyses. It is possible that this element may function as a general 
enhancer that modulates an already specified expression.  
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It is important to note at this point the number of disadvantages of the 
transient transgenesis system, namely the inability to visualise dynamic enhancer 
activity. Indeed, to get a complete overview of the activity of an enhancer 
multiple developmental and postnatal time points would have to be analysed. 
Moreover this strategy is focused towards the identification of regulatory 
elements that confer positive activity on gene expression, and do not lend to the 
discovery of regions that are involved in fine-tuning or indeed repressing gene 
regulation. Enhancer screening strategies would therefore benefit from co-
injections with a well-characterised enhancer, such as the limb enhancer (Lettice 
et al., 2003), to drive expression of a different reporter gene as a positive control. 
Furthermore, this strategy is based on the assumption that the putative enhancer 
of interest is sufficient to drive reporter gene expression in a context independent 
manner with regards to the original locus and surrounding genomic regions from 
where it was extracted. Mammalian genomes are organized into high-level three-
dimensional structures; therefore it is not surprising that chromatin interactions 
constitute a primary mechanism for regulating transcription. Indeed, distal 
binding sites have been shown to regulate transcription through the formation of 
functional long-range chromatin interactions (Fullwood et al., 2009; West and 
Fraser, 2005; Woodcock, 2006). In addition, some cis-regulatory elements may 
require the native basal promoter of the particular gene it regulates to confer 
appropriate cell-specific transcription in vivo. However, cloning individual gene 
specific basal promoters for a large enhancer screen is impractical, and it is more 
convenient to use a heterologous basal promoter such as the -globin minimal 
promoter.  
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Interestingly, a sequence referred to as ULTRA, for ultraconserved, 
(mm8_chr16: 91,029,26-91,029,835) residing within the Olig2 genomic region 
tested has been isolated (Chen et al., 2008). Briefly, ultraconserved elements 
were first defined as at least 200 base pair long sequences that show perfect 
conservation in alignments of the human, mouse and rat reference genomes, and 
are thought to represent sequences under selection for specific functions 
(Bejerano et al., 2004; Chen et al., 2007). ULTRA contains 106 base pair and 45 
base pair sequences of perfect human, mouse and rat conservation, which are 
separated by only a 1 base mismatch in the human genome and is significantly 
enriched for putative TF binding motifs (Chen et al., 2008).  
The activity of ULTRA in mouse undifferentiated ES cells and neural 
precursor cells has been characterised using the native basal promoter from the 
Olig2 locus which is constitutively active in both cell types (Zhang et al., 2008; 
Xian et al., 2005). These analyses show that ULTRA contains sequences that 
repress Olig2 expression in undifferentiated ES cells, but not in neural precursor 
cells and therefore ULTRA may play a significant part in maintaining Olig2 
expression off in the former (Chen et al., 2008). It is interesting with this 
information to think about the possible biological significance of Mash1 and 
Sox9 binding to this element. We predict a model in which Mash1 and Sox9 
proteins functionally synergise to relieve the repression of Olig2 by interactions 
on the ULTRA segment as cells develop along the neural lineage, and thus 
permitting Olig2 expression.  
 
  Indeed we provide genetic evidence to support the fact that Mash1 
regulates Olig2 expression in vivo (Figure 35) that corroborates with Mash1 null  160 
embryonic expression array data, which demonstrate a significant reduction in 
Olig2 transcripts (p-value, 1.79x10
-7; Carlos Parras, unpublished data). However, 
we are yet to define the regulatory modules that confer Mash1 activity on this 
gene. Indeed, Olig2 regulatory elements are complex and scattered over a large 
genomic distance, which renders the analysis of its regulation difficult (Sun et 
al., 2006; Xian et al., 2005). We propose that by adopting a more gene centric 
strategy, using a comparative approach to identify evolutionary conserved Mash1 
type E-boxes (CAG[C/G]TG) surrounding the Olig2 locus, validating Mash1 
binding using ChIP-PCR, and defining their in vivo spatial and temporal activity 
using mouse transient transgenics, will help to identify Olig2 regulatory regions 
modulated by Mash1 activity in the oligodendroglial lineage of the CNS.   
 
3.6.2 Validation of distal Sox9 enhancer activity 
 
 Distal  cis-regulatory elements in vertebrates can be located far from the 
gene (Vavouri et al., 2006). The regulatory domain responsible for directing 
tissue specific expression of Sox9 spans a vast genomic distance, and involves 
more than 1 Mb of upstream and downstream sequence from SOX9 (Jakobsen et 
al., 2007; Benko et al., 2009; Velagaleti et al., 2005; Gordon et al., 2009), to 
suggest that the total genomic domain regulating SOX9 expression may extend 
over 3 Mb. Notably, these studies highlight the complexity of Sox9 gene 
regulation, and the need to identify still elusive enhancers such as those 
responsible for Sox9 expression during oligodendrogenesis. 
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  To identify additional TF binding sites within the putative Sox9 distal 
enhancer element, we performed phylogenetic footprinting (as described before 
for the Olig2 element). The putative Sox9 distal element was found to be 
evolutionary conserved across a number of mammalian species including human, 
rat, dog, chicken and cow (Figure 36A-C). Detailed analysis of the sequence 
revealed evolutionary conserved putative consensus binding sites including two 
proximal bHLH Mash1 type E-boxes (Figure 36C, red boxes), and two 
overlapping octamer motifs for the POU family of homeodomain proteins 
(Figure 36C blue boxes), as expected since this element was isolated from an in 
silico screen on the basis of the presence of proximal Mash1 (CAGSTG, where 
S, (C/G)) and Brn (ATTWNYAW, where W, (A/T) and Y, (C/T)) conserved 
binding sites. In addition we identified an SRY-like putative consensus sequence 
(Figure 36C green box).  
 
  To investigate the regulatory potential of the putative Sox9 distal 
enhancer in vitro, we used a luciferase based transcription assay to test the ability 
of this genomic element to direct reporter gene expression in the NS5 cell line 
(as described before for the Olig2 element). Note that Sox9 is endogenously 
expressed in the NS5 cell line (Figure 12F).  We examined whether Mash1, Sox9 
or Olig2 alone could interact with this genomic segment and activate luciferase 
reporter gene expression. Moreover, we asked whether a potential synergy 
between Mash1 and Olig2 or Sox9, exist on this genomic region. The Sox9 
segment showed a high basal level of enhancer activity without addition of any 
exogenous TFs (Figure 36D).  Addition of Mash1 or Sox9 alone resulted in a 
moderate but significant increased enhancer activity compared to control.  162 
Moreover the activity of Mash1 or Sox9 on this element was reduced with 
Sox9EngR or Mash1EngR respectively, suggesting that these TFs synergise at 
this genomic region. Note that addition of Olig2 to this system did not have a 
pronounced effect in this assay. Similar to the Olig2 element, we propose that the 
high basal activity, the relatively small increases in enhancer activity following 
the exogenous addition of TFs, and the significant repression of basal activity 
with Mash1EngR or Sox9EngR constructs, can be accounted for by the fact that 
Mash1, Olig2 and Sox9 are already endogenously expressed by the NS5 cells. In 
conclusion, these data demonstrate that Mash1 and Sox9 proteins interact with 
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Figure 36. Activation of the Sox9 enhancer requires Mash1 and Sox9 in NS5 
cells. A, Sox9 enhancer (red asterisk) lies approximately 500kb upstream of the 
Sox9 locus, from the UCSC Genome Browser (http://genome.ucsc.edu/ 
[coordinates are from the February 2006, mm8 NCBI Build 36UCSC Genome 
Browser Mouse assembly]). B, Enlargement of the Sox9 enhancer, a 137bp 
interval. C, Alignment of the Sox9 enhancer sequences from the mouse, human, 
rat, cow and dog genomes. Red boxes delineate the sequences of two conserved 
E-boxes, blue boxes delineate the sequence of two conserved octamer, and a 
green box delineates the sequence of a conserved SRY-like putative consensus 
sequence.  D, Transcriptional assay in NS5 cells cotransfected with a Mash1, 
Sox9, Olig2, Mash1 Engrailed Repressor, or Sox9 Engrailed Repress or plasmid 
and a reporter construct expressing luciferase under the control of the Sox9 
enhancer. * P<0.05, ** P<0.01, *** P<0.001. 
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To verify whether Mash1 could play a role in the regulation of Sox9 in 
vivo, Sox9 expression was analysed in Mash1 null embryos, during a period 
where Mash1 function is required for oligodendrogenesis in the ventral 
telencephalon. Notably, Sox9 expression was strongly reduced in the VZ of the 
MGE, a region where PDGFR+ OPCs are specified and Mash1 is normally 
expressed, in Mash1 null mutant embryos compared to wild-type aged-matched 
control at E12.5 (Figure 37).  In contrast, Sox9 expression remained unperturbed 
in the VZ of the dorsal telencephalon, a region where Mash1 is expressed albeit 
at low levels (Britz et al., 2006), in Mash1 null mutant embryos compared to 
wild-type control at E12.5 (Figure 37). These data suggest that Sox9 expression 
is likely to be regulated by Mash1 in the ventral telencephalon, whilst different 













  167 
  Sox9 is expressed in the VZ in the developing spinal cord and 
telencephalon, and is maintained in proliferating and migrating OPCs (Stolt et 
al., 2003; Figure 10 and data not shown). To determine whether the putative 
Sox9 enhancer could recapitulate part of this expression we tested its ability to 
regulate gene expression in vivo with a lacZ reporter gene using mouse transient 
transgenesis (as previously described). Reporter gene expression was analysed 
by X-Gal staining of tissue sections at E12.5 of embryonic development. We 
found that the Sox9 enhancer directed reporter gene expression in the dorsal and 
more prominently in the ventral telencephalon at E12.5 (n=1, Figure 38A). 
Specifically X-gal staining was visualised in a salt-and pepper fashion in the VZ 
of the ventral telencephalon (Figure 38A1), similar to the patterns observed in 
characterised Mash1 targets (Castro et al., 2006; Gohlke et al., 2008). We 
detected intense X-gal staining in the mantle zone of the ventral telencephalon, 
where post-mitotic neurons differentiate. Interestingly, we also identified two 
streams of X-gal positive cells migrating tangentially from the ventral ganglionic 
eminences to the developing cortex. Note that these tangentially migrating cells 
are a significant source of cortical interneurons and other cell types, including 
oligodendrocytes (Corbin et al., 2001). To determine whether the Sox9 enhancer 
is active in the oligodendroglial lineage we used an antibody to PDGFR in 
order to identify OPCs, and an antibody to -galactosidase (-gal) to identify 
cells that have experienced reporter activity. We identified a subset of PDGFR+ 
cells that coepxressed -gal close to the VZ in the ventral telencephalon (Figure 
38B and C, white arrows). We propose that the Sox9 enhancer is active in neural 
progenitors that reside in the VZ of the developing ventral telencephalon, that 
subsequently give rise to neuronal and oligodendroglial cells. From these  168 
transient transgenic analysis we conclude that the Sox9 genomic sequences 
described contained regulatory sequences able to recapitulate some temporal and 
spatial pattern of the endogenous Sox9 expression in the developing mouse 
telencephalon, which include the oligodendroglial lineage.  
  
  Indeed we provide genetic evidence to support the fact that Mash1 
regulates Sox9 expression in vivo (Figure 37) that corroborates with Mash1 null 
embryonic expression array data, which demonstrate a significant reduction in 
Sox9 transcripts (p-value, 5.98x10
-5; Carlos Parras, unpublished data). To 
determine whether this distal enhancer mediates the regulation of Sox9 by 
Mash1, stable transgenic mouse lines would be established, and bred with Mash1 
null mutant mice (Guillemot et al., 1993). Indeed these analyses would detail the 
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Figure 38. Distal Sox9 enhancer is able to recapitulate part of Sox9 gene 
expression in the ventral telencephalon, including the oligodendroglial 
lineage at E12.5. A,  Coronal section through the telencephalon of an X-gal 
stained transgenic embryo for the Sox9 enhancer at E12.5. Note the two streams 
of dorsally migrating cells into the cortex from the ventral ganglionic eminences 
(black arrows), and high intensity of X-gal staining in the mantle zone of the 
ventral telencephalon, where neurons differentiate (white asterisks). Inset A1 is 
an enlargement of the area outlined by the square in A, where X-gal staining in 
the VZ demonstrates a salt and pepper pattern. B & C, A subset of PDGFR+ 
OPCs close to the VZ in the ventral telencephalon co-express -gal (white 
arrows).  
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3.6.3 A mouse transient transgenic screen to isolate proximal genomic 
elements bound by Mash1 with activity in the oligodendroglial lineage 
 
  To establish a robust screening strategy, to identify genomic segments 
with regulatory activity in the oligodendroglial lineage from the list of Mash1 
bound genomic elements, we performed mouse transient transgenesis (as 
described previously). We concluded that luciferase assays were not a reliable 
system to identify de novo enhancers, namely because enhancer activity in this 
assay is highly dependent on the cellular context. Moreover, this strategy fails to 
identify enhancer activity at the level of the cell, which can be addressed by 
transient transgenics in combination with X-gal staining and immunostaining for 
specific oligodendroglial lineage markers such as PDGFR, to identify OPCs.  
 
3.6.4 Validation of proximal Notch1 enhancer activity  
 
  To identify TF binding sites within the putative Notch1 enhancer element, 
we performed phylogenetic footprinting (as described previously). The putative 
Notch1 element was found to be evolutionary conserved across a number of 
mammalian species including human, rat, dog, chicken and cow (Figure 39). 
Detailed analysis of the sequence revealed evolutionary conserved putative 
consensus binding sites including a bHLH Mash1 type E-box (Figure 39B, red 
box) and a SRY-like putative consensus sequence (Figure 39B green box).  
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  Notch1 is expressed in the VZ of the developing CNS, and is more 
prominent in the ventral rather than dorsal telencephalon during development 
(Tokunaga et al., 2004; Guillemot & Joyner, 1993; Lindsell et al., 1996). To 
determine whether the putative Notch1 enhancer could recapitulate part of this 
expression we tested its ability to regulate gene expression in vivo with a lacZ 
reporter gene using mouse transient transgenesis (as previously described). 
Reporter gene expression was analysed by X-Gal staining of tissue sections at 
E13.5 of embryonic development. We found that the Notch1 enhancer directed 
reporter gene expression in the ventral telencephalon (n=1, Figure 40A). To 
determine whether the Notch1 enhancer is active in the oligodendroglial lineage 
we identify OPCs with an antibody to PDGFR, and we used an antibody to -
gal to identify cells that have seen reporter activity. We found that PDGFR+ 
cells did not coexpressed -gal, indeed their pattern of expression were mutually 
exclusive (Figure 40B-E). From these transient transgenic analysis we concluded 
that the Notch1  genomic sequences described contained regulatory sequences 
able to recapitulate some temporal and spatial pattern of the endogenous Notch1 
expression in the developing mouse telencephalon, which does not include the 
oligodendroglial lineage. Note that Mash1 null embryonic expression array data 
demonstrate a significant reduction in Notch1 transcripts (p-value, 2.41x10
-7; 
Carlos Parras, unpublished data). A gene centric strategy, similar to that 
described for the Olig2 locus, could also be implemented for the Notch1 locus in 
order to identify regulatory elements bound by Mash1 that are active in the 
oligodendroglial lineage. 
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3.6.5 Validation of proximal Brevican enhancer activity  
 
  To identify TF binding sites within the putative Bcan enhancer element, 
we performed phylogenetic footprinting (as described previously). The putative 
Bcan element was not strongly conserved throughout mammalian evolution 
(Figure 41A). Detailed analysis of the sequence revealed that although specific 
Mash1 type E-boxes were present, none were evolutionary conserved (data not 
shown). A number of mechanisms have been proposed to account for the 
recruitment of a particular factor in the absence of a consensus motif and may 
include, binding at a distal site that contains a consensus motif and looping to the 
site in question through protein-protein interactions; or assisted binding to a site 
that is similar to the consensus site, which is enhanced by protein–protein 
interaction with another site-specific DNA binding factor or with a specifically 
modified histone. 
 
  Bcan expression is restricted to zones of active proliferation in the CNS 
during development, and commences after the peak of neurogenesis at the onset 
of gliogenesis (Jaworski et al., 1994; Jaworski et al., 1995). To determine 
whether the putative Bcan enhancer could recapitulate part of this expression we 
tested its ability to regulate gene expression in vivo with a LacZ reporter gene 
using mouse transient transgenesis (as previously described). Reporter gene 
expression was analysed by X-Gal staining of tissue sections at E13.5 of 
embryonic development. We found that the Bcan enhancer directed reporter gene 
expression in scattered cells located in the dorsal and ventral telencephalon (n=1, 
Figure 41B). To determine whether the Bcan enhancer is active in the  176 
oligodendroglial lineage we used an antibody to PDGFR, to identify OPCs, and 
an antibody to -gal to identify cells with reporter activity. We found that 
PDGFR+ cells did not coexpressed -gal (Figure 41C and D). From these 
transient transgenic analysis we concluded that the Bcan genomic sequences 
described contained regulatory sequences able to drive lacZ expression, however 
we cannot be sure whether the X-gal pattern observed recapitulate some temporal 
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  In conclusion, we have generated transient transgenics with 4 genomic 
regions that were bound by Mash1 in the oligosphere cultures, one of which had 
no independent enhancer activity, whilst the others contained regulatory 
sequences that conferred enhancer activity. Moreover, we have isolated a distal 
Sox9  enhancer element that clearly recapitulates some temporal and spatial 
pattern of the endogenous Sox9 gene expression in mouse telencephalon, which 
includes the oligodendroglial lineage. It is evident that not all genomic elements 
bound by Mash1 in the oligosphere cultures, represent enhancers with activity in 
the oligodendroglial lineage. Therefore, whilst this strategy is immensely 
powerful in defining the activity of enhancers with a cellular resolution, transient 
transgenic analysis in a faster developmental model, such in Danerio rerio or 
zebrafish, would increase the speed of the screen and thus identification of 
regulatory regions active in oligodendroglial cells. Notably these studies would 
further allow the functional categorisation of those targets with specific activity 
in different and overlapping cell lineages, and facilitate the identification of 
putative signature motifs of Mash1, which may vary between neuronal and 
oligodendroglial specific enhancers. Indeed, these studies would further elucidate 
potential co-regulators of Mash1 in oligodendroglial cell fate specification.   179 
3.7 Combinatorial regulation in oligodendrogenesis 
 
  The combinatorial interaction of TFs and their binding to specific motifs 
in DNA are critical for gene regulation. Models of combinatorial regulation by 
several TFs at a particular genomic region can be inferred from multiple data 
sources, including evolutionary conservation, DNase hypersensitive sites and 
ChIP-on-chip binding data. Note that the average length of DNA fragments in 
ChIP experiments are approximately 300-500 base pairs, and thus the spatial 
resolution of this technique permits co-regulator analysis. Notably, the proneural 
protein Mash1 is likely to function in combination with other TFs in the 
specification of OPCs (Parras et al., 2007; Sugimori et al., 2007). To identify 
potential co-regulators, we asked whether genomic elements enriched in the 
Mash1 ChIP-on-chip study, were also bound by other oligodendrocyte promoting 
TFs, namely Sox9 and Olig2. Notably both Sox9 and Olig2 are coexpressed with 
Mash1, and a subset of these also coexpress the early OPC marker PDGFR, 
both in oligosphere cultures (Figure 18), and during oligodendrogenesis in the 
developing mouse ventral telencephalon (Figure 10, Parras et al., 2007) and 
therefore have the potential to cooperate in oligodendroglial cell fate 
specification. Specific antibodies to Sox9 and Olig2 proteins, which have been 
extensively characterised for ChIP (Ben Martynoga, personal communication), 
were used to coprecipitate chromatin from mouse oligosphere culture material, 
and ChIP-PCR performed with specific primer sequences to Mash1 bound 
segments.  
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  Previously experiments were performed at day 14 of oligosphere 
formation based on the published protocol (Chen et al., 2007), but the timing of 
oligodendrogenesis  in vitro was re-examined to optimise the ChIP protocol. 
Briefly, oligospheres were generated over a period of 21 days, and time points 
were taken at 3, 5, 7, 14, and 21 days of oligosphere formation and expression 
levels were assayed. Note that expression levels are normalised to neurosphere 
cultures (at day 4 of neurosphere formation). We found that both early OPC 
markers, PDGFR and Sox10, peaked at day 5 of oligosphere formation, after 
which they declined and were drastically reduced by day 14 and day 21 of 
oligosphere formation (Figure 42). All subsequent ChIP experiments were 
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3.7.1 Mash1 ChIP 
 
  We asked whether the Mash1 proneural protein directly interacts with the 
DeltaM, Fbxw7, Notch1, Sox8, Mog, Olig1, Sulf1, Bcan and Omg enhancers in 
addition to Tubb3 and MAP2, Mash1 neurogenic enhancers (Diogo Castro, 
unpublished data) in oligosphere cultures material at day 5 of oligosphere 
formation, in order to confirm our previous analysis of Mash1 binding in day 14 
oligospheres, by performing ChIP-PCR.  An antibody to Mash1 coprecipitated 
the DeltaM, Fbxw7, Notch1, Sox8, Mog, Olig1, Sulf1, Bcan, Omg, Tubb3 and 
MAP2 sequences in chromatin prepared from oligosphere cultures, but not the 
Dll1 ORF nor Fbxw7 ORF negative controls (Figure 43A and B). Conversely, a 
control IgG antibody did not coprecipitated the DeltaM, Fbxw7, Notch1, Sox8, 
Mog, Olig1, Sulf1, Bcan, Omg, Tubb3 and MAP2 sequences nor the Dll1 ORF, 
Fbxw7  ORF (Figure 43A and B). Therefore, in oligosphere cultures Mash1 
specifically binds to the DeltaM, Fbxw7, Notch1, Sox8, Mog, Olig1, Sulf1, Bcan, 
Omg, Tubb3 and MAP2 genomic regions. We therefore confirmed that elements 
bound by Mash1 at day 14 were also bound at day 5 of oligosphere formation, 
and thus concluded that this material was suitable for ChIP analyses. Note that 
the fact that Mash1 was bound to neurogenic targets, Tubb3 and MAP2, likely 
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Figure 43. Mash1 enriched elements in day 5 oligospheres. A, DelatM and 
Fbxw7 regions are enriched in ChIP, using an antibody to Mash1 and chromatin 
from oligosphere day 5 material, compared to negative regions Dll1 ORF and 
Fbxw7 ORF (blue asterisk), respectively. B, Elements enriched in the Mash1 
ChIP using chromatin prepared from day 14 oligospheres are also enriched in 
chromatin from day 5 oligospheres. Mash1 binds to neurogenic targets including 
Tubb3 and MAP2. * P<0.05, ** P<0.01, *** P<0.001. 
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3.7.2 Olig2 ChIP 
 
  To determine whether Olig2 was a potential co-regulator of Mash1 in 
oligosphere cultures, we asked whether DeltaM,  Notch1,  Sox8,  Mog,  Olig1, 
Sulf1, Bcan, Omg, Tubb3 and MAP2 genomic elements enriched in the Mash1 
ChIP, were also bound by the Olig2 protein in oligosphere cultures material (at 
day 5 of oligosphere formation) by performing ChIP-PCR. An antibody to Olig2 
coprecipitated the DeltaM, Notch1, Sox8, Mog, Olig1, Sulf1, Bcan, Omg, Tubb3 
and MAP2 sequences in chromatin prepared from oligosphere cultures, but not 
the Dll1 ORF negative control (Figure 44A). Conversely, a control IgG antibody 
did not coprecipitated the DeltaM, Notch1, Sox8, Mog, Olig1, Sulf1, Bcan, Omg, 
Tubb3 or MAP2 sequences nor the Dll1 ORF (Figure 44A). Therefore, in 
oligosphere cultures Olig2 specifically binds to the DeltaM, Notch1, Sox8, Mog, 
Olig1, Sulf1, Bcan, Omg, Tubb3 and MAP2 genomic regions. Thus, all elements 
bound by Mash1, were also bound by Olig2 (Figure 43 and 44A). The bHLH TF 
Olig2 like Mash1 binds degenerate E-boxes, however whether a specific Olig2 
type E-box exists is yet to be described. It is plausible that Olig2 and Mash1 bind 
the same sites, or that these TFs heterodimerise and bind together, analogous to 
the behaviour of Olig2 in the spinal cord, which not only recognises the same E-
box elements that are bound by Neurogenin2 but is also capable of 
heterodimersation with this TF (Lee et al., 2005). Nevertheless the molecular 
mechanisms underlying the transcriptional synergy of Mash1 and Olig2 have not 
been detailed, and are likely to be complex since Mash1 and Olig2 have been 
shown so far to act as a transcriptional activator and repressor, respectively. 
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3.7.3 Sox9 ChIP 
 
  To determine whether Sox9 was a potential co-regulator of Mash1 in 
oligosphere cultures, we asked whether Notch1, Sox8, Mog, Olig1, Sulf1, Bcan, 
and Omg genomic elements enriched in the Mash1 ChIP, were also bound by the 
Sox9 protein in oligosphere cultures material (at day 5 of oligosphere formation) 
by performing ChIP-PCR. In addition, we included two genomic segments that 
are located upstream of the mouse PDGFR gene as controls, defined as C1 
(evolutionary conserved, proximal 5’ flanking region) and N2 (non evolutionary 
conserved, distal 5’ flanking region), which are bound and not bound, 
respectively by Sox9 in the developing embryonic spinal cord (Finzsch et al., 
2008). An antibody to Sox9 coprecipitated the Notch1, Sox8, Mog, Olig1, and 
Omg sequences in chromatin prepared from oligosphere cultures, but not C1, 
Sulf1 nor Bcan sequences nor the N2 negative control (Figure 44B). Conversely, 
a control IgG antibody did not coprecipitated the Notch1, Sox8, Mog, Olig1, 
Sulf1, Bcan, Omg, nor C1 sequences nor the N2 element (Figure 44B). Therefore, 
in oligosphere cultures Sox9 specifically binds to the Notch1, Sox8, Mog, Olig1, 
and Omg genomic regions. Thus, Sox9 binds to a subset of elements bound by 
Mash1 (Figure 43 and 44B). Note that Sox9 does not bind the C1 element in 
oligosphere cultures, which is bound in embryonic spinal cord chromatin 
preparations, such inconsistencies may result from inherent regional differences. 
Assuming that oligosphere cultures retain regional identity, it is possible that 
different elements for PDGFR expression exist in the spinal cord and the 
telencephalon, respectively.  
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Figure 44. Olig2 and Sox9 bind to Mash1 enriched elements in day 5 
oligospheres.  A, ChIP, using an antibody to Olig2 and chromatin from 
oligosphere day 5 material, is enriched for all elements bound by Mash1 
compared to negative control region Dll1 ORF (black asterisk). B, ChIP, using 
and antibody to Sox9 and chromatin from oligosphere day 5 material, is enriched 
for Notch1, Sox8, Olig1, Omg and Mog elements compared to negative region N2 
(black asterisk). * P<0.05, ** P<0.01, *** P<0.001. 
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  Gene expression regulation is a multipart process that requires the 
collaborative action of numerous proteins, including sequence-specific TFs, 
cofactors, and chromatin proteins. However, the interactions between these 
factors and the genome are still poorly understood. It is widely accepted that TFs 
and their cofactors show strong overlapping localization patterns on the genome. 
Indeed the fact that Mash1, Sox9 and Olig2 show a high degree of overlap in 
binding to specific genomic elements in oligosphere cultures enforces the notion 
that these regions are likely functional enhancers. Moreover, these data support 
the hypothesis that Mash1 interacts with other oligodendrogenic TFs, such as 
Sox9 and Olig2 to promote oligo-specific gene expression and specify OPCs. 
However there are clear limitations to this approach, namely that it does not 
directly address combinatorial binding or indeed regulation by these TFs. To 
determine whether these TFs are bound to the same segments rather than 
alternatively bound in different cells, sequential ChIP assays should be employed 
(Medeiros et al., 2009). A more complete picture of Mash1 function in 
oligodendroglial cell fate specification are yet to be described, undoubtedly this 
would be aided by adopting an integrated approach with ChIP and microarray 





















    Chapter 4 
        
      D i s c u s s i o n  
        191 
  The cellular functions of the proneural gene Mash1 are well characterised 
(Bertrand et al., 2002), and more recently significant efforts to understand the 
molecular mechanisms underlying its activity in neurogenesis have been made 
(Castro et al., 2006; Gohlke et al., 2008; Henke et al., 2009; Long et al., 2009; 
Del Barrio et al., 2007). However, very little is known about the molecular 
mechanisms underpinning Mash1 activity in oligodendroglial cell fate 
specification, including target genes and interacting partners (Parras et al., 2004, 
2007; Sugimori et al., 2007). This project has made an initial step towards the 
discovery of the gene regulatory network downstream of Mash1 in the 
oligodendrogenic program.  
 
  There are three main components to this work. Firstly, the identification 
of a suitable cellular system in which to study the role of Mash1 in 
oligodendrogenesis. Secondly, a promoter occupancy analysis using ChIP-on-
chip technology to locate genomic regions bound by Mash1, in addition to a 
ChIP approach with oligodendrocyte promoting TFs, Sox9 and Olig2, to identify 
Mash1 co-regulators in the oligodendroglial lineage. Finally, an in vivo enhancer 
screen to assay the spatial and temporal activity of enhancers using mouse 
transient transgenics, in order to isolate genomic elements with regulatory 
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4.1 Mash1 is coexpressed with early OPC marker PDGFR and 
oligodendrocyte promoting TFs Sox9 and Olig2 in oligosphere cultures  
 
  We describe an in vitro cellular system in which to study the gene 
regulatory network downstream of Mash1 in oligodendrogenesis, using 
oligosphere cultures derived from E14.5 mouse cortex (Chen et al., 2007). 
Mash1 protein was expressed in a significant proportion of cells in oligospheres 
(Figure 18A and B). Analogous to the patterns of coexpression in the developing 
ventral telencephalon (Figure 10; Parras et al., 2007), Mash1 was coexpressed 
with oligodendrocyte promoting TFs, Olig2 and Sox9 (Figure 18C and D). 
Moreover, a subset of Mash1+/Olig2+ and Mash1+/Sox9+ cells also coexpressed 
the early OPC marker, PDGFR (Figure 18C-E). Contrary to the previously 
published protocol we found that: (i) oligosphere cultures were most optimal at 
day 5 of oligosphere formation, as defined by gene expression profiling with 
early OPC markers, PDGFR and Sox10 (Figure 42); (ii) only a small fraction of 
cells in the oligospheres were in fact OPCs (Figure 18C-E). We propose that 
perhaps a difference in B104CM batch preparations may account for these 
discrepancies. Nevertheless, the capacity to generate significant quantities of 
oligosphere culture material, compared to the difficulties in isolating sufficient 
numbers of oligodendroglial cells from the ventral telencephalon of 
Sox10Cre/Rosa26YFP transgenic embryos using a cell sorting approach (Figure 
11B), makes this in vitro cellular system ideal for use in genomic strategies.  
 
  The requirement for Mash1 function in the specification of OPCs in 
oligosphere cultures is yet to be defined. To address this question, oligosphere  193 
cultures from Mash1 conditional knockout mice (Mash1CDKO, Guillemot 
unpublished) crossed with a tamoxifen inducible Cre recombinase under the 
control of the Nestin promoter (Nestin-CreER, Burns et al., 2007) would be 
established. Nestin is a Class VI intermediate filament, which is expressed in 
early embryonic neuroepithelial stem cells of the developing CNS, and is used as 
a marker for stem/progenitor cells. Addition of tamoxifen to fully formed 
neurospheres, and therefore removal of Mash1 function prior to oligosphere 
formation, would define the requirement of Mash1 function for the specification 
of OPC in oligosphere cultures. On the basis of the requirement for Mash1 in the 
generation of OPCs in vivo (Parras et al., 2004, 2007; Sugimori et al., 2007), we 
hypothesise that a subset of OPCs in the oligospheres would require Mash1 
function for their specification.  
  
  Mash1 plays multiple roles throughout the oligodendrocyte lineage, early 
in the generation of OPCs (Parras et al., 2004, 2007; Sugimori et al., 2007), and 
in terminal differentiation of oligodendrocytes later in development (Sugimori et 
al., 2008). A synchronously differentiating population of mouse cells; from a 
NSC to an early OPC, and finally to a mature myelinating oligodendrocyte, 
would present an ideal system in which to study the temporal dynamics of gene 
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4.2 Mash1 binds to proximal genomic regions of early OPC and late 
oligodendrocyte genes  
 
  Mash1 locational analysis was performed in mouse oligosphere cultures, 
using a ChIP-on-chip strategy with a custom designed oligodendrocyte-specific 
array (Figure 23). We identified genomic segments proximal to early OPC genes, 
Olig1 and Sox8, which were bound by Mash1 protein in oligosphere cultures 
(Figure 27B). In the developing mouse embryo, Olig1 and Sox8 gene expressions 
are not entirely restricted to the oligodendroglial lineage, and extends to non-
differentiated neural progenitors in the VZ of the ventral telencephalon (Figure 
29B and 28B, respectively). We hypothesise that Mash1 is likely first expressed 
in uncommitted VZ stem cells in the developing telencephalon, as is the case in a 
fraction of neural stem cells or type B cells in the adult SVZ (Pastrana et al., 
2009, and Melanie Lebel, personal communication), and in the multipotent NS5 
neural stem cell line (Conti et al., 2005). However, without documentation of the 
in vivo activity of the Olig1 and Sox8 putative enhancers, we cannot be certain 
whether these Mash1 bound elements are involved in regulating the expression 
of Olig1 or Sox8 TFs respectively, in cell fate restricted oligodendroglial cells or 
uncommitted progenitors cells in the VZ. 
 
  We also identified genomic segments proximal to late/mature 
oligodendrocyte genes, Mog and Omg, which were bound by Mash1 protein in 
oligosphere cultures (Figure 26B). Mog and Omg are not expressed early in the 
oligodendrocyte lineage, however Mash1 protein was capable of binding to 
proximal genomic regions of these genes in non-differentiated oligosphere  195 
cultures (that present minimal MBP+ mature oligodendrocytes, Figure 19D). We 
propose a number of possible scenarios to explain for Mash1 binding activity at 
these elements. Firstly, that Mash1 functions to prime these promoters for rapid 
induction of gene expression in response to specific cues that promote 
oligodendrocyte differentiation and maturation later in development. Notably, 
the engagement of target genes by enhancer binding factors may facilitate a more 
rapid and homogeneous activation of a specific genetic program in a field of 
progenitor cells, in response to inductive signals. Indeed, FoxA1 binds the liver-
specific Alb1 enhancer, in the endoderm and facilitates chromatin remodelling 
and transcriptional activation upon liver specification (Gualdi et al. 1996; Cirillo 
et al. 2002). 
  Secondly, that Mash1 may serve to facilitate the recruitment of essential 
cofactors necessary for transcriptional initiation of these genes later in 
development. In this hypothetical situation, Mash1 would function as a pioneer 
factor binding to chromatin domains early in development to help establish 
competence for expression states. FoxA proteins function as pioneer TFs, that are 
among the first to bind chromatin domains prior to target gene activation during 
development and enable gene activity (Zaret 1999, 2002; Zaret et al., 2008). 
Specifically, binding of FoxA1 to nucleosomal templates in vitro enables binding 
by GATA-4 and NF1 factors at neighbouring sites (Cirillo and Zaret 1999; 
Cirillo et al. 2002). Moreover, FoxA1 binding to chromatin in vivo creates 
hypersensitive sites to facilitate estrogen receptor binding (Carroll et al. 2005). It 
is possible that the first two hypotheses are correct and that Mash1 binding may 
facilitate the recruitment of co-factors with chromatin remodelling activity.  196 
  Finally it is also possible that Mash1 activity at these sites is repressed 
during OPC specification, and is derepressed at the onset of oligodendrocyte 
differentiation. In this model, we propose that repression and activation activities 
of Mash1 at specific genomic loci are likely to be regulated by the formation of 
complexes with other factors. The myogenic bHLH transcription factor MyoD, 
plays a key role in establishing the myogenic lineage during embryogenesis and 
regulating the myogenic program in satellite cells of adult skeletal muscles (Puri 
and Sartorelli, 2000; Sabourin and Rudnicki, 2000). Notably, MyoD is a decisive 
transcriptional activator, however in complex with the gene repressor histone 
deacetylase1 (HDAC1) (Mal et al., 2001) at the myogenin promoter, MyoD 
behaves as a transcriptional repressor in proliferating myoblasts (Mal and Harter, 
2003). Following the induction of myoblast differentiation, the myogenin 
promoter is replaced with a functional acetyltransferase P/CAF and MyoD 
complex (Mal et al., 2001), in this context MyoD behaves as a transcriptional 
activator and myogenin expression is induced (Mal and Harter, 2003).  
 
4.3 Mash1 binds to proximal genomic regions of genes involved in different 
aspects of the oligodendroglial lineage  
 
  We identified genomic segments proximal to other genes of interest 
including  Sulf1,  Notch1 and Bcan, which were bound by Mash1 protein in 
oligosphere cultures (Figure 26B). Sulf1, a secreted enzyme that modulates the 
sulfation state of heparan sulfate proteoglycans, is expressed in the ventral 
neuroepithelium prior to OPC specification (Danesin et al., 2006; García-López 
et al., 2009). Elevated Shh concentrations are sufficient to induce premature OPC  197 
specification at the expense of neurogenesis, in ventral progenitors of the 
developing spinal cord (Danesin et al., 2006). Notably, over expression of Sulf1 
protein in ventral neural progenitors of the spinal cord prior to OPC 
specification, leads to the apical concentration of Shh on neuroepithelial cells, a 
process that is critical for the neuronal to oligodendroglial switch (Danesin et al., 
2006). We propose a model in which Mash1 induces Sulf1 gene expression in 
ventral progenitors of the CNS, which could contribute to the mechanisms 
involved in cell fate switch towards the oligodendroglial cell lineage. Notably 
this model would provide a means through which intrinsic and extrinsic cues are 
integrated in progenitors at the VZ, in order to promote oligodendroglial cell fate 
specification.  
  
  Interestingly, we found that genomic segments proximal to a number of 
Notch signalling genes, including Notch1 were bound by Mash1 protein in 
oligosphere cultures (Figure 20 and 26B). Canonical Notch signalling, mediated 
via binding of ligands, including Jagged 1-2 and Delta 1-4 to Notch1 and Notch2 
receptors, restricts OPC maturation in the developing CNS and is permissive for 
proliferation (Louvi and Artavanis-Tsakonas, 2006). Notch activation inhibits 
oligodendrocyte differentiation, as demonstrated in vitro in the developing rat 
optic nerve (Wang et al., 1998), and confirmed in vivo with Notch1 heterozygous 
mice, which show premature myelination (Givogri et al., 2002), and by specific 
ablation of Notch1 in oligodendrocytes, which ultimately affects the 
differentiation of precursors into immature oligodendrocyte cells (Genoud et al., 
2002). In this context Mash1 may function, in a cell autonomous manner, to 
prevent premature differentiation of newly born OPCs into oligodendrocytes, and  198 
allow OPCs to propagate. Note that regulation of Notch signalling pathway 
components are not specific to OPCs but also occur in neuronal precursors 
(Castro et al., 2006). 
 
  Finally, we also identified a genomic segment proximal to Bcan that was 
bound by Mash1 protein in oligosphere cultures (Figure 26B). Bcan is a neural 
specific CSPG from the lectin family, and is a major component of the 
extracellular matrix (Yamaguchi, 2000; Jaworski et al., 1994; Yamada et al., 
1994). Bcan is expressed in the VZ along the neuraxis of the developing embryo, 
and coincides with the onset of gliogenesis (Jaworski et al., 1995). Notably, Bcan 
expression is up-regulated in primary tumours and has been implicated in glioma 
cell invasion and thus glial cell motility (Jaworski et al., 1996; Zhang et al., 
1998). Furthermore, Bcan expression is up-regulated in response to acute brain 
injury, to suggest a role in reactive gliosis (Jaworski et al., 1999). Indeed, glial 
process extension, a central feature in the glial response to injury, may require 
the re-expression of both cytoskeletal and matrix elements that are normally 
expressed during glial motility in the developing brain. OPCs specified in the 
developing ventral telencephalon display a strong inherent migratory behaviour, 
we propose a model in which Mash1 regulates Bcan  expression early in the 
oligodendroglial lineage, and therefore may contribute to the molecular 
mechanisms that confer glial cell motility. To determine the requirement of 
Mash1 function in the migration of OPCs in the ventral telencephalon, 
Sox10Cre/ Mash1CDKO mice would be utilised, in order to remove Mash1 
function following OPC specification.  
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  Although locational analysis using Chip-on-chip generated detailed 
binding data in proximal promoter regions, no information on gene regulation in 
terms of expression can be extrapolated. Indeed, integration of gene expression 
data profiling the transition from neurosphere to oligosphere, with Mash1 
binding data from ChIP-on-chip experiments using chromatin prepared from 
neurospheres and oligospheres respectively, would allow the identification and 
categorisation of genomic regions bound by Mash1 that are proximal to either 
active or repressed genes, in two distinct cell states. To identify genes 
specifically expressed in OPCs, oligosphere cultures established from 
Sox10Cre/R26YFP transgenic mice, would be used to sort for GFP+ 
oligodendroglial lineage cells. We hypothesise that this type of analysis would 
display overlapping and mutually exclusive Mash1 binding events in 
neurosphere and oligosphere cultures, and reflect a bias towards oligodendroglial 
cell fate specification in the latter. In conjunction these data would facilitate the 
identification of genomic regions bound and regulated by Mash1 in OPCs.  
 
4.4 Olig2 binds to Mash1 enriched genomic regions  
 
  Olig2 locational analysis was performed in mouse oligosphere cultures, 
using a ChIP-PCR strategy, with primer specific sequences to genomic regions 
bound by Mash1 (Figure 44A). All genomic regions tested, including segments 
proximal to early OPC genes, Olig1 and Sox8; segments proximal to late/mature 
oligodendrocyte genes, Mog and Omg; segments proximal to genes of interest 
Notch1, Sulf1, and Bcan; and segments proximal to Mash1 neurogenic target  200 
genes  Tubb3  and  MAP2, were also bound by Olig2 protein in oligosphere 
cultures (Figure 44A). 
 
  Mash1 and Olig2 are coexpressed in progenitor cells and in OPCs at the 
time of their specification in the VZ of the developing ventral telencephalon 
(Parras et al., 2007).  In vitro studies have indicated that Mash1 can cooperate 
with Olig2 to activate the MBP promoter (Gokhan et al., 2005). In addition, 
Olig2 was shown to selectively promote the oligodendrogenic activities of 
Mash1 in gain of function studies in rat spinal cord neurosphere cultures 
(Sugimori et al., 2007). More recently, the requirement for Mash1 function for 
the specification of an early population of OPCs that involves a genetic 
interaction with Olig2 in the ventral telencepahlon was demonstrated (Parras et 
al., 2007). Nevertheless, whilst it is clear that Mash1 and Olig2 cooperate in 
oligodendroglial cell fate specification, the molecular mechanisms that underlie 
this synergy are yet to be detailed.  
  Currently, the interaction between activators and repressors on the same 
gene promoter is not well-understood. We hypothesise that two distinct types of 
interactions exist between Mash1 and Olig2 TFs on different regulatory 
elements, either synergistic or antagonistic on oligodendroglial or neuronal 
enhancers respectively (Figure 45). Olig2 functions as a transcriptional repressor 
to specify motor neuron and oligodendrocyte cell fate in the ventral spinal cord 
(Novitch et al, 2001; Mizuguchi et al 2001; Zhou 2001). Indeed these data have 
led to the proposal that Olig2 functions by repressing a repressor of 
oligodendrocyte development (Zhou et al., 2001). However, the possibility that 
Olig2 may also function as an activator to promote the oligodendrocyte fate can  201 
not be entirely excluded (Figure 45). We propose that Olig2 may repress Mash1 
neurogenic targets, either through competition to bind to E-box motifs or by 
heterodimersation with E47 and/or Mash1. In the developing ventral spinal cord, 
specifically within the pMN domain, Olig2 prevents premature expression of 
post-mitotic motor neuron genes (Lee et al., 2005). In this system gene specific 
repression is achieved through a combination of mechanisms, which include 
interactions with bifunctional activator/suppressor E-boxes in the promoter of the 
Hb9 gene, and formation of weak heterointeractions between Olig2 and E47 or 
Ngn2 (Lee et al., 2005). To determine whether this hypothesis is true, 
oligodendroglial and neuronal specific enhancers identified in transgenic 
embryos would be tested in luciferase reporter assays, in order to examine the 
synergy versus antagonism theory of Mash1 and Olig2 combinatorial activity on 



















Figure 45. Regulation of neuronal and oligodendroglial target genes by 
Olig2 and Mash1 activities. In the scheme arrows and T-bars define positive 
and inhibitory interactions on target promoters.  
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4.5 Sox9 binds to Notch1, Sox8, Omg and Mog Mash1 enriched genomic 
regions  
 
  Sox9 locational analysis was performed in mouse oligosphere cultures, 
using a ChIP-PCR strategy, with primer specific sequences to genomic regions 
bound by Mash1 (Figure 44B). Genomic regions tested, including segments 
proximal to early OPC genes, Olig1 and Sox8, segments proximal to late/mature 
oligodendrocyte genes, Mog and Omg, and segments proximal to a gene of 
interest Notch1 were all bound by Sox9 protein in oligosphere cultures (Figure 
44B). Note that unlike ChIP experiments using an antibody to Olig2, not all 
Mash1 bound elements were significantly enriched using an antibody to Sox9, 
including segments proximal to Bcan and Sulf1 genes (Figure 44B and schematic 
Figure 46). The biological significance of this difference in co-occupancy of 
























Figure 46. Mash1 binds to genomic elements that are also co-occupied by 
oligodendrocyte promoting TFs Olig2 and Sox9. Arrows represent occupancy. 
Yellow boxes (a-f) represent genomic elements.  
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  Mash1 and Sox9 are coexpressed in progenitor cells and in OPCs at the 
time of their specification in the VZ of the developing ventral telencephalon 
(Figure 10). Early in development, Sox9 plays a key role in the generation of 
OPCs from the pMN domain, and has been defined as a major molecular 
component of the neuron-glia switch in the developing spinal cord (Stolt et al., 
2003). Sox proteins bind to the minor groove of the DNA, and endorse the 
formation of multimeric protein complexes through modifications in DNA 
conformation, and thus impact on local chromatin remodelling (Wolffe, 1994; 
Werner and Burley, 1997). The SoxE group gene, Sox10 functions both as a 
DNA-binding protein and
 as a molecular scaffold to recruit bHLH heterodimers 
to activate gene expression on the MBP promoter (Gokhan et al., 2005).  We 
propose a hypothesis in which Sox9 functions to recruit Mash1 at 
oligodendroglial enhancers, contributing to the mechanism of discrimination 
between neuronal and oligodendroglial enhancers by Mash1 in neuronal versus 
oligodendroglial precursors respectively.  
 
4.6 Biological significance of Mash1 co-regulators 
 
  This study has highlighted the potential function of Mash1 beyond OPC 
specification, oligodendrocyte differentiation and myelination. Mash1 has 
multiple roles throughout neurogenesis, including neuronal and sub-type 
specification, cell cycle regulation, Notch signalling and neuronal migration 
(Bertrand et al., 2002). We hypothesise that Mash1 plays a number of different 
roles throughout oligodendrogenesis, similar to that in neurogenesis. Notably, the 
functions of Mash1 are likely to overlap in the neuronal and oligodendroglial  206 
lineages, and may include Notch signalling and migration. Recently, Sox9 and 
Sox10 TFs were shown to influence the survival and migration of OPCs in the 
developing spinal cord, through the regulation of PDGFR gene expression 
(Finzsch et al., 2008). Similarly, the role of Mash1 in the survival and migration 
of OPCs could be assayed with Sox10Cre/ Mash1CDKO animals, as described 
previously.  
 
  We propose that Mash1 interacts with different DNA-binding cofactors to 
activate different subprograms of oligodendrogenesis, as has been proposed for 
Mash1 in neurogenesis (Castro et al., 2006; Gholke et al., 2008), and MyoD 
during myogenesis (Tapscott, 2005). Notably, there is a huge biological 
advantage in adopting such mechanisms of action. Firstly, TF interactions with 
distinct DNA-binding partners on different promoters allow an array of target 
genes to be independently regulated, a phenomenon that is well studied in the 
myogenic program (Tapscott, 2005). Secondly, this mode of activity permits 
synchronisation of independently regulated developmental programs. TF 
interactions may also function to prevent overlap between dissimilar programs. 
Olig2 and Sox9 TFs function in cell proliferation and oligodendroglial cell fate 
specification, as well as in neurogenesis and astrogenesis for Olig2 and Sox9 
respectively (Charlie Scott, unpublished data; Lu et al., 2002: Hack et al., 2004; 
Stolt et al., 2003; Ligon et al., 2007). We propose that Olig2 and Sox9 TFs 
interact with different co-factors in order to coordinate incompatible 
developmental programs. We hypothesis that these TFs interact with Mash1 to 
promote the generation of OPCs, and that this mechanism may prevent 
premature oligodendroglial cell fate specification in neural precursor cells.   207 
 
  Mash1 functions in an instructive manner to induce oligodendroglial cell 
fate specification. However, although OPC numbers are drastically reduced in 
Mash1 null mutant embryos, they are not completely absent, and are gradually 
recovered later in development (Parras et al., 2007; Sugimori et al., 2007). These 
data suggest loss of Mash1 in OPCs may be compensated for by other TFs in the 
CNS, to suggest that Mash1 independent networks in oligodendroglial cell fate 
specification likely exist. Similarly, early in development Sox9-deficient spinal 
cords demonstrate a severe reduction in the numbers of OPCs, with very few 
OPCs remaining (Stolt et al., 2003). However, a recovery in OPC numbers was 
evident at later stages of development, perhaps resulting from compensatory 
activities of other SoxE group members, Sox10 and Sox8, whose expressions 
overlap with Sox9 in the oligodendrocyte lineage (Stolt et al., 2003). Notably 
these data highlight the heterogeneity in the transcriptional mechanisms 
governing oligodendroglial cell fate specification in the CNS.  
 
4.7 ChIP technology a general perspective for the future 
 
  In principle the ChIP-on-chip method permits the unbiased detection of 
DNA binding sites for proteins throughout the genome. It has the advantage of 
readily identifying target genes associated with bound promoters, avoiding the 
difficulties of identifying genes associated with bound distal elements in whole 
genome location analyses. However, since this approach is restricted to 
interrogating proximal promoter regions, it is difficult to determine whether the 
binding sites identified in this study were representative of the majority of the  208 
genomic binding sites for Mash1 in oligosphere cultures. Indeed analyses of 1% 
of the human genome, in order to identify functional elements, performed in the 
ENCyclopedia Of DNA Elements (ENCODE) pilot project and by the ENCODE 
Consortium and others (Birney et al., 2007; Bieda et al., 2006; Kim et al., 2005; 
ENCODE Project Consortium, 2004; Carroll et al., 2005) have demonstrated that 
the incidence of TFs that bind almost exclusively at proximal promoters are 
likely an exception. Instead, TFs may bind to diverse regions of the genome, 
which include extragenic regions distant from the TSS in addition to intragenic 
regions (reviewed Farnham, 2009). Evidently a more unbiased method, such as 
the recently developed ChIP coupled with next-generation sequencing 
techniques, referred to as ChIP-seq, would overcome these limitations. Recently, 
in vivo mapping of p300 binding, using ChIP-seq technology has been 
demonstrated to be a highly accurate means for identifying enhancers (Visel et 
al., 2009). Note p300 is a histone acetyltransferase that is frequently located at 
enhancer regions (Heintzman et al., 2007; Ogryzko et al., 1996). Indeed, 
locational analysis with the transcriptional coactivator p300 using chromatin 
prepared from oligosphere cultures would further assign functionality to the 
Mash1 binding data set.  
 
  It is hypothesised that distal binding sites regulate transcription via long-
range chromatin interactions. Indeed for these regions it is not yet possible to 
conclusively link a specific binding site with a specific target gene. Using 
methods such as chromosome conformation capture (3C), in order to identify 
chromosomal loops that result form long range protein–protein interactions 
(Dekker et al., 2002), would help to disclose a connection between an enhancer  209 
binding protein and the promoter of a distant gene. Recently, a new unbiased 
technology termed ChIA-PET (Chromatin Interaction Analysis using Paired End 
Tag sequencing) was developed to identify de novo chromatin interactions on a 
genome-wide scale, and furthermore to interrogate the influence of these 
interactions on transcriptional regulation (Fullwood et al., 2009). 
  A clear limitation to current ChIP methods are the large quantities of 
material required, which consequently limits the applicability of this technology 
for rare cell samples. Recently, a fast microChIP (muChIP) assay using only 
1,000 cells in combination with microarrays to generate a genome wide scan of 
histone modifications was described (Dahl et al., 2009). Notably, this new 
technology could be used to assay Mash1 occupancy in OPCs, following cell 
sorting analysis of ventral telencephalic tissue from Sox10Cre/Rosa26YFP 
embryos, in order to isolate GFP+ oligodendroglial cells. 
 
  We demonstrate that Mash1 binds close to TSSs, and thus likely regulates 
transcription at these sites by stabilizing TFs at the core promoter elements. 
Moreover, ChIP-seq experiments have shown that Mash1 is also capable of 
binding to distal regions (Diogo Castro, personal communication), at these sites 
Mash1 may regulate transcription by means of protein–protein interactions, 
perhaps by a loop formation mechanism, between distal complexes and the 
generic transcriptional machinery at TSSs. The discovery that regulatory regions 
are bound by combinations of different TFs resulted in the formation of a general 
concept, which states that TFs have a tendency to cluster in close proximity to 
cooperate in transcriptional regulatory activities (Mann & Carroll, 2002). We 
demonstrate that Olig2 and Sox9 TFs bind Mash1 enriched genomic elements in  210 
oligosphere cultures. However, it is difficult to prove that these TFs bind 
sequences simultaneously, rather than in different cells. To investigate promoter 
co-occupancy using sequential ChIP technology (Medeiros et al., 2009), 
consecutive immunoprecipitation of chromatin for one and then a second factor 
would be performed in order to demonstrate that binding of these TFs occurs in 
the same cell and on the same DNA molecule, suggestive of molecular 
interactions. In conclusion, comprehensive mapping of TF-binding sites, of 
oligodendrocyte promoting factors, including Mash1, Olig2 and Sox9 using a 
whole genome ChIP approach would identify important features of the 
transcriptional regulatory networks that define oligodendroglial cell identity. 
 
4.8 Transient transgenics a means to visualise enhancer activity in vivo  
 
  We exploit mouse transient transgenic technology using reporter 
constructs that include the regulatory element of interest, to visualise enhancer 
activity in vivo. Previously, the distal genomic segment to the early OPC gene 
Sox9 was shown to be bound by Mash1 protein in the mouse ventral 
telencephalon at E12.5 (Diogo Castro, personal communication). We have 
validated Mash1 binding of this element in oligosphere cultures (Figure 26B). 
Furthermore we demonstrated that the Sox9 distal enhancer element had the 
capacity to recapitulate part of Sox9 endogenous expression in vivo, including 
that in non-differentiated neural progenitors in the VZ of the ventral 
telencephalon and in PDGFR+ oligodendroglial lineage cells (Figure 38). To 
determine the requirement of specific binding sites within this element, including 
Mash1 type E-box motifs to drive reporter gene expression in transgenic  211 
embryos, site-directed mutagenesis would be employed as has been described 
previously (Castro et al., 2006). Furthermore, to test whether Mash1 function is 
required for the regulation of this enhancer, stable transgenic lines would be bred 
with  Mash1 null mutant mice and reporter gene activity assayed. Note the 
regulation by other oligodendroglial TFs, Sox9 and Olig2, could also be similarly 
assayed.  
 
  To establish a large-scale functional screen of noncoding sequences, 
which is both efficient and rapid, we are working towards a transgenic strategy in 
zebrafish based on the Tol2 transposon (Fisher et al., 2006). The Tol2 transposon 
identified in the teleost, Medaka, is a highly mobile element. Indeed, in the 
presence of transposase there is a significant increase in the efficiency of genome 
integration mediated by the transposon. To evaluate the regulatory potential of a 
candidate sequence, the desired PCR-amplified intervals flanked by Tol2 
transposon target sites, are injected into 1-2-cell zebrafish embryos and reporter 
activity analyzed at specific times throughout development. Notably, recent data 
demonstrates that this approach provides a high fidelity read out for the 
regulatory function of conserved non-coding Sox10 mouse sequences, even in the 
absence of overt sequence conservation between mammals and teleosts 
(Antonellis et al., 2008).  
 
  Identification of differentially regulated enhancers in oligodendroglial 
and neuronal cell lineages in vivo would provide a means in which to categorise 
these elements and further determine whether Mash1 lineage specific signature 
motifs exist. To identify motifs associated with Mash1 binding sites in the  212 
oligosphere cultures, a bioinformatics approach using validated software would 
be utilised. These include: Weeder, a software tool for the discovery of 
conserved TFBSs in sequences from co-regulated genes (Pavesi et al., 2001, 
2004); Trawler, an integrated pipeline for the analysis of ChIP data, to identify 
over-represented motifs (Ettwiller et al., 2007); and Pscan, a software tool that 
scans promoter sequences from
 co-regulated or co-expressed genes in search for 
over- or under-represented
  motifs, which also assigns TF binding specificity 
(Zambelli et al., 2009). Notably the formulation of an oligodendroglial specific 
motif would provide a framework on which to perform a genome wide in silco 
screen, in order to identify co-regulated genes in oligodendroglial cell fate 
specification.  
 
4.9 Conclusions and perspectives 
 
  Oligodendrogenesis is a complex process, and involves the generation of 
spatially and temporally separated populations that originate from molecularly 
distinct regions of the CNS (Richardson et al., 2006; Woodruff et al., 2001; 
Vallstedt et al., 2005; Cai et al., 2005; Ivanova et al., 2003; Spassky et al., 2001). 
Indeed, during development Mash1 function is specifically required for the 
specification of a subset of OPCs during the first wave of oligodendrogenesis in 
the ventral telencephalon (Parras et al., 2007), and in the spinal cord (Sugimori et 
al., 2007).  
 
  We have made an initial attempt to uncover the molecular mechanisms 
underlying Mash1 activity in oligodendrogenesis. In this study we demonstrate  213 
that Mash1 binds directly to regulatory elements of genes expressed early in 
specification events and late in differentiation and maturation of the 
oligodendroglial programme.  We propose that Mash1 functions at the top of a 
transcription hierarchy as a key factor, to orchestrate the expression of a wide 
repertoire of downstream genes in oligodendrogenesis. We hypothesise that 
Mash1 activity is temporally modulated by sequence specific co-regulators, 
which contribute to its recruitment to specific proximal promoter regions in 
different cell types.  
  In this study we demonstrated that Olig2 and Sox9 protein levels are 
significantly reduced in the VZ of the ventral telencephalon in Mash1 null 
mutants (Figure 35 and 37, respectively). These data corroborate with gene 
expression array studies using ventral telencephalic tissue from Mash1 null 
mutant embryos, in which Olig2 and Sox9 transcripts are also significant reduced 
(Carlos Parras, personal communication). Moreover, we have identified a distal 
Sox9 enhancer with activity in the oligodendroglial lineage (Figure 38C and D), 
which is bound by Mash1 in the ventral telencephalon at E12.5 (Diogo Castro, 
personal communication) and in oligosphere cultures (Figure 26B). Sox9 
overexpression in the chick spinal cord is sufficient to induce expression of the 
vital oligodendrocyte regulator Olig2 (Gaber and Novitch, unpublished data). On 
the basis of these data, we propose a potential feed-forward loop, in which 
Mash1 directly regulates Sox9 and both Mash1 and Sox9 regulate Olig2, either 
directly or indirectly through intermediates (Figure 47). Feed-forward loops 
confer certain advantages, indeed multiple inputs provide consistent activity that 
subsequently render it relatively insensitive to transient changes in individual 













Figure 47. A feed-forward loop in which Mash1 regulates Sox9 and both 
Mash1 and Sox9 regulate Olig2.  
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In conclusion this model functions as useful framework on which to map the 
gene regulatory network downstream of Mash1 in oligodendrogenesis. 
  
  Understanding how key factors control gene expression in the transition 
from a neural stem cell to an oligodendroglial cell during development is 
imperative. The progression in oligodendroglial cell fate commitment requires 
the temporal activation of a unique transcription program. Indeed deconstructing 
the molecular mechanisms in this transition would provide a means to direct 
neural stem cells towards an oligodendroglial cell identity, a vital process for 
therapeutic transplantation strategies to treat demyelinating diseases. The recent 
surge in the identification of TF binding events on a genome wide scale has 
revealed the existence of complex gene regulatory networks. Understanding the 
mechanisms that underlie the interactions between TFs and chromatin, in 
particular how the epigenetic state of chromatin controls the specificity of factor 
recruitment and subsequently alters the permissiveness to transcription activity in 
addition to the requirement and function of a combinatorial code of co-regulators 
will prove to be the next challenging steps.  
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